{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":2980,"total_is_capped":false,"direct_labels_cover":12,"predictions_cover":2980,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"6147ccd71970","filters":{"topic":"Cancer Immunotherapy and Biomarkers"}},"results":[{"id":"W2527905628","doi":"10.1056/nejmoa1606774","title":"Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer","year":2016,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":10101,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Kingston General Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Lung cancer; Internal medicine; Hazard ratio; Oncology; Chemotherapy; Cancer; Gastroenterology; Confidence interval; Immunotherapy","authors":[{"name":"Martin Reck","is_ca":false},{"name":"Delvys Rodríguez‐Abreu","is_ca":false},{"name":"Andrew Robinson","is_ca":true},{"name":"Rina Hui","is_ca":false},{"name":"Tibor Csőszi","is_ca":false},{"name":"Andrea Fülöp","is_ca":false},{"name":"Maya Gottfried","is_ca":false},{"name":"Nir Peled","is_ca":false},{"name":"Ali Tafreshi","is_ca":false},{"name":"Sinéad Cuffe","is_ca":false},{"name":"Mary O’Brien","is_ca":false},{"name":"Suman Rao","is_ca":false},{"name":"Katsuyuki Hotta","is_ca":false},{"name":"Melanie A. Leiby","is_ca":false},{"name":"Gregory M. Lubiniecki","is_ca":false},{"name":"Yue Shentu","is_ca":false},{"name":"Reshma Rangwala","is_ca":false},{"name":"Julie R. Brahmer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01779133937735275,"gpt":0.3044793150951555,"spread":0.2866879757178028,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002308439,0.0006270246,0.002030534,0.0004499498,0.0002998387,0.0005936326,0.0004813695,0.001089221,0.004202615],"category_scores_gemma":[0.003058453,0.0003007109,0.001273606,0.0002697822,0.000687104,0.0007579654,0.0003108952,0.001894058,0.0004279195],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008319173,"about_ca_system_score_gemma":0.001052031,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004650641,"about_ca_topic_score_gemma":0.001084554,"domain_scores_codex":[0.9988316,0.0007548305,0.00008984653,0.0001428265,0.00007265717,0.0001082714],"domain_scores_gemma":[0.9981855,0.0009300206,0.0003262708,0.00006903888,0.00004868228,0.0004405128],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9481348,0.005690425,0.0008681286,0.0004169563,0.0005752858,0.00003161538,0.00005493194,0.000880319,0.002801542,0.0001708539,0.0004027853,0.03997241],"study_design_scores_gemma":[0.7004181,0.2869536,0.006479701,0.0001243231,0.0007377037,0.00009014857,0.0000325138,0.001873604,0.001175881,0.000580871,0.001512029,0.00002161445],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900292,0.005336107,0.0006442705,0.000500648,0.0003778304,0.001517227,0.0002012057,0.00003975352,0.001353828],"genre_scores_gemma":[0.995587,0.001190705,0.0006805165,0.0004056404,0.0002071333,0.001238723,0.0001364379,0.000006500113,0.0005475331],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004202615,"threshold_uncertainty_score":0.01405913,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2166662937","doi":"10.1056/nejmoa1504030","title":"Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma","year":2015,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":8144,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hotel Dieu Hospital","funders":"National Cancer Institute","keywords":"Nivolumab; Ipilimumab; Medicine; Melanoma; Oncology; Metastatic melanoma; Internal medicine; Dermatology; Immunotherapy; Cancer research; Cancer","authors":[{"name":"James Larkin","is_ca":false},{"name":"Vanna Chiarion‐Sileni","is_ca":false},{"name":"René González","is_ca":false},{"name":"Jean‐Jacques Grob","is_ca":false},{"name":"C. Lance Cowey","is_ca":false},{"name":"Christopher D. Lao","is_ca":false},{"name":"Dirk Schadendorf","is_ca":false},{"name":"Reinhard Dummer","is_ca":false},{"name":"Michael Smylie","is_ca":false},{"name":"Piotr Rutkowski","is_ca":false},{"name":"Pier Francesco Ferrucci","is_ca":false},{"name":"Andrew Hill","is_ca":false},{"name":"John Wagstaff","is_ca":false},{"name":"Matteo S. Carlino","is_ca":false},{"name":"John B.A.G. Haanen","is_ca":false},{"name":"Michele Maio","is_ca":false},{"name":"Iván Márquez‐Rodas","is_ca":false},{"name":"Grant A. McArthur","is_ca":false},{"name":"Paolo A. Ascierto","is_ca":false},{"name":"Georgina V. Long","is_ca":false},{"name":"Margaret K. Callahan","is_ca":false},{"name":"Michael A. Postow","is_ca":false},{"name":"Kenneth F. Grossmann","is_ca":false},{"name":"Mario Sznol","is_ca":false},{"name":"Brigitte Dréno","is_ca":true},{"name":"Lars Bastholt","is_ca":false},{"name":"Arvin Yang","is_ca":false},{"name":"Linda M. Rollin","is_ca":false},{"name":"Christine E. Horak","is_ca":false},{"name":"F. Stephen Hodi","is_ca":false},{"name":"Jedd D. Wolchok","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03693018645658255,"gpt":0.2979048351264862,"spread":0.2609746486699037,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001482531,0.0006086729,0.00187591,0.0004906123,0.0002493568,0.0005792086,0.0005276426,0.0005856596,0.002273006],"category_scores_gemma":[0.001412981,0.0003716011,0.0009536662,0.000328609,0.0003929242,0.0005320949,0.0003661099,0.001173271,0.0004077682],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008348993,"about_ca_system_score_gemma":0.0008924744,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007281049,"about_ca_topic_score_gemma":0.002115632,"domain_scores_codex":[0.999209,0.0004334119,0.0000577395,0.0001392918,0.00007499525,0.00008549343],"domain_scores_gemma":[0.9993683,0.000243364,0.00009973144,0.00004877726,0.0000219767,0.0002180403],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7041777,0.01581324,0.01238966,0.001430641,0.004382761,0.0003363854,0.0002735594,0.004265074,0.03142558,0.0003260285,0.001353869,0.2238256],"study_design_scores_gemma":[0.2191222,0.7053751,0.0472942,0.0003355589,0.003566604,0.0006300131,0.0001313026,0.004712111,0.01048754,0.0008909121,0.007379352,0.00007518422],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918087,0.006034349,0.0002614172,0.0001446865,0.0001722692,0.000223571,0.0001153409,0.00002465508,0.001215019],"genre_scores_gemma":[0.9964864,0.001733206,0.0004968474,0.0001903979,0.0001417978,0.0002034989,0.0001489611,0.000007029363,0.0005917201],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002273006,"threshold_uncertainty_score":0.007840455,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2796582438","doi":"10.1056/nejmoa1801005","title":"Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer","year":2018,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":6613,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Merck","keywords":"Pembrolizumab; Chemotherapy; Lung cancer; Medicine; Oncology; Internal medicine; Cancer; Immunotherapy","authors":[{"name":"Leena Gandhi","is_ca":false},{"name":"Delvys Rodríguez‐Abreu","is_ca":false},{"name":"Shirish M. Gadgeel","is_ca":false},{"name":"Emilio Esteban","is_ca":false},{"name":"Enriqueta Felip","is_ca":false},{"name":"Flávia De Angelis","is_ca":false},{"name":"Manuel Dómine","is_ca":false},{"name":"Philip R. Clingan","is_ca":false},{"name":"Maximilian J. Hochmair","is_ca":false},{"name":"Steven Powell","is_ca":false},{"name":"Susanna Y. Cheng","is_ca":true},{"name":"Helge Bischoff","is_ca":false},{"name":"Nir Peled","is_ca":false},{"name":"Francesco Grossi","is_ca":false},{"name":"Ross Jennens","is_ca":false},{"name":"Martin Reck","is_ca":false},{"name":"Rina Hui","is_ca":false},{"name":"Edward B. Garon","is_ca":false},{"name":"Michael Boyer","is_ca":false},{"name":"Belén Rubio‐Viqueira","is_ca":false},{"name":"Silvia Novello","is_ca":false},{"name":"Takayasu Kurata","is_ca":false},{"name":"Jhanelle E. Gray","is_ca":false},{"name":"John Vida","is_ca":false},{"name":"Ziwen Wei","is_ca":false},{"name":"Jing Yang","is_ca":false},{"name":"Harry Raftopoulos","is_ca":false},{"name":"M. Catherine Pietanza","is_ca":false},{"name":"Marina Chiara Garassino","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01975310630683914,"gpt":0.3120918999598457,"spread":0.2923387936530065,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002149055,0.0003984757,0.001414144,0.0003414786,0.0002174911,0.000287315,0.0003589094,0.0004797927,0.001910802],"category_scores_gemma":[0.003012876,0.0002691487,0.0006203543,0.0003850163,0.0004140425,0.0003184328,0.0002967295,0.001055769,0.0002772533],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006237773,"about_ca_system_score_gemma":0.000704916,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000626358,"about_ca_topic_score_gemma":0.001238239,"domain_scores_codex":[0.9988425,0.0007904429,0.00008557749,0.0001211674,0.0001068308,0.00005347223],"domain_scores_gemma":[0.9989343,0.0005345494,0.0002222684,0.00005647919,0.0000332304,0.000219058],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7994949,0.009483032,0.005831027,0.001753233,0.001320189,0.000128146,0.000102501,0.00366938,0.007810586,0.0002942646,0.0008574247,0.1692553],"study_design_scores_gemma":[0.4999373,0.4562846,0.02921075,0.0002105433,0.001430111,0.0003990839,0.00003204459,0.004560297,0.002625062,0.0006569016,0.004622958,0.00003031307],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886108,0.007852877,0.0006011855,0.0003344637,0.000191094,0.001165916,0.0001201286,0.00002081585,0.001102773],"genre_scores_gemma":[0.9942865,0.003191142,0.0008111283,0.0001862655,0.0001595917,0.000713174,0.0001116721,0.000003669425,0.0005369978],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002149055,"threshold_uncertainty_score":0.01136547,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1982488143","doi":"10.1056/nejmoa1501824","title":"Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer","year":2015,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":6228,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Lung cancer; Oncology; Internal medicine; PD-L1; Cancer; Immunotherapy","authors":[{"name":"Edward B. Garon","is_ca":false},{"name":"Naiyer A. Rizvi","is_ca":false},{"name":"Rina Hui","is_ca":false},{"name":"Natasha B. Leighl","is_ca":true},{"name":"Ani Sarkis Balmanoukian","is_ca":false},{"name":"Joseph P. Eder","is_ca":false},{"name":"Amita Patnaik","is_ca":false},{"name":"Charu Aggarwal","is_ca":false},{"name":"Matthew A. Gubens","is_ca":false},{"name":"Leora Horn","is_ca":false},{"name":"Enric Carcereny","is_ca":false},{"name":"Myung‐Ju Ahn","is_ca":false},{"name":"Enriqueta Felip","is_ca":false},{"name":"Jong-Seok Lee","is_ca":false},{"name":"Matthew D. Hellmann","is_ca":false},{"name":"Omid Hamid","is_ca":false},{"name":"Jonathan W. Goldman","is_ca":false},{"name":"Jean‐Charles Soria","is_ca":false},{"name":"Marisa Dolled‐Filhart","is_ca":false},{"name":"Ruth Z. Rutledge","is_ca":false},{"name":"Jin Zhang","is_ca":false},{"name":"Jared Lunceford","is_ca":false},{"name":"Reshma Rangwala","is_ca":false},{"name":"Gregory M. Lubiniecki","is_ca":false},{"name":"Charlotte Roach","is_ca":false},{"name":"Kenneth Emancipator","is_ca":false},{"name":"Leena Gandhi","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03835118192736064,"gpt":0.3276515059079407,"spread":0.28930032398058,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009839737,0.0002503118,0.0004701889,0.0001819092,0.000231401,0.0001758949,0.0002502686,0.0002291245,0.001123612],"category_scores_gemma":[0.0006061216,0.0000878493,0.0002659441,0.0001796761,0.0001803656,0.0001377628,0.0001270572,0.0005297756,0.0002008971],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006024201,"about_ca_system_score_gemma":0.0005665041,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006455207,"about_ca_topic_score_gemma":0.001995226,"domain_scores_codex":[0.9997991,0.000094929,0.00001606273,0.00002788407,0.00003650643,0.00002562057],"domain_scores_gemma":[0.9997165,0.0001025459,0.00007411469,0.00001622126,0.00002599359,0.00006459543],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.07174838,0.008541657,0.1834984,0.001764028,0.001110942,0.0009142325,0.0003740827,0.003684347,0.1333806,0.0003346227,0.003767588,0.590881],"study_design_scores_gemma":[0.0434292,0.1815488,0.7054225,0.0003010211,0.001350848,0.003983507,0.0001352069,0.008076943,0.02997601,0.0004287125,0.02530907,0.00003808351],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.99317,0.005080255,0.0003042855,0.0002681658,0.0000255936,0.0002581571,0.0001120281,0.00001415515,0.0007673813],"genre_scores_gemma":[0.9968874,0.001567468,0.0007370246,0.0001548951,0.00004104547,0.0001168837,0.0002127873,0.0000016879,0.0002809323],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001123612,"threshold_uncertainty_score":0.005203784,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2796207838","doi":"10.1016/j.immuni.2018.03.023","title":"The Immune Landscape of Cancer","year":2018,"lang":"en","type":"article","venue":"Immunity","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":6191,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Mount Sinai Hospital; University of Calgary; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"U.S. National Library of Medicine; National Institute of Environmental Health Sciences; National Cancer Institute; U.S. Department of Health and Human Services; National Institutes of Health; National Institute of General Medical Sciences; Cancer Research Institute; National Human Genome Research Institute; U.S. Department of Defense","keywords":"Biology; Immune system; Neuroblastoma RAS viral oncogene homolog; Epigenetics; FOXP3; Cancer research; Immunology; Melanoma; Cancer; Epigenome; KRAS; Gene; Genetics; Gene expression; DNA methylation; Colorectal cancer","authors":[{"name":"Vésteinn Thórsson","is_ca":false},{"name":"David L. Gibbs","is_ca":false},{"name":"Scott D. Brown","is_ca":true},{"name":"Denise M. Wolf","is_ca":false},{"name":"Dante S. Bortone","is_ca":false},{"name":"Tai-Hsien Ou Yang","is_ca":false},{"name":"Eduard Porta‐Pardo","is_ca":false},{"name":"Christopher Plaisier","is_ca":false},{"name":"James A. Eddy","is_ca":false},{"name":"Elad Ziv","is_ca":false},{"name":"Aedín C. Culhane","is_ca":false},{"name":"Evan Paull","is_ca":false},{"name":"I.K. Ashok Sivakumar","is_ca":false},{"name":"Andrew J. Gentles","is_ca":false},{"name":"Raunaq Malhotra","is_ca":false},{"name":"Farshad Farshidfar","is_ca":true},{"name":"Antonio Colaprico","is_ca":false},{"name":"Joel S. Parker","is_ca":false},{"name":"Lisle E. Mose","is_ca":false},{"name":"Nam S. Vo","is_ca":false},{"name":"Jianfang Liu","is_ca":false},{"name":"Yuexin Liu","is_ca":false},{"name":"Janet S. Rader","is_ca":false},{"name":"Varsha Dhankani","is_ca":false},{"name":"Sheila M. Reynolds","is_ca":false},{"name":"Reanne Bowlby","is_ca":true},{"name":"Andrea Califano","is_ca":false},{"name":"Andrew D. Cherniack","is_ca":false},{"name":"Dimitris Anastassiou","is_ca":false},{"name":"Davide Bedognetti","is_ca":false},{"name":"Younes Mokrab","is_ca":false},{"name":"Aaron M. Newman","is_ca":false},{"name":"Arvind Rao","is_ca":false},{"name":"Ken Chen","is_ca":false},{"name":"Alexander Krasnitz","is_ca":false},{"name":"Hai Hu","is_ca":false},{"name":"Tathiane M. Malta","is_ca":false},{"name":"Houtan Noushmehr","is_ca":false},{"name":"Chandra Sekhar Pedamallu","is_ca":false},{"name":"Susan Bullman","is_ca":false},{"name":"Akinyemi I. Ojesina","is_ca":false},{"name":"Andrew Lamb","is_ca":false},{"name":"Wanding Zhou","is_ca":false},{"name":"Hui Shen","is_ca":false},{"name":"Toni K. Choueiri","is_ca":false},{"name":"John N. Weinstein","is_ca":false},{"name":"Justin Guinney","is_ca":false},{"name":"Joel Saltz","is_ca":false},{"name":"Robert A. Holt","is_ca":true},{"name":"Charles S. Rabkin","is_ca":false},{"name":"Rory Johnson","is_ca":false},{"name":"John A. Demchok","is_ca":false},{"name":"Ina Felau","is_ca":true},{"name":"Melpomeni Kasapi","is_ca":false},{"name":"Martin L. Ferguson","is_ca":false},{"name":"Carolyn M. Hutter","is_ca":false},{"name":"Heidi J. Sofia","is_ca":false},{"name":"Roy Tarnuzzer","is_ca":false},{"name":"Zhining Wang","is_ca":false},{"name":"Liming Yang","is_ca":false},{"name":"Jean C. Zenklusen","is_ca":false},{"name":"Jiashan Zhang","is_ca":false},{"name":"Sudha Chudamani","is_ca":false},{"name":"Jia Liu","is_ca":false},{"name":"Laxmi Lolla","is_ca":false},{"name":"Rashi Naresh","is_ca":false},{"name":"Todd Pihl","is_ca":false},{"name":"Qiang Sun","is_ca":false},{"name":"Yunhu Wan","is_ca":false},{"name":"Ye Wu","is_ca":false},{"name":"Juok Cho","is_ca":false},{"name":"Timothy Defreitas","is_ca":false},{"name":"Scott Frazer","is_ca":false},{"name":"Nils Gehlenborg","is_ca":false},{"name":"Gad Getz","is_ca":false},{"name":"David I. Heiman","is_ca":false},{"name":"Michael S. Lawrence","is_ca":false},{"name":"Pei Lin","is_ca":true},{"name":"Michael S. Noble","is_ca":false},{"name":"Gordon Saksena","is_ca":false},{"name":"Doug Voet","is_ca":false},{"name":"Hailei Zhang","is_ca":false},{"name":"Brady Bernard","is_ca":false},{"name":"Nyasha Chambwe","is_ca":false},{"name":"Theo Knijnenburg","is_ca":false},{"name":"Roger Kramer","is_ca":false},{"name":"Kalle Leinonen","is_ca":false},{"name":"Michael Miller","is_ca":false},{"name":"Ilya Shmulevich","is_ca":false},{"name":"Wei Zhang","is_ca":false},{"name":"Rehan Akbani","is_ca":false},{"name":"Bradley M. Broom","is_ca":false},{"name":"Apurva M. Hegde","is_ca":false},{"name":"Zhenlin Ju","is_ca":false},{"name":"Rupa S. Kanchi","is_ca":false},{"name":"Anil Korkut","is_ca":false},{"name":"Jun Li","is_ca":false},{"name":"Han Liang","is_ca":false},{"name":"Shiyun Ling","is_ca":false},{"name":"Wenbin Liu","is_ca":false},{"name":"Yiling Lu","is_ca":false},{"name":"Gordon B. Mills","is_ca":false},{"name":"Kwok-Shing Ng","is_ca":true},{"name":"Michael P. Ryan","is_ca":false},{"name":"Jing Wang","is_ca":false},{"name":"Jiexin Zhang","is_ca":false},{"name":"Adam Abeshouse","is_ca":false},{"name":"Joshua Armenia","is_ca":false},{"name":"Debyani Chakravarty","is_ca":false},{"name":"Walid K. Chatila","is_ca":false},{"name":"Ino de Bruijn","is_ca":false},{"name":"Galen F. Gao","is_ca":false},{"name":"Benjamin Groß","is_ca":false},{"name":"Zachary Heins","is_ca":false},{"name":"Ritika Kundra","is_ca":false},{"name":"Konnor La","is_ca":false},{"name":"Marc Ladanyi","is_ca":false},{"name":"Augustin Luna","is_ca":false},{"name":"Moriah G. Nissan","is_ca":false},{"name":"Angelica Ochoa","is_ca":false},{"name":"Sarah Phillips","is_ca":false},{"name":"Ed Reznik","is_ca":false},{"name":"Francisco Sánchez-Vega","is_ca":false},{"name":"Chris Sander","is_ca":false},{"name":"Nikolaus Schultz","is_ca":false},{"name":"Robert P. Sheridan","is_ca":false},{"name":"S. Onur Sumer","is_ca":false},{"name":"Yichao Sun","is_ca":false},{"name":"Barry S. Taylor","is_ca":false},{"name":"Jioajiao Wang","is_ca":false},{"name":"Hongxin Zhang","is_ca":false},{"name":"Pavana Anur","is_ca":true},{"name":"Myron Peto","is_ca":false},{"name":"Paul T. Spellman","is_ca":false},{"name":"Christopher C. Benz","is_ca":false},{"name":"Joshua M. Stuart","is_ca":false},{"name":"Christopher K. Wong","is_ca":false},{"name":"Christina Yau","is_ca":false},{"name":"D. Neil Hayes","is_ca":false},{"name":"Matthew D. Wilkerson","is_ca":false},{"name":"Adrian Ally","is_ca":false},{"name":"Miruna Balasundaram","is_ca":false},{"name":"Denise Brooks","is_ca":false},{"name":"Rebecca Carlsen","is_ca":false},{"name":"Eric Chuah","is_ca":false},{"name":"Noreen Dhalla","is_ca":false},{"name":"Steven J.M. Jones","is_ca":true},{"name":"Darlene Lee","is_ca":false},{"name":"Yussanne Ma","is_ca":false},{"name":"Marco A. Marra","is_ca":false},{"name":"Michael Mayo","is_ca":true},{"name":"Richard A. Moore","is_ca":false},{"name":"Andrew J. Mungall","is_ca":false},{"name":"Karen Mungall","is_ca":false},{"name":"A. Gordon Robertson","is_ca":false},{"name":"Sara Sadeghi","is_ca":false},{"name":"Jacqueline E. Schein","is_ca":false},{"name":"Payal Sipahimalani","is_ca":false},{"name":"Angela Tam","is_ca":false},{"name":"Nina Thiessen","is_ca":false},{"name":"Kane Tse","is_ca":false},{"name":"Tina Wong","is_ca":false},{"name":"Ashton C. Berger","is_ca":false},{"name":"Rameen Beroukhim","is_ca":false},{"name":"Carrie Cibulskis","is_ca":false},{"name":"Stacey Gabriel","is_ca":false},{"name":"Gavin Ha","is_ca":false},{"name":"Matthew Meyerson","is_ca":false},{"name":"Steven E. Schumacher","is_ca":false},{"name":"Juliann Shih","is_ca":false},{"name":"Melanie H. Kucherlapati","is_ca":false},{"name":"Raju Kucherlapati","is_ca":false},{"name":"Stephen B. Baylin","is_ca":false},{"name":"Leslie Cope","is_ca":false},{"name":"Ludmila Danilova","is_ca":false},{"name":"Phillip H. Lai","is_ca":false},{"name":"Dennis T. Maglinte","is_ca":false},{"name":"David Van Den Berg","is_ca":false},{"name":"Daniel J. Weisenberger","is_ca":false},{"name":"J. Todd Auman","is_ca":false},{"name":"Saianand Balu","is_ca":false},{"name":"Tom Bodenheimer","is_ca":false},{"name":"Katherine A. Hoadley","is_ca":false},{"name":"Alan P. Hoyle","is_ca":false},{"name":"Corbin D. Jones","is_ca":false},{"name":"Shaowu Meng","is_ca":false},{"name":"Piotr A. Mieczkowski","is_ca":false},{"name":"Amy H. Perou","is_ca":false},{"name":"Charles M. Perou","is_ca":false},{"name":"Jeffrey Roach","is_ca":false},{"name":"Yan Shi","is_ca":false},{"name":"Janae V. Simons","is_ca":false},{"name":"Tara Skelly","is_ca":false},{"name":"Matthew G. Soloway","is_ca":false},{"name":"Donghui Tan","is_ca":false},{"name":"Umadevi Veluvolu","is_ca":false},{"name":"Huihui Fan","is_ca":true},{"name":"Toshinori Hinoue","is_ca":false},{"name":"Peter W. Laird","is_ca":false},{"name":"Michelle Bellair","is_ca":false},{"name":"Kyle Chang","is_ca":false},{"name":"Kyle R. Covington","is_ca":false},{"name":"Chad J. Creighton","is_ca":false},{"name":"Huyen Dinh","is_ca":false},{"name":"HarshaVardhan Doddapaneni","is_ca":false},{"name":"Lawrence A. Donehower","is_ca":false},{"name":"Jennifer Drummond","is_ca":false},{"name":"Richard A. Gibbs","is_ca":false},{"name":"Robert Glenn","is_ca":false},{"name":"Walker Hale","is_ca":false},{"name":"Yi Han","is_ca":false},{"name":"Viktoriya Korchina","is_ca":false},{"name":"Lora Lewis","is_ca":true},{"name":"Wei Li","is_ca":false},{"name":"Xiuping Liu","is_ca":false},{"name":"Margaret Morgan","is_ca":false},{"name":"Donna Morton","is_ca":false},{"name":"Donna M. Muzny","is_ca":false},{"name":"Jireh Santibanez","is_ca":false},{"name":"Margi Sheth","is_ca":true},{"name":"Eve Shinbrot","is_ca":false},{"name":"Linghua Wang","is_ca":false},{"name":"Min Wang","is_ca":false},{"name":"David A. Wheeler","is_ca":false},{"name":"Liu Xi","is_ca":false},{"name":"Fengmei Zhao","is_ca":false},{"name":"Julian M. Hess","is_ca":false},{"name":"Elizabeth L. Appelbaum","is_ca":false},{"name":"Matthew H. Bailey","is_ca":false},{"name":"Matthew G. Cordes","is_ca":false},{"name":"Li Ding","is_ca":false},{"name":"Catrina C. Fronick","is_ca":false},{"name":"Lucinda A. Fulton","is_ca":false},{"name":"Robert S. Fulton","is_ca":false},{"name":"Cyriac Kandoth","is_ca":false},{"name":"Elaine R. Mardis","is_ca":false},{"name":"Michael D. McLellan","is_ca":false},{"name":"Christopher A. Miller","is_ca":false},{"name":"Heather K. Schmidt","is_ca":false},{"name":"Richard K. Wilson","is_ca":false},{"name":"Daniel Crain","is_ca":false},{"name":"Erin Curley","is_ca":false},{"name":"Johanna Gardner","is_ca":false},{"name":"Kevin Lau","is_ca":false},{"name":"David Mallery","is_ca":false},{"name":"Scott Morris","is_ca":false},{"name":"Joseph Paulauskis","is_ca":false},{"name":"Robert Penny","is_ca":false},{"name":"Candace Shelton","is_ca":false},{"name":"Troy Shelton","is_ca":false},{"name":"Mark E. Sherman","is_ca":false},{"name":"Eric Thompson","is_ca":true},{"name":"Peggy Yena","is_ca":false},{"name":"Jay Bowen","is_ca":true},{"name":"Julie M. Gastier-Foster","is_ca":false},{"name":"Mark Gerken","is_ca":false},{"name":"Kristen M. Leraas","is_ca":false},{"name":"Tara M. Lichtenberg","is_ca":false},{"name":"Nilsa C. Ramirez","is_ca":false},{"name":"Lisa Wise","is_ca":false},{"name":"Erik Zmuda","is_ca":false},{"name":"Niall M. Corcoran","is_ca":false},{"name":"Tony Costello","is_ca":false},{"name":"Christopher M. Hovens","is_ca":false},{"name":"André Lopes Carvalho","is_ca":false},{"name":"Ana Carolina de Carvalho","is_ca":false},{"name":"José Humberto Tavares Guerreiro Fregnani","is_ca":false},{"name":"Adhemar Longatto‐Filho","is_ca":false},{"name":"Rui Manuel Reis","is_ca":false},{"name":"Cristovam Scapulatempo‐Neto","is_ca":false},{"name":"Henrique C.S. Silveira","is_ca":false},{"name":"Daniel Onofre Vidal","is_ca":false},{"name":"Andrew Burnette","is_ca":false},{"name":"Jennifer Eschbacher","is_ca":false},{"name":"Beth Hermes","is_ca":false},{"name":"Ardene Noss","is_ca":false},{"name":"Rosy Singh","is_ca":false},{"name":"Matthew L. Anderson","is_ca":false},{"name":"Patricia D. Castro","is_ca":false},{"name":"Michael Ittmann","is_ca":false},{"name":"David Huntsman","is_ca":true},{"name":"Bernard Kohl","is_ca":false},{"name":"Xuan Le","is_ca":false},{"name":"Richard Thorp","is_ca":false},{"name":"Chris Andry","is_ca":false},{"name":"Elizabeth R. Duffy","is_ca":false},{"name":"Vladimir Lyadov","is_ca":false},{"name":"Oxana Paklina","is_ca":false},{"name":"Galiya Setdikova","is_ca":false},{"name":"Shabunin Av","is_ca":false},{"name":"Mikhail Tavobilov","is_ca":false},{"name":"Christopher McPherson","is_ca":false},{"name":"Ronald E. Warnick","is_ca":false},{"name":"Ross S. Berkowitz","is_ca":false},{"name":"Daniel Cramer","is_ca":false},{"name":"Colleen M. Feltmate","is_ca":false},{"name":"Neil S. Horowitz","is_ca":false},{"name":"Adam S. Kibel","is_ca":false},{"name":"Michael G. Muto","is_ca":false},{"name":"Chandrajit P. Raut","is_ca":false},{"name":"Andrei Malykh","is_ca":false},{"name":"Jill S. Barnholtz‐Sloan","is_ca":false},{"name":"Wendi Barrett","is_ca":false},{"name":"Karen Devine","is_ca":false},{"name":"Jordonna Fulop","is_ca":false},{"name":"Quinn T. Ostrom","is_ca":false},{"name":"Kristen Shimmel","is_ca":false},{"name":"Yingli Wolinsky","is_ca":false},{"name":"Andrew E. Sloan","is_ca":false},{"name":"Agostino Maria De Rose","is_ca":false},{"name":"Felice Giuliante","is_ca":false},{"name":"Marc T. Goodman","is_ca":false},{"name":"Beth Y. Karlan","is_ca":false},{"name":"Curt H. Hagedorn","is_ca":false},{"name":"John Eckman","is_ca":false},{"name":"Jodi Harr","is_ca":false},{"name":"Jerome K. Myers","is_ca":false},{"name":"Kelinda Tucker","is_ca":false},{"name":"Leigh Anne Zach","is_ca":false},{"name":"Brenda Deyarmin","is_ca":false},{"name":"Leonid Kvecher","is_ca":false},{"name":"Caroline Larson","is_ca":false},{"name":"Richard Mural","is_ca":false},{"name":"Stella Somiari","is_ca":false},{"name":"Aleš Vícha","is_ca":false},{"name":"Tomáš Zelinka","is_ca":false},{"name":"Joseph Bennett","is_ca":false},{"name":"Mary Iacocca","is_ca":false},{"name":"Brenda Rabeno","is_ca":false},{"name":"Patricia Swanson","is_ca":false},{"name":"Mathieu Latour","is_ca":false},{"name":"Louis Lacombe","is_ca":false},{"name":"Bernard Têtu","is_ca":false},{"name":"Alain Bergeron","is_ca":false},{"name":"Mary McGraw","is_ca":false},{"name":"Susan M. Staugaitis","is_ca":false},{"name":"John A. Chabot","is_ca":false},{"name":"Hanina Hibshoosh","is_ca":false},{"name":"Antonia R. Sepulveda","is_ca":false},{"name":"Tao Su","is_ca":false},{"name":"Timothy C. Wang","is_ca":false},{"name":"Olga Potapova","is_ca":false},{"name":"Olga L. Voronina","is_ca":false},{"name":"Laurence Desjardins","is_ca":false},{"name":"Odette Mariani","is_ca":false},{"name":"Sergio Roman‐Roman","is_ca":false},{"name":"Xavier Sastre","is_ca":false},{"name":"Marc‐Henri Stern","is_ca":false},{"name":"Feixiong Cheng","is_ca":false},{"name":"Sabina Signoretti","is_ca":false},{"name":"Andrew Berchuck","is_ca":false},{"name":"Darell D. Bigner","is_ca":false},{"name":"Eric Lipp","is_ca":false},{"name":"Jeffrey S. Marks","is_ca":false},{"name":"Shannon J. McCall","is_ca":false},{"name":"Roger E. McLendon","is_ca":false},{"name":"Angeles Alvarez Secord","is_ca":false},{"name":"Alexis Sharp","is_ca":false},{"name":"Madhusmita Behera","is_ca":false},{"name":"Daniel J. Brat","is_ca":false},{"name":"Amy Chen","is_ca":false},{"name":"Keith A. Delman","is_ca":false},{"name":"Seth Force","is_ca":false},{"name":"Fadlo R. Khuri","is_ca":false},{"name":"Kelly R. Magliocca","is_ca":false},{"name":"Shishir K. Maithel","is_ca":false},{"name":"Jeffrey J. Olson","is_ca":false},{"name":"Taofeek K. Owonikoko","is_ca":false},{"name":"Alan Pickens","is_ca":false},{"name":"Suresh S. Ramalingam","is_ca":false},{"name":"Dong M. Shin","is_ca":false},{"name":"Gabriel Sica","is_ca":false},{"name":"Erwin G. Van Meir","is_ca":false},{"name":"Hongzheng Zhang","is_ca":false},{"name":"Wil Eijckenboom","is_ca":false},{"name":"Ad Gillis","is_ca":false},{"name":"Esther Korpershoek","is_ca":false},{"name":"Leendert H. J. Looijenga","is_ca":false},{"name":"Wolter Oosterhuis","is_ca":false},{"name":"Hans Stoop","is_ca":false},{"name":"Kim E. van Kessel","is_ca":false},{"name":"Ellen C. Zwarthoff","is_ca":false},{"name":"Chiara Calatozzolo","is_ca":false},{"name":"Lucia Cuppini","is_ca":false},{"name":"Stefania Cuzzubbo","is_ca":false},{"name":"Francesco DiMeco","is_ca":false},{"name":"Gaetano Finocchiaro","is_ca":false},{"name":"Luca Mattei","is_ca":false},{"name":"Alessandro Perin","is_ca":false},{"name":"Bianca Pollo","is_ca":false},{"name":"Chu Chen","is_ca":false},{"name":"J. C. Houck","is_ca":false},{"name":"Pawadee Lohavanichbutr","is_ca":false},{"name":"Arndt Hartmann","is_ca":false},{"name":"Robert Stoehr","is_ca":false},{"name":"Helge Täubert","is_ca":false},{"name":"Sven Wach","is_ca":false},{"name":"Bernd Wullich","is_ca":false},{"name":"Witold Kycler","is_ca":false},{"name":"Dawid Murawa","is_ca":false},{"name":"Maciej Wiznerowicz","is_ca":true},{"name":"Ki Wung Chung","is_ca":false},{"name":"W. Jeffrey Edenfield","is_ca":false},{"name":"Julie Martin","is_ca":false},{"name":"Éric Baudin","is_ca":false},{"name":"Glenn J. Bubley","is_ca":false},{"name":"Raphael Bueno","is_ca":false},{"name":"Assunta De Rienzo","is_ca":false},{"name":"William G. Richards","is_ca":false},{"name":"Steven N. Kalkanis","is_ca":false},{"name":"Tom Mikkelsen","is_ca":false},{"name":"Lisa Scarpace","is_ca":false},{"name":"Nicolas Girard","is_ca":false},{"name":"Marta Aymerich","is_ca":false},{"name":"Elı́as Campo","is_ca":false},{"name":"Eva Giné","is_ca":false},{"name":"Armando López Guillermo","is_ca":false},{"name":"Nguyen Van Bang","is_ca":false},{"name":"Phan Thi Hanh","is_ca":false},{"name":"Bùi Đức Phú","is_ca":false},{"name":"Yufang Tang","is_ca":false},{"name":"Howard Colman","is_ca":false},{"name":"Kimberley Evason","is_ca":false},{"name":"Peter R. Dottino","is_ca":false},{"name":"John A. Martignetti","is_ca":false},{"name":"Hani Gabra","is_ca":false},{"name":"Hartmut Juhl","is_ca":false},{"name":"Teniola Akeredolu","is_ca":false},{"name":"Serghei Stepa","is_ca":false},{"name":"Dave S.�B. Hoon","is_ca":false},{"name":"Keunsoo Ahn","is_ca":false},{"name":"Koo Jeong Kang","is_ca":false},{"name":"Felix Beuschlein","is_ca":false},{"name":"Anne Breggia","is_ca":false},{"name":"Michael J. Birrer","is_ca":false},{"name":"Debra Bell","is_ca":false},{"name":"Mitesh J. Borad","is_ca":false},{"name":"Alan H. Bryce","is_ca":false},{"name":"Erik P. Castle","is_ca":false},{"name":"Vishal S. Chandan","is_ca":true},{"name":"John C. Cheville","is_ca":false},{"name":"John A. Copland","is_ca":false},{"name":"Michael B. Farnell","is_ca":false},{"name":"Thomas J. Flotte","is_ca":false},{"name":"Nasra H. Giama","is_ca":false},{"name":"Thai H. Ho","is_ca":false},{"name":"Michael L. Kendrick","is_ca":false},{"name":"Jean‐Pierre Kocher","is_ca":false},{"name":"Karla Kopp","is_ca":false},{"name":"Catherine D. Moser","is_ca":false},{"name":"David M. Nagorney","is_ca":false},{"name":"Daniel J. O’Brien","is_ca":true},{"name":"Brian Patrick O’Neill","is_ca":false},{"name":"Tushar Patel","is_ca":false},{"name":"Gloria Petersen","is_ca":false},{"name":"Florencia G. Que","is_ca":false},{"name":"Michael Rivera","is_ca":false},{"name":"Lewis R. Roberts","is_ca":false},{"name":"Robert C. Smallridge","is_ca":false},{"name":"Thomas C. Smyrk","is_ca":false},{"name":"Melissa Stanton","is_ca":false},{"name":"R. Houston Thompson","is_ca":false},{"name":"Michael Torbenson","is_ca":false},{"name":"Ju Dong Yang","is_ca":false},{"name":"Lizhi Zhang","is_ca":true},{"name":"Fadi Brimo","is_ca":false},{"name":"Jaffer A. Ajani","is_ca":false},{"name":"Ana Maria Angulo Gonzalez","is_ca":false},{"name":"Carmen Behrens","is_ca":false},{"name":"Jolanta Bondaruk","is_ca":false},{"name":"Russell R. Broaddus","is_ca":false},{"name":"Bogdan Czerniak","is_ca":false},{"name":"Bita Esmaeli","is_ca":false},{"name":"Junya Fujimoto","is_ca":false},{"name":"Charles C. Guo","is_ca":false},{"name":"Alexander J. Lazar","is_ca":false},{"name":"Christopher J. Logothetis","is_ca":false},{"name":"Funda Meric‐Bernstam","is_ca":false},{"name":"César A. Moran","is_ca":false},{"name":"Lois M. Ramondetta","is_ca":false},{"name":"David C. Rice","is_ca":false},{"name":"Anil K. Sood","is_ca":false},{"name":"Pheroze Tamboli","is_ca":false},{"name":"Timothy Thompson","is_ca":false},{"name":"Patricia Troncoso","is_ca":false},{"name":"Anne S. Tsao","is_ca":false},{"name":"Ignacio Wistuba","is_ca":false},{"name":"Candace Carter","is_ca":false},{"name":"Lauren E. Haydu","is_ca":false},{"name":"Peter Hersey","is_ca":false},{"name":"Valerie Jakrot","is_ca":false},{"name":"Hojabr Kakavand","is_ca":true},{"name":"Richard Kefford","is_ca":false},{"name":"Kenneth Lee","is_ca":false},{"name":"Georgina V. Long","is_ca":false},{"name":"Graham J. Mann","is_ca":false},{"name":"Michael C. Quinn","is_ca":false},{"name":"Robyn P.M. Saw","is_ca":false},{"name":"Richard A. Scolyer","is_ca":false},{"name":"Kerwin F. Shannon","is_ca":false},{"name":"Andrew J. Spillane","is_ca":false},{"name":"onathan Stretch","is_ca":false},{"name":"Maria Synott","is_ca":false},{"name":"John F. Thompson","is_ca":false},{"name":"James S. Wilmott","is_ca":false},{"name":"Hikmat Al‐Ahmadie","is_ca":false},{"name":"Timothy A. Chan","is_ca":false},{"name":"Ronald Ghossein","is_ca":false},{"name":"Anuradha Gopalan","is_ca":false},{"name":"Douglas A. Levine","is_ca":false},{"name":"Victor Reuter","is_ca":false},{"name":"Samuel Singer","is_ca":false},{"name":"Bhuvanesh Singh","is_ca":false},{"name":"Nguyen Viet Tien","is_ca":false},{"name":"Thomas Broudy","is_ca":false},{"name":"Cyrus Mirsaidi","is_ca":false},{"name":"Praveen Nair","is_ca":false},{"name":"Paul Drwiega","is_ca":false},{"name":"Judy Miller","is_ca":false},{"name":"Jennifer A. Smith","is_ca":false},{"name":"Howard Zaren","is_ca":false},{"name":"Joong-Won Park","is_ca":false},{"name":"Nguyễn Phi Hùng","is_ca":false},{"name":"Electron Kebebew","is_ca":false},{"name":"W. Marston Linehan","is_ca":false},{"name":"Adam R. Metwalli","is_ca":false},{"name":"Karel Pacák","is_ca":false},{"name":"Peter A. Pinto","is_ca":false},{"name":"Mark Schiffman","is_ca":false},{"name":"Laura S. Schmidt","is_ca":false},{"name":"Cathy D. Vocke","is_ca":false},{"name":"Nicolas Wentzensen","is_ca":false},{"name":"Robert Worrell","is_ca":false},{"name":"Hannah Yang","is_ca":false},{"name":"Marc Moncrieff","is_ca":false},{"name":"Chandra Goparaju","is_ca":false},{"name":"Jonathan Melamed","is_ca":false},{"name":"Harvey I. Pass","is_ca":false},{"name":"Natalia Botnariuc","is_ca":true},{"name":"Irina Caraman","is_ca":false},{"name":"Mircea Cernat","is_ca":false},{"name":"Inga Chemencedji","is_ca":false},{"name":"Adrian Clipca","is_ca":false},{"name":"Serghei Doruc","is_ca":false},{"name":"Ghenadie Gorincioi","is_ca":false},{"name":"Sergiu Mura","is_ca":false},{"name":"Maria Pirtac","is_ca":false},{"name":"Irina Stancul","is_ca":false},{"name":"Diana Tcaciuc","is_ca":false},{"name":"Monique Albert","is_ca":false},{"name":"Iakovina Alexopoulou","is_ca":false},{"name":"Angel Arnaout","is_ca":false},{"name":"John Bartlett","is_ca":false},{"name":"Jay Engel","is_ca":false},{"name":"Sébastien Gilbert","is_ca":false},{"name":"Jeremy Parfitt","is_ca":false},{"name":"Harman Sekhon","is_ca":false},{"name":"George Thomas","is_ca":false},{"name":"Doris M. Rassl","is_ca":false},{"name":"Robert C. Rintoul","is_ca":false},{"name":"Carlo Bifulco","is_ca":false},{"name":"Raina Tamakawa","is_ca":false},{"name":"Walter J. Urba","is_ca":false},{"name":"Nicholas K. Hayward","is_ca":false},{"name":"Henri Timmers","is_ca":false},{"name":"Anna Antenucci","is_ca":false},{"name":"Francesco Facciolo","is_ca":false},{"name":"Gian Luca Grazi","is_ca":false},{"name":"Mirella Marino","is_ca":false},{"name":"Roberta Merola","is_ca":false},{"name":"Ronald R. de Krijger","is_ca":false},{"name":"Anne‐Paule Gimenez‐Roqueplo","is_ca":false},{"name":"Alain Piché","is_ca":false},{"name":"Simone Chevalier","is_ca":false},{"name":"Ginette McKercher","is_ca":false},{"name":"Kıvanç Birsoy","is_ca":false},{"name":"Gene H. Barnett","is_ca":false},{"name":"Cathy Brewer","is_ca":false},{"name":"Carol Farver","is_ca":false},{"name":"Theresa Naska","is_ca":false},{"name":"Nathan A. Pennell","is_ca":false},{"name":"Daniel Raymond","is_ca":false},{"name":"Cathy Schilero","is_ca":false},{"name":"Kathy Smolenski","is_ca":false},{"name":"Quaid Morris","is_ca":false},{"name":"Jeffrey A. Borgia","is_ca":false},{"name":"Mark Pool","is_ca":false},{"name":"Christopher W. Seder","is_ca":false},{"name":"Kerstin Junker","is_ca":false},{"name":"Larsson Omberg","is_ca":false},{"name":"Mikhail Dinkin","is_ca":false},{"name":"George Manikhas","is_ca":false},{"name":"Domenico Alvaro","is_ca":false},{"name":"Maria Consiglia Bragazzi","is_ca":false},{"name":"Vincenzo Cardinale","is_ca":false},{"name":"Guido Carpino","is_ca":false},{"name":"Eugenio Gaudio","is_ca":false},{"name":"David Chesla","is_ca":false},{"name":"Sandra Cottingham","is_ca":false},{"name":"Michael Dubina","is_ca":false},{"name":"Fedor Moiseenko","is_ca":false},{"name":"Renumathy Dhanasekaran","is_ca":false},{"name":"Karl‐Friedrich Becker","is_ca":false},{"name":"Klaus‐Peter Janssen","is_ca":false},{"name":"Julia Slotta‐Huspenina","is_ca":false},{"name":"Mohamed H. Abdel‐Rahman","is_ca":false},{"name":"Dina Aziz","is_ca":false},{"name":"Sue Bell","is_ca":false},{"name":"Colleen M. Cebulla","is_ca":false},{"name":"Amy Davis","is_ca":false},{"name":"Rebecca Duell","is_ca":false},{"name":"J. Bradley Elder","is_ca":false},{"name":"Joe Hilty","is_ca":false},{"name":"Bahavna Kumar","is_ca":false},{"name":"James C. Lang","is_ca":false},{"name":"Norman L. Lehman","is_ca":false},{"name":"Randy Mandt","is_ca":false},{"name":"Phuong Nguyen","is_ca":false},{"name":"Robert Pilarski","is_ca":false},{"name":"Karan Rai","is_ca":false},{"name":"Lynn Schoenfield","is_ca":false},{"name":"Kelly Senecal","is_ca":false},{"name":"Paul E. Wakely","is_ca":false},{"name":"Paul Hansen","is_ca":false},{"name":"Ronald M. Lechan","is_ca":true},{"name":"James Powers","is_ca":false},{"name":"Arthur S. Tischler","is_ca":false},{"name":"William E. Grizzle","is_ca":false},{"name":"Katherine C. Sexton","is_ca":false},{"name":"Alison Kastl","is_ca":false},{"name":"Joel Henderson","is_ca":false},{"name":"Sima P. Porten","is_ca":false},{"name":"Jens Waldmann","is_ca":false},{"name":"Martin Faßnacht","is_ca":false},{"name":"L. Sylvia","is_ca":false},{"name":"Dirk Schadendorf","is_ca":false},{"name":"Marta Couce","is_ca":false},{"name":"Markus Graefen","is_ca":false},{"name":"Hartwig Huland","is_ca":false},{"name":"Guido Sauter","is_ca":false},{"name":"Thorsten Schlomm","is_ca":false},{"name":"Ronald Simon","is_ca":false},{"name":"Pierre Tennstedt","is_ca":false},{"name":"Oluwole Olabode","is_ca":false},{"name":"Mark A. Nelson","is_ca":false},{"name":"Oliver F. Bathe","is_ca":false},{"name":"Peter R. Carroll","is_ca":false},{"name":"June M. Chan","is_ca":false},{"name":"Philip J. DiSaia","is_ca":false},{"name":"Pat Glenn","is_ca":false},{"name":"Robin Kate Kelley","is_ca":false},{"name":"Charles N. Landen","is_ca":false},{"name":"Joanna Phillips","is_ca":false},{"name":"Michael Prados","is_ca":false},{"name":"Jeffry Simko","is_ca":false},{"name":"Karen Smith‐McCune","is_ca":false},{"name":"Scott R. VandenBerg","is_ca":false},{"name":"Kevin K. Roggin","is_ca":false},{"name":"Ashley Fehrenbach","is_ca":false},{"name":"Ady Kendler","is_ca":false},{"name":"Suzanne Sifri","is_ca":false},{"name":"Ruth Steele","is_ca":false},{"name":"Antonio Jimeno","is_ca":true},{"name":"Francis A. Carey","is_ca":false},{"name":"Ian Forgie","is_ca":false},{"name":"Massimo Mannelli","is_ca":false},{"name":"Michael E. Carney","is_ca":false},{"name":"Brenda Hernandez","is_ca":false},{"name":"Benito Campos","is_ca":false},{"name":"Christel Herold‐Mende","is_ca":false},{"name":"Christin Jungk","is_ca":false},{"name":"Andreas Unterberg","is_ca":false},{"name":"Andreas von Deimling","is_ca":false},{"name":"Aaron Bossler","is_ca":false},{"name":"Joseph Galbraith","is_ca":false},{"name":"Laura Jacobus","is_ca":false},{"name":"Michael Knudson","is_ca":false},{"name":"Tina Knutson","is_ca":false},{"name":"Deqin Ma","is_ca":false},{"name":"Mohammed Milhem","is_ca":false},{"name":"Rita Sigmund","is_ca":false},{"name":"Andrew K. Godwin","is_ca":false},{"name":"Rashna Madan","is_ca":false},{"name":"Howard G. Rosenthal","is_ca":false},{"name":"Clement Adebamowo","is_ca":false},{"name":"Sally N. Adebamowo","is_ca":false},{"name":"Alex Boussioutas","is_ca":false},{"name":"David G. Beer","is_ca":false},{"name":"Thomas J. Giordano","is_ca":false},{"name":"Anne‐Marie Mes‐Masson","is_ca":false},{"name":"Fred Saad","is_ca":false},{"name":"Thèrése Bocklage","is_ca":false},{"name":"Lisa M. Landrum","is_ca":false},{"name":"Robert S. Mannel","is_ca":false},{"name":"Kathleen N. Moore","is_ca":false},{"name":"Katherine Moxley","is_ca":false},{"name":"Russel Postier","is_ca":false},{"name":"Joan Walker","is_ca":false},{"name":"Rosemary E. Zuna","is_ca":false},{"name":"Michael D. Feldman","is_ca":true},{"name":"Federico Valdivieso","is_ca":false},{"name":"Rajiv Dhir","is_ca":false},{"name":"James D. Luketich","is_ca":false},{"name":"Edna M. Mora Pinero","is_ca":false},{"name":"Mario Quintero-Aguilo","is_ca":false},{"name":"Carlos Gilberto Carlotti","is_ca":false},{"name":"José Sebastião dos Santos","is_ca":false},{"name":"Rafael Kemp","is_ca":false},{"name":"Ajith Sankarankuty","is_ca":false},{"name":"Daniela Pretti da Cunha Tirapelli","is_ca":false},{"name":"James W.F. Catto","is_ca":false},{"name":"Kathy Agnew","is_ca":false},{"name":"Elizabeth M. Swisher","is_ca":false},{"name":"Jenette Creaney","is_ca":false},{"name":"Bruce Robinson","is_ca":false},{"name":"Carl Simon Shelley","is_ca":false},{"name":"Eryn M. Godwin","is_ca":false},{"name":"Sara Kendall","is_ca":false},{"name":"Cassaundra Shipman","is_ca":true},{"name":"Carol R. Bradford","is_ca":false},{"name":"Thomas E. Carey","is_ca":false},{"name":"Jeffey Moyer","is_ca":false},{"name":"Lisa A. Peterson","is_ca":false},{"name":"Mark E. Prince","is_ca":false},{"name":"Laura S. Rozek","is_ca":false},{"name":"Gregory T. Wolf","is_ca":false},{"name":"Rayleen Bowman","is_ca":false},{"name":"Kwun M. Fong","is_ca":false},{"name":"Ian A. Yang","is_ca":false},{"name":"Robert J. Korst","is_ca":false},{"name":"W. Kimryn Rathmell","is_ca":false},{"name":"J. Leigh Fantacone-Campbell","is_ca":false},{"name":"Jeffrey A. Hooke","is_ca":false},{"name":"Albert J. Kovatich","is_ca":false},{"name":"Craig D. Shriver","is_ca":false},{"name":"John F. DiPersio","is_ca":true},{"name":"Bettina F. Drake","is_ca":false},{"name":"Ramaswamy Govindan","is_ca":false},{"name":"Sharon E. Heath","is_ca":false},{"name":"Timothy J. Ley","is_ca":false},{"name":"Brian A. Van Tine","is_ca":false},{"name":"Peter Westervelt","is_ca":false},{"name":"Mark A. Rubin","is_ca":false},{"name":"Jung Il Lee","is_ca":false},{"name":"Natália D. Aredes","is_ca":false},{"name":"Armaz Mariamidze","is_ca":false},{"name":"Jonathan S. Serody","is_ca":false},{"name":"Elizabeth G. Demicco","is_ca":true},{"name":"Mary L. Disis","is_ca":false},{"name":"Benjamin G. Vincent","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01786348163548429,"gpt":0.3127203879480663,"spread":0.294856906312582,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009661475,0.0002534123,0.0004722922,0.0008441113,0.0006808333,0.002851078,0.0003441159,0.001075963,0.003816415],"category_scores_gemma":[0.001369495,0.0001248677,0.0001756601,0.0004574413,0.00217948,0.002296882,0.001335357,0.002094253,0.0006557823],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007643834,"about_ca_system_score_gemma":0.0009048269,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002761166,"about_ca_topic_score_gemma":0.0004842985,"domain_scores_codex":[0.9994412,0.0002270215,0.00001654668,0.00008046296,0.000142588,0.0000921011],"domain_scores_gemma":[0.9995819,0.0001629437,0.00005427628,0.00002688124,0.00006117638,0.0001129535],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.0004501283,0.0002076042,0.0221203,0.001225673,0.0001725083,0.001361245,0.001844489,0.002437728,0.05974126,0.3350057,0.06821287,0.5072204],"study_design_scores_gemma":[0.00005299406,0.0004207911,0.02150183,0.0006609756,0.0000845184,0.002547189,0.002729892,0.002139125,0.005247992,0.3623519,0.60221,0.0000528661],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1477933,0.5864481,0.01099795,0.1663198,0.004080527,0.00005695129,0.0004164987,0.0002369391,0.08364987],"genre_scores_gemma":[0.8394396,0.1225066,0.002705864,0.01785649,0.005866685,0.00005677402,0.0001436249,0.00003966524,0.01138475],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003816415,"threshold_uncertainty_score":0.0127672,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2753432434","doi":"10.1056/nejmoa1709684","title":"Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma","year":2017,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5392,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Ipilimumab; Nivolumab; Medicine; Melanoma; Oncology; Internal medicine; Overall survival; Metastatic melanoma; Clinical trial; Immunotherapy; Cancer; Cancer research","authors":[{"name":"Jedd D. Wolchok","is_ca":false},{"name":"Vanna Chiarion‐Sileni","is_ca":false},{"name":"René González","is_ca":false},{"name":"Piotr Rutkowski","is_ca":false},{"name":"Jean‐Jacques Grob","is_ca":false},{"name":"C. Lance Cowey","is_ca":false},{"name":"Christopher D. Lao","is_ca":false},{"name":"John Wagstaff","is_ca":false},{"name":"Dirk Schadendorf","is_ca":false},{"name":"Pier Francesco Ferrucci","is_ca":false},{"name":"Michael Smylie","is_ca":false},{"name":"Reinhard Dummer","is_ca":false},{"name":"Andrew Hill","is_ca":false},{"name":"David Hogg","is_ca":true},{"name":"John B.A.G. Haanen","is_ca":false},{"name":"Matteo S. Carlino","is_ca":false},{"name":"Oliver Bechter","is_ca":false},{"name":"Michele Maio","is_ca":false},{"name":"Iván Márquez‐Rodas","is_ca":false},{"name":"Massimo Guidoboni","is_ca":false},{"name":"Grant A. McArthur","is_ca":false},{"name":"Célèste Lebbé","is_ca":false},{"name":"Paolo A. Ascierto","is_ca":false},{"name":"Georgina V. Long","is_ca":false},{"name":"Jonathan Cebon","is_ca":false},{"name":"Jeffrey A. Sosman","is_ca":false},{"name":"Michael A. Postow","is_ca":false},{"name":"Margaret K. Callahan","is_ca":false},{"name":"Linda Rollin","is_ca":false},{"name":"Rafia Bhore","is_ca":false},{"name":"F. Stephen Hodi","is_ca":false},{"name":"James Larkin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01592681096580529,"gpt":0.2789838467585548,"spread":0.2630570357927495,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001491288,0.0006851782,0.001466082,0.0005527525,0.0002262609,0.0004320903,0.0004825973,0.0004959525,0.001844862],"category_scores_gemma":[0.0009108472,0.0002007372,0.001052765,0.0003290074,0.0005525482,0.0004197545,0.0004908129,0.001305697,0.0002277046],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000643428,"about_ca_system_score_gemma":0.0005937549,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003830998,"about_ca_topic_score_gemma":0.0009185041,"domain_scores_codex":[0.9994652,0.0002600507,0.00003444933,0.00008593802,0.00006171752,0.00009269529],"domain_scores_gemma":[0.9995162,0.0001280846,0.00008700956,0.00004991581,0.00002377707,0.0001949791],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6335706,0.01727054,0.01750996,0.001045628,0.00263834,0.0001881588,0.0001712408,0.009986844,0.04056438,0.000252505,0.001306165,0.2754956],"study_design_scores_gemma":[0.1948547,0.7104626,0.07014928,0.0001994197,0.003351359,0.0003749568,0.00005093975,0.00617767,0.009448806,0.000811435,0.004066079,0.0000527357],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946285,0.003732098,0.0003595563,0.0001940817,0.00008151899,0.0001656206,0.0001033688,0.00003146376,0.0007038615],"genre_scores_gemma":[0.9977387,0.000962851,0.0004030123,0.0001240049,0.000088739,0.0002432515,0.0001488571,0.00000598703,0.0002846019],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001844862,"threshold_uncertainty_score":0.007886827,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2606495925","doi":"10.1186/s13073-017-0424-2","title":"Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden","year":2017,"lang":"en","type":"article","venue":"Genome Medicine","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3730,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"Prostate Cancer Foundation; Foundation Medicine; U.S. Department of Defense","keywords":"Microsatellite instability; Exome sequencing; Germline; Exome; Biology; Somatic cell; Germline mutation; PMS2; Cancer; Computational biology; Cancer research; Medicine; Oncology; Genetics; Gene; Mutation; Microsatellite; Allele","authors":[{"name":"Zachary R. Chalmers","is_ca":false},{"name":"Caitlin Connelly","is_ca":false},{"name":"David Fabrizio","is_ca":false},{"name":"Laurie M. Gay","is_ca":false},{"name":"Siraj M. Ali","is_ca":false},{"name":"Riley Ennis","is_ca":false},{"name":"Alexa B. Schrock","is_ca":false},{"name":"Brittany Campbell","is_ca":true},{"name":"Adam Shlien","is_ca":true},{"name":"Juliann Chmielecki","is_ca":false},{"name":"Franklin W. Huang","is_ca":false},{"name":"Yuting He","is_ca":false},{"name":"James Sun","is_ca":false},{"name":"Uri Tabori","is_ca":true},{"name":"Mark Kennedy","is_ca":false},{"name":"Daniel S. Lieber","is_ca":false},{"name":"Steven Roels","is_ca":false},{"name":"Jared White","is_ca":false},{"name":"Geoffrey A. Otto","is_ca":false},{"name":"Jeffrey S. Ross","is_ca":false},{"name":"Levi A. Garraway","is_ca":false},{"name":"Vincent A. Miller","is_ca":false},{"name":"P. J. Stephens","is_ca":false},{"name":"Garrett M. Frampton","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03098793945691034,"gpt":0.3341593594147079,"spread":0.3031714199577975,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006460742,0.0002881844,0.0004153063,0.001188646,0.00029099,0.0005975472,0.0002174194,0.0004469519,0.000716214],"category_scores_gemma":[0.002757924,0.0001898577,0.0004049296,0.001918396,0.0002364932,0.0003138094,0.0006435209,0.0003808824,0.0001730093],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003494379,"about_ca_system_score_gemma":0.000216649,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002127187,"about_ca_topic_score_gemma":0.003135641,"domain_scores_codex":[0.9994621,0.00009765728,0.00003535075,0.000235461,0.0001209003,0.00004852526],"domain_scores_gemma":[0.9984838,0.0007047693,0.0004417983,0.0001444248,0.0001268326,0.00009829229],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005209904,0.00006091317,0.8457748,0.0004595414,0.001370393,0.0005029683,0.000310624,0.01012828,0.08556053,0.0007945147,0.002380301,0.0521361],"study_design_scores_gemma":[0.00001520216,0.000116877,0.9801241,0.00003135432,0.0002057013,0.0009139136,0.0001647782,0.007229097,0.004479899,0.001244713,0.005458469,0.00001579164],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9864914,0.001387863,0.003689589,0.0002516308,0.00000914189,0.0000164649,0.007530754,0.0001186279,0.0005044902],"genre_scores_gemma":[0.9790289,0.0009575492,0.00571986,0.0002054597,0.00001567529,0.00004873337,0.0136903,0.0000337848,0.0002997308],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002127187,"threshold_uncertainty_score":0.004229605,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3043703771","doi":"10.1056/nejmoa1910836","title":"Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma","year":2019,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3708,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"EMD Serono; Pharmacyclics; Genentech; AstraZeneca; EUSA Pharma; Eisai; National Institute for Health and Care Research; Plexxikon; Array BioPharma; Ipsen; Syndax Pharmaceuticals; Sanofi Genzyme; Pfizer; Incyte; National Cancer Institute; LEO Pharma; Massachusetts Medical Society; Regeneron Pharmaceuticals; Sanofi; GlaxoSmithKline; Amgen; Les Laboratories Pierre Fabre; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Ipilimumab; Nivolumab; Melanoma; Medicine; Oncology; Internal medicine; Metastatic melanoma; Immunotherapy; Cancer research; Cancer","authors":[{"name":"James Larkin","is_ca":false},{"name":"Vanna Chiarion‐Sileni","is_ca":false},{"name":"René González","is_ca":false},{"name":"Jean‐Jacques Grob","is_ca":false},{"name":"Piotr Rutkowski","is_ca":false},{"name":"Christopher D. Lao","is_ca":false},{"name":"C. Lance Cowey","is_ca":false},{"name":"Dirk Schadendorf","is_ca":false},{"name":"John Wagstaff","is_ca":false},{"name":"Reinhard Dummer","is_ca":false},{"name":"Pier Francesco Ferrucci","is_ca":false},{"name":"Michael Smylie","is_ca":false},{"name":"David Hogg","is_ca":true},{"name":"Andrew F. Hill","is_ca":false},{"name":"Iván Márquez‐Rodas","is_ca":false},{"name":"John B.A.G. Haanen","is_ca":false},{"name":"Massimo Guidoboni","is_ca":false},{"name":"Michele Maio","is_ca":false},{"name":"Patrick Schöffski","is_ca":false},{"name":"Matteo S. Carlino","is_ca":false},{"name":"Célèste Lebbé","is_ca":false},{"name":"Grant A. McArthur","is_ca":false},{"name":"Paolo A. Ascierto","is_ca":false},{"name":"Gregory A. Daniels","is_ca":false},{"name":"Georgina V. Long","is_ca":false},{"name":"Lars Bastholt","is_ca":false},{"name":"Jasmine I. Rizzo","is_ca":false},{"name":"Ágnes Balogh","is_ca":false},{"name":"Andriy Moshyk","is_ca":false},{"name":"F. Stephen Hodi","is_ca":false},{"name":"Jedd D. Wolchok","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007370799521923161,"gpt":0.2433068734822652,"spread":0.235936073960342,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001682867,0.0005152463,0.00119788,0.0005386737,0.0002182818,0.0003752849,0.0003761035,0.0004292729,0.001129302],"category_scores_gemma":[0.0008856901,0.0001652863,0.001080805,0.0002839851,0.0004058807,0.0003360049,0.0004542085,0.0008451946,0.0001406892],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005503133,"about_ca_system_score_gemma":0.0004863887,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006720931,"about_ca_topic_score_gemma":0.001003354,"domain_scores_codex":[0.9994071,0.0002882732,0.00004107045,0.00008664815,0.00007825971,0.00009866674],"domain_scores_gemma":[0.9994747,0.0001341806,0.00008952159,0.00004158292,0.00002485683,0.0002351622],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7376485,0.01128726,0.04143576,0.0006621447,0.002331374,0.0001944145,0.0001337383,0.009689346,0.02450717,0.0002485419,0.0008402108,0.1710215],"study_design_scores_gemma":[0.1503393,0.6605682,0.1631439,0.0001474422,0.003591222,0.0003957543,0.00006542814,0.008953174,0.008569658,0.0009178232,0.003251208,0.00005689035],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958735,0.003049785,0.0002604394,0.00009111652,0.00005438627,0.00008316676,0.00008280967,0.00001514519,0.0004897643],"genre_scores_gemma":[0.9986886,0.0005929051,0.0002125314,0.00005786336,0.00005303468,0.0000859227,0.0001083717,0.000002085954,0.0001988572],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001682867,"threshold_uncertainty_score":0.008899927,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2118982164","doi":"10.1056/nejmoa1305133","title":"Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma","year":2013,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3395,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute","keywords":"Medicine; Ipilimumab; Rash; Adverse effect; Melanoma; Internal medicine; Response Evaluation Criteria in Solid Tumors; Gastroenterology; Cohort; Cancer; Confidence interval; Surgery; Immunotherapy; Chemotherapy; Phases of clinical research","authors":[{"name":"Omid Hamid","is_ca":false},{"name":"Caroline Robert","is_ca":false},{"name":"Adil Daud","is_ca":false},{"name":"F. Stephen Hodi","is_ca":false},{"name":"Wen-Jen Hwu","is_ca":false},{"name":"Richard Kefford","is_ca":false},{"name":"Jedd D. Wolchok","is_ca":false},{"name":"Peter Hersey","is_ca":false},{"name":"Richard W. Joseph","is_ca":false},{"name":"Jeffrey S. Weber","is_ca":false},{"name":"Roxana Dronca","is_ca":false},{"name":"Tara C. Gangadhar","is_ca":false},{"name":"Amita Patnaik","is_ca":false},{"name":"Hassane M. Zarour","is_ca":false},{"name":"Anthony M. Joshua","is_ca":true},{"name":"Kevin Gergich","is_ca":false},{"name":"Jeroen Elassaiss‐Schaap","is_ca":false},{"name":"Alain P. Algazi","is_ca":false},{"name":"Christine Mateus","is_ca":false},{"name":"Peter D. Boasberg","is_ca":false},{"name":"Paul C. Tumeh","is_ca":false},{"name":"Bartosz Chmielowski","is_ca":false},{"name":"Scot Ebbinghaus","is_ca":false},{"name":"Xiaoyun Li","is_ca":false},{"name":"Sunyu Kang","is_ca":false},{"name":"Antoni Ribas","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01063699293075173,"gpt":0.2538321199604192,"spread":0.2431951270296674,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001282689,0.0001831721,0.0004447452,0.0001678541,0.0001129537,0.0002766697,0.0001971735,0.0003279071,0.0005659955],"category_scores_gemma":[0.001195198,0.000109567,0.0005242609,0.0001462808,0.0002198599,0.0002220625,0.0001272328,0.0008798392,0.0001343968],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004756523,"about_ca_system_score_gemma":0.0003050062,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003486689,"about_ca_topic_score_gemma":0.0003883723,"domain_scores_codex":[0.9995494,0.0001923509,0.00003840193,0.00007219367,0.00009981298,0.00004770618],"domain_scores_gemma":[0.9990335,0.0002753848,0.0004077982,0.00005934597,0.00008142643,0.0001425997],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.149788,0.01053866,0.2683672,0.001186643,0.001442056,0.0009370212,0.0007073621,0.009731565,0.1597119,0.000278284,0.002628064,0.3946832],"study_design_scores_gemma":[0.01964003,0.4067774,0.5161633,0.0001640371,0.001009248,0.003232127,0.0001767728,0.006202263,0.03799253,0.0004009471,0.008203245,0.00003815845],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961445,0.002763895,0.0002647273,0.00009660212,0.00001685144,0.00006261202,0.0001063388,0.0000169863,0.0005273849],"genre_scores_gemma":[0.9991091,0.000403552,0.0001111023,0.00009369733,0.00002364476,0.00002132246,0.0001233196,0.000002767104,0.0001114977],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001282689,"threshold_uncertainty_score":0.006783605,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2120431466","doi":"10.1093/annonc/mdu450","title":"The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3136,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University of British Columbia; University Health Network","funders":"","keywords":"Medicine; Tumor-infiltrating lymphocytes; H&E stain; Breast cancer; Oncology; Medical physics; Cancer; Pathology; Internal medicine; Immunotherapy; Staining","authors":[{"name":"Roberto Salgado","is_ca":false},{"name":"Carsten Denkert","is_ca":false},{"name":"Sandra Demaria","is_ca":false},{"name":"Nicolas Sirtaine","is_ca":false},{"name":"Frederick Klauschen","is_ca":false},{"name":"Giancarlo Pruneri","is_ca":false},{"name":"Stephan Wienert","is_ca":false},{"name":"Gert Van den Eynden","is_ca":false},{"name":"Frederick L. Baehner","is_ca":false},{"name":"Frédérique Penault‐Llorca","is_ca":false},{"name":"Edith A. Perez","is_ca":false},{"name":"E. Aubrey Thompson","is_ca":false},{"name":"W. Fraser Symmans","is_ca":false},{"name":"Andrea L. Richardson","is_ca":false},{"name":"Jane Brock","is_ca":false},{"name":"Carmen Criscitiello","is_ca":false},{"name":"Helen D. Bailey","is_ca":false},{"name":"M. Ignatiadis","is_ca":false},{"name":"Giuseppe Floris","is_ca":false},{"name":"Joseph A. Sparano","is_ca":false},{"name":"Zuzana Kos","is_ca":true},{"name":"Torsten O. Nielsen","is_ca":true},{"name":"David L. Rimm","is_ca":false},{"name":"Kimberly H. Allison","is_ca":false},{"name":"Jorge S. Reis‐Filho","is_ca":false},{"name":"Sibylle Loibl","is_ca":false},{"name":"Christos Sotiriou","is_ca":false},{"name":"Giuseppe Viale","is_ca":false},{"name":"Sunil Badve","is_ca":false},{"name":"Sylvia Adams","is_ca":false},{"name":"Karen Willard‐Gallo","is_ca":false},{"name":"Sherene Loi","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08993888139496703,"gpt":0.4238221072094491,"spread":0.3338832258144821,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.049282,0.001736251,0.003392383,0.004177373,0.001425019,0.003820522,0.007001656,0.005423771,0.001348724],"category_scores_gemma":[0.03308433,0.0008744727,0.003701025,0.002991406,0.002686138,0.00253404,0.00379779,0.0101955,0.001845079],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0029292,"about_ca_system_score_gemma":0.01069792,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01185809,"about_ca_topic_score_gemma":0.0109657,"domain_scores_codex":[0.9802529,0.007543778,0.004477563,0.0008880621,0.005674631,0.001163203],"domain_scores_gemma":[0.9526957,0.01389811,0.004483825,0.001384191,0.02502188,0.002516213],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001490866,0.0006221613,0.05438123,0.006950316,0.000563236,0.0004925962,0.001031863,0.001894882,0.006541606,0.004395303,0.2961295,0.6255065],"study_design_scores_gemma":[0.0006777268,0.001908905,0.08051847,0.02580828,0.002490156,0.001857777,0.003314502,0.003630356,0.01517487,0.0106352,0.8537619,0.0002218048],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"methods","genre_scores_codex":[0.02974264,0.4230468,0.04705701,0.4253927,0.02951718,0.003252578,0.006157308,0.001011004,0.03482281],"genre_scores_gemma":[0.2128299,0.2351474,0.3096841,0.1754745,0.01726714,0.008964187,0.01748032,0.0008415732,0.02231093],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.049282,"threshold_uncertainty_score":0.2606313,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3171517418","doi":"10.1016/s0140-6736(21)00797-2","title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","year":2021,"lang":"en","type":"article","venue":"The Lancet","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2927,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute; Ono Pharmaceutical; Bristol-Myers Squibb","keywords":"Medicine; Gastric adenocarcinoma; Gastro-; Chemotherapy; Nivolumab; Internal medicine; Gastroenterology; Open label; Adenocarcinoma; Gastroesophageal Junction; Oncology; Clinical trial; Cancer; Reflux; Immunotherapy; Disease","authors":[{"name":"Yelena Y. Janjigian","is_ca":false},{"name":"Kohei Shitara","is_ca":false},{"name":"Markus Moehler","is_ca":false},{"name":"Marcelo Garrido","is_ca":false},{"name":"Pamela Salman","is_ca":false},{"name":"Lin Shen","is_ca":false},{"name":"Lucjan Wyrwicz","is_ca":false},{"name":"Kensei Yamaguchi","is_ca":false},{"name":"Tomasz Skoczylas","is_ca":false},{"name":"Arinilda Campos Bragagnoli","is_ca":false},{"name":"Tianshu Liu","is_ca":false},{"name":"Michael Schenker","is_ca":false},{"name":"Patricio Yañez","is_ca":false},{"name":"Mustapha Tehfé","is_ca":true},{"name":"Rubén Dario Kowalyszyn","is_ca":false},{"name":"Michalis V. Karamouzis","is_ca":false},{"name":"Ricardo Brugés","is_ca":false},{"name":"Thomas Zander","is_ca":false},{"name":"Roberto Pazo-Cid","is_ca":false},{"name":"Erika Hitre","is_ca":false},{"name":"Kynan Feeney","is_ca":false},{"name":"James M. Cleary","is_ca":false},{"name":"Valerie Poulart","is_ca":false},{"name":"Dana Cullen","is_ca":false},{"name":"Ming Lei","is_ca":false},{"name":"Hong Xiao","is_ca":false},{"name":"Kaoru Kondo","is_ca":false},{"name":"Mingshun Li","is_ca":false},{"name":"Jaffer A. Ajani","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05805096571869594,"gpt":0.3440784328444417,"spread":0.2860274671257457,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001569715,0.002067124,0.003254962,0.0003867145,0.0003932741,0.001283234,0.001197572,0.002125001,0.007684815],"category_scores_gemma":[0.001683507,0.0007426777,0.003276245,0.0003399473,0.001261621,0.001339519,0.0005315502,0.004241104,0.001376254],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001310294,"about_ca_system_score_gemma":0.0009660908,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001861719,"about_ca_topic_score_gemma":0.00460943,"domain_scores_codex":[0.9995345,0.0002328726,0.00002152301,0.0001028049,0.00002679926,0.00008151009],"domain_scores_gemma":[0.999243,0.0002362806,0.0001381896,0.00005648517,0.00003978236,0.0002862618],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9821545,0.003466672,0.0003371595,0.000600995,0.001004552,0.00002510499,0.00003688836,0.0003926591,0.00119256,0.00008408963,0.000835203,0.009869664],"study_design_scores_gemma":[0.9520676,0.04560302,0.0008094803,0.00003450251,0.0004447921,0.00002280825,0.00001901086,0.0003054004,0.0001692471,0.0001341778,0.0003766627,0.0000132918],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9830275,0.007083546,0.0006160243,0.001110357,0.001512469,0.002769847,0.001374673,0.0001539528,0.002351668],"genre_scores_gemma":[0.9818896,0.003773522,0.001514689,0.001732364,0.0005885524,0.002775828,0.00159045,0.00004119746,0.006093894],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007684815,"threshold_uncertainty_score":0.02570832,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2112121482","doi":"10.1016/s1470-2045(15)70076-8","title":"Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial","year":2015,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2666,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital; McGill University","funders":"National Institutes of Health; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; GlaxoSmithKline; Bristol-Myers Squibb","keywords":"Open label; Medicine; Nivolumab; Oncology; Chemotherapy; Internal medicine; Ipilimumab; Randomized controlled trial; Immunotherapy; Cancer","authors":[{"name":"Jeffrey S. Weber","is_ca":false},{"name":"Sandra P. D’Angelo","is_ca":false},{"name":"David R. Minor","is_ca":false},{"name":"F. Stephen Hodi","is_ca":false},{"name":"Ralf Gutzmer","is_ca":false},{"name":"Bart Neyns","is_ca":false},{"name":"Christoph Höeller","is_ca":false},{"name":"Nikhil I. Khushalani","is_ca":false},{"name":"Wilson H. Miller","is_ca":true},{"name":"Christopher D. Lao","is_ca":false},{"name":"Gerald P. Linette","is_ca":false},{"name":"L. Thomas","is_ca":false},{"name":"Paul Lorigan","is_ca":false},{"name":"Kenneth F. Grossmann","is_ca":false},{"name":"Jessica C. Hassel","is_ca":false},{"name":"Michele Maio","is_ca":false},{"name":"Mario Sznol","is_ca":false},{"name":"Paolo A. Ascierto","is_ca":false},{"name":"Peter Mohr","is_ca":false},{"name":"Bartosz Chmielowski","is_ca":false},{"name":"Alan H. Bryce","is_ca":false},{"name":"Inge Marie Svane","is_ca":false},{"name":"Jean‐Jacques Grob","is_ca":false},{"name":"Angela M. Krackhardt","is_ca":false},{"name":"Christine E. Horak","is_ca":false},{"name":"Alexandre Lambert","is_ca":false},{"name":"Arvin Yang","is_ca":false},{"name":"James Larkin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05803676378711036,"gpt":0.3752254400827541,"spread":0.3171886762956437,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001287974,0.001181378,0.002264216,0.000287398,0.0003047606,0.001052349,0.000757686,0.001575787,0.004668729],"category_scores_gemma":[0.00151519,0.0005328783,0.002323075,0.000304987,0.0009018492,0.001014309,0.0003563082,0.00318503,0.0007976077],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008749823,"about_ca_system_score_gemma":0.0007385144,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001245803,"about_ca_topic_score_gemma":0.00323372,"domain_scores_codex":[0.9995334,0.000266114,0.00002098991,0.00007855015,0.00002465633,0.00007625762],"domain_scores_gemma":[0.99938,0.0002167655,0.0001159185,0.00004502973,0.00003359313,0.0002087002],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9747882,0.003232023,0.0007450425,0.0006180034,0.001150378,0.00003686139,0.00005489419,0.000455368,0.001718183,0.0001138567,0.0009111848,0.01617604],"study_design_scores_gemma":[0.9433854,0.05296362,0.001582022,0.00004171962,0.0005183443,0.00002796396,0.00002767848,0.0004429325,0.0002413988,0.0001881716,0.0005666455,0.00001417169],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895294,0.004473193,0.0003984792,0.0008100087,0.0006925181,0.001541807,0.0007464513,0.00008765172,0.001720464],"genre_scores_gemma":[0.9911916,0.001974671,0.0007296998,0.001088308,0.0002739143,0.001244984,0.0007534458,0.00002094508,0.002722509],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004668729,"threshold_uncertainty_score":0.0156185,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2635951006","doi":"10.1056/nejmoa1613493","title":"First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer","year":2017,"lang":"en","type":"letter","venue":"New England Journal of Medicine","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2575,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Juravinski Cancer Centre","funders":"National Cancer Institute","keywords":"Nivolumab; Docetaxel; Medicine; Oncology; Lung cancer; Chemotherapy; Internal medicine; Lung; Cancer; Stage (stratigraphy); Immunotherapy","authors":[{"name":"David P. Carbone","is_ca":false},{"name":"Martin Reck","is_ca":false},{"name":"Luis Paz‐Ares","is_ca":false},{"name":"Ben Creelan","is_ca":false},{"name":"Leora Horn","is_ca":false},{"name":"Martin Steins","is_ca":false},{"name":"Enriqueta Felip","is_ca":false},{"name":"Michel M. van den Heuvel","is_ca":false},{"name":"Tudor–Eliade Ciuleanu","is_ca":false},{"name":"Firas Badin","is_ca":false},{"name":"Neal Ready","is_ca":false},{"name":"T. Jeroen N. Hiltermann","is_ca":false},{"name":"Suresh Nair","is_ca":false},{"name":"Rosalyn A. Juergens","is_ca":true},{"name":"Solange Peters","is_ca":false},{"name":"Elisa Minenza","is_ca":false},{"name":"John Wrangle","is_ca":false},{"name":"Delvys Rodríguez‐Abreu","is_ca":false},{"name":"Hossein Borghaei","is_ca":false},{"name":"George R. Blumenschein","is_ca":false},{"name":"Liza C. Villaruz","is_ca":false},{"name":"Libor Havel","is_ca":false},{"name":"Jana Krejčí","is_ca":false},{"name":"Jesus Corral Jaime","is_ca":false},{"name":"Han Chang","is_ca":false},{"name":"William J. Geese","is_ca":false},{"name":"Prabhu Bhagavatheeswaran","is_ca":false},{"name":"Allen C. Chen","is_ca":false},{"name":"Mark A. Socinski","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03511857503314067,"gpt":0.3199291267709563,"spread":0.2848105517378156,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001449795,0.0004073133,0.001436677,0.0002291938,0.0002046282,0.0004363937,0.0005985444,0.0006273591,0.001528847],"category_scores_gemma":[0.001782789,0.0002092553,0.0008589214,0.0001747616,0.0003555901,0.0003124627,0.0002305892,0.00120841,0.0002130705],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001190644,"about_ca_system_score_gemma":0.000988376,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008944154,"about_ca_topic_score_gemma":0.003245738,"domain_scores_codex":[0.9995322,0.0002340248,0.00003063403,0.00007181174,0.00006169765,0.0000696502],"domain_scores_gemma":[0.9991853,0.0002629652,0.0001558849,0.00004902107,0.00004998944,0.0002967532],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5343983,0.01406265,0.0514078,0.00237654,0.002163161,0.000338076,0.0003410515,0.00512767,0.02168603,0.0002896049,0.003591515,0.3642175],"study_design_scores_gemma":[0.277343,0.4946924,0.1892891,0.0004428255,0.002817696,0.001917552,0.0002380248,0.007268304,0.01518739,0.0008095567,0.009914649,0.00007948939],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929263,0.005713487,0.0001426545,0.0001734318,0.0001210207,0.0002148817,0.00007509616,0.0000217678,0.000611358],"genre_scores_gemma":[0.9975612,0.001421773,0.0002392881,0.0001639113,0.00006945395,0.0001193295,0.0001376692,0.000004777601,0.0002825152],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001528847,"threshold_uncertainty_score":0.008638799,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3083986479","doi":"10.1016/s1470-2045(20)30445-9","title":"Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study","year":2020,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2492,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Pembrolizumab; Internal medicine; Response Evaluation Criteria in Solid Tumors; Oncology; Cohort; Mesothelioma; Biomarker; Clinical endpoint; Prospective cohort study; Cancer; Progressive disease; Disease; Immunotherapy; Pathology; Clinical trial","authors":[{"name":"Aurélien Marabelle","is_ca":false},{"name":"Marwan Fakih","is_ca":false},{"name":"Juanita Lopez","is_ca":false},{"name":"Manisha H. Shah","is_ca":false},{"name":"Ronnie Shapira‐Frommer","is_ca":false},{"name":"Kazuhiko Nakagawa","is_ca":false},{"name":"Hyun Cheol Chung","is_ca":false},{"name":"Hedy L. Kindler","is_ca":false},{"name":"José A. López-Martín","is_ca":false},{"name":"Wilson H. Miller","is_ca":true},{"name":"Antoîne Italiano","is_ca":false},{"name":"Steven Kao","is_ca":false},{"name":"Sarina A. Piha‐Paul","is_ca":false},{"name":"Jean‐Pierre Delord","is_ca":false},{"name":"Robert R. McWilliams","is_ca":false},{"name":"David Fabrizio","is_ca":false},{"name":"Deepti Aurora-Garg","is_ca":false},{"name":"Lei Xu","is_ca":false},{"name":"Fan Jin","is_ca":false},{"name":"Kevin Norwood","is_ca":false},{"name":"Yung‐Jue Bang","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03122114611269687,"gpt":0.3549706413578277,"spread":0.3237494952451308,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002044662,0.0005779573,0.0008804951,0.0002999585,0.0002637473,0.0009462599,0.0004744206,0.0007805817,0.001038533],"category_scores_gemma":[0.002396993,0.0003890384,0.001208496,0.0005414016,0.00032742,0.0009004441,0.000548395,0.001114607,0.0002096881],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003302834,"about_ca_system_score_gemma":0.0002602457,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004088657,"about_ca_topic_score_gemma":0.0006477624,"domain_scores_codex":[0.9992494,0.0003395058,0.00004875937,0.0002002903,0.0000804466,0.00008168501],"domain_scores_gemma":[0.9979256,0.0005268918,0.000928387,0.0002651329,0.0001197622,0.0002341068],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1576905,0.001284371,0.7985094,0.0003973178,0.008238673,0.0001557756,0.0001610856,0.001227037,0.008561851,0.0001818771,0.001443428,0.02214871],"study_design_scores_gemma":[0.007741352,0.01045787,0.9749591,0.00004000811,0.003151659,0.0002958422,0.00009875603,0.001207453,0.0007344431,0.0003059846,0.0009699062,0.00003763095],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980667,0.0008749082,0.0001060147,0.00006018845,0.00001311712,0.00002589774,0.0006366805,0.000005697666,0.0002108506],"genre_scores_gemma":[0.9983196,0.0002194005,0.0001402587,0.00007901016,0.00003278097,0.00003825469,0.0009819688,0.000004325914,0.000184426],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002044662,"threshold_uncertainty_score":0.01081336,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2592144107","doi":"10.1016/s1470-2045(17)30074-8","title":"iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics","year":2017,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2408,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"National Cancer Institute","keywords":"Guideline; Clinical trial; Medicine; Medical physics; Response Evaluation Criteria in Solid Tumors; Immunotherapy; Cancer; Intensive care medicine; Oncology; Internal medicine; Pathology","authors":[{"name":"Lesley Seymour","is_ca":true},{"name":"Jan Bogaerts","is_ca":false},{"name":"Andrea Perrone","is_ca":false},{"name":"Robert Ford","is_ca":false},{"name":"Lawrence H. Schwartz","is_ca":false},{"name":"Sumithra J. Mandrekar","is_ca":false},{"name":"Nancy U. Lin","is_ca":false},{"name":"Saskia Litière","is_ca":false},{"name":"Janet Dancey","is_ca":true},{"name":"Alice Chen","is_ca":false},{"name":"F. Stephen Hodi","is_ca":false},{"name":"Patrick Therasse","is_ca":false},{"name":"Otto S. Hoekstra","is_ca":false},{"name":"Lalitha Shankar","is_ca":false},{"name":"Jedd D. Wolchok","is_ca":false},{"name":"Marcus Ballinger","is_ca":false},{"name":"Caroline Caramella","is_ca":false},{"name":"Elisabeth G.E. de Vries","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.8623875272759276,"gpt":0.6325735133841923,"spread":0.2298140138917353,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.1349909,0.003440459,0.01252942,0.009299776,0.002077428,0.009136073,0.008366374,0.009820137,0.02228388],"category_scores_gemma":[0.22507,0.002080813,0.01696014,0.007763213,0.003562039,0.004254583,0.008199942,0.01316734,0.01493832],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006520491,"about_ca_system_score_gemma":0.01940069,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004107356,"about_ca_topic_score_gemma":0.008364408,"domain_scores_codex":[0.8593028,0.07368834,0.04572547,0.002145861,0.0168187,0.002318891],"domain_scores_gemma":[0.7733223,0.1577296,0.02770566,0.006530099,0.03186608,0.002846226],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002605387,0.0001503663,0.001336166,0.1290278,0.003058723,0.0001754469,0.0006869669,0.0009350352,0.000937429,0.01450458,0.3442957,0.5022865],"study_design_scores_gemma":[0.002830973,0.0004273887,0.003979693,0.1518821,0.00449629,0.0004792835,0.0002905843,0.0006331754,0.00107662,0.0261819,0.8075159,0.0002061102],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"methods","genre_scores_codex":[0.001252779,0.7475554,0.05752648,0.07057121,0.01607583,0.03137224,0.02504126,0.003536735,0.04706803],"genre_scores_gemma":[0.02066108,0.2780234,0.3852513,0.1268914,0.008644222,0.1216651,0.03247377,0.002347013,0.02404267],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.8650091,"threshold_uncertainty_score":0.7139089,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2752227448","doi":"10.1056/nejmoa1709030","title":"Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma","year":2017,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2207,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Medical Research Council; Cancer Research UK","keywords":"Ipilimumab; Nivolumab; Medicine; Melanoma; Adjuvant; Adjuvant therapy; Oncology; Internal medicine; Placebo; Immunotherapy; Chemotherapy; Cancer; Cancer research; Pathology","authors":[{"name":"Jeffrey S. Weber","is_ca":false},{"name":"Mario Mandalà","is_ca":false},{"name":"Michele Del Vecchio","is_ca":false},{"name":"Helen Gogas","is_ca":false},{"name":"Ana Arance","is_ca":false},{"name":"C. Lance Cowey","is_ca":false},{"name":"Stéphane Dalle","is_ca":false},{"name":"Michael Schenker","is_ca":false},{"name":"Vanna Chiarion‐Sileni","is_ca":false},{"name":"Iván Márquez‐Rodas","is_ca":false},{"name":"Jean-Jacques Grob","is_ca":false},{"name":"Marcus O. Butler","is_ca":true},{"name":"Mark R. Middleton","is_ca":false},{"name":"Michele Maio","is_ca":false},{"name":"Victoria Atkinson","is_ca":false},{"name":"Paola Queirolo","is_ca":false},{"name":"René González","is_ca":false},{"name":"Ragini R. Kudchadkar","is_ca":false},{"name":"Michael Smylie","is_ca":false},{"name":"Nicolás Meyer","is_ca":false},{"name":"Laurent Mortier","is_ca":false},{"name":"Michael B. Atkins","is_ca":false},{"name":"Georgina V. Long","is_ca":false},{"name":"Shailender Bhatia","is_ca":false},{"name":"Célèste Lebbé","is_ca":false},{"name":"Piotr Rutkowski","is_ca":false},{"name":"Kenji Yokota","is_ca":false},{"name":"Naoya Yamazaki","is_ca":false},{"name":"Tae M. Kim","is_ca":false},{"name":"Veerle de Pril","is_ca":false},{"name":"Javier Sabater","is_ca":false},{"name":"Anila Qureshi","is_ca":false},{"name":"James Larkin","is_ca":false},{"name":"Paolo A. Ascierto","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05226193040225233,"gpt":0.3429099879807146,"spread":0.2906480575784622,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001473913,0.0006143393,0.001712756,0.0002843452,0.0002321909,0.0005076934,0.0004559985,0.0005947761,0.002066283],"category_scores_gemma":[0.001768366,0.0003015665,0.001364241,0.0002030177,0.0004242888,0.0003558553,0.0002568492,0.00164053,0.0003092442],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007433989,"about_ca_system_score_gemma":0.001043184,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008117885,"about_ca_topic_score_gemma":0.001612446,"domain_scores_codex":[0.9994882,0.0002836933,0.00005537202,0.0000636179,0.00004484124,0.00006427089],"domain_scores_gemma":[0.9991672,0.0002998586,0.0001734524,0.00004296536,0.00003485299,0.000281715],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9273387,0.00553244,0.003168524,0.0005761403,0.0009142619,0.00006870637,0.00006832361,0.001442543,0.0057706,0.00007757105,0.0005400695,0.05450215],"study_design_scores_gemma":[0.525883,0.4437955,0.0186043,0.0002232401,0.001681681,0.0002609348,0.00006689094,0.003388907,0.003793669,0.0004279182,0.001842728,0.00003122657],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938591,0.004370653,0.0002830582,0.0001939231,0.0001999304,0.000433887,0.0001144138,0.00002362644,0.0005213511],"genre_scores_gemma":[0.9965984,0.001778668,0.0004013922,0.0002312449,0.0001426015,0.000291602,0.0001445033,0.000004963545,0.0004066198],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002066283,"threshold_uncertainty_score":0.007794917,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2802206159","doi":"10.1016/s0140-6736(18)30789-x","title":"International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study","year":2018,"lang":"en","type":"article","venue":"The Lancet","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2058,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"Institut National de la Santé et de la Recherche Médicale; National Institutes of Health; Agence Nationale de la Recherche","keywords":"Medicine; Colorectal cancer; Oncology; Internal medicine; Cancer; Nomogram; Confounding; Proportional hazards model; Stage (stratigraphy); Immunotherapy; Clinical endpoint; Prognostic variable; Clinical trial","authors":[{"name":"Franck Pagès","is_ca":false},{"name":"Bernhard Mlecnik","is_ca":false},{"name":"Florence Marliot","is_ca":false},{"name":"Gabriela Bindea","is_ca":false},{"name":"Fang‐Shu Ou","is_ca":false},{"name":"Carlo Bifulco","is_ca":false},{"name":"Alessandro Lugli","is_ca":false},{"name":"Inti Zlobec","is_ca":false},{"name":"Tilman T. Rau","is_ca":false},{"name":"Martin D. Berger","is_ca":false},{"name":"Irıs D. Nagtegaal","is_ca":false},{"name":"Elisa Vink‐Börger","is_ca":false},{"name":"Arndt Hartmann","is_ca":false},{"name":"Carol Geppert","is_ca":false},{"name":"Julie Kolwelter","is_ca":false},{"name":"Susanne Merkel","is_ca":false},{"name":"Robert Grützmann","is_ca":false},{"name":"Marc Van den Eynde","is_ca":false},{"name":"Anne Jouret‐Mourin","is_ca":false},{"name":"Alex Kartheuser","is_ca":false},{"name":"Daniel Léonard","is_ca":false},{"name":"Christophe Remue","is_ca":false},{"name":"Julia Y. Wang","is_ca":true},{"name":"Prashant Bavi","is_ca":true},{"name":"Michael H. A. Roehrl","is_ca":true},{"name":"Pamela S. Ohashi","is_ca":true},{"name":"Linh T. Nguyen","is_ca":true},{"name":"SeongJun Han","is_ca":true},{"name":"Heather MacGregor","is_ca":true},{"name":"Sara Hafezi‐Bakhtiari","is_ca":true},{"name":"Bradly G. Wouters","is_ca":true},{"name":"Giuseppe Masucci","is_ca":false},{"name":"Emilia Andersson","is_ca":false},{"name":"Eva Závadová","is_ca":false},{"name":"Michal Vočka","is_ca":false},{"name":"Jiří Špaček","is_ca":false},{"name":"Luboš Petruželka","is_ca":false},{"name":"B Konopásek","is_ca":false},{"name":"Pavel Dundr","is_ca":false},{"name":"Helena Skálová","is_ca":false},{"name":"Kristýna Němejcová","is_ca":false},{"name":"Gerardo Botti","is_ca":false},{"name":"Fabiana Tatangelo","is_ca":false},{"name":"Paolo Delrio","is_ca":false},{"name":"Gennaro Ciliberto","is_ca":false},{"name":"Michele Maio","is_ca":false},{"name":"Luigi Laghi","is_ca":false},{"name":"Fabio Grizzi","is_ca":false},{"name":"Tessa Fredriksen","is_ca":false},{"name":"Bénédicte Buttard","is_ca":false},{"name":"Mihaela Angelova","is_ca":false},{"name":"Angela Vasaturo","is_ca":false},{"name":"Pauline Maby","is_ca":false},{"name":"S. Church","is_ca":false},{"name":"Helen K. Angell","is_ca":false},{"name":"Lucie Lafontaine","is_ca":false},{"name":"Daniela Bruni","is_ca":false},{"name":"Carine El Sissy","is_ca":false},{"name":"Nacilla Haicheur","is_ca":false},{"name":"Amos Kirilovsky","is_ca":false},{"name":"Anne Berger","is_ca":false},{"name":"Christine Lagorce","is_ca":false},{"name":"Jeffrey P. Meyers","is_ca":false},{"name":"Christopher Paustian","is_ca":false},{"name":"Zipei Feng","is_ca":false},{"name":"Carmen Ballesteros‐Merino","is_ca":false},{"name":"Jeroen R. Dijkstra","is_ca":false},{"name":"Carlijn van de Water","is_ca":false},{"name":"Shannon van Vliet","is_ca":false},{"name":"Nikki Knijn","is_ca":false},{"name":"Ana-Maria Mușină","is_ca":false},{"name":"Dragoş Viorel Scripcariu","is_ca":false},{"name":"Boryana Konstantinova Popivanova","is_ca":false},{"name":"Mingli Xu","is_ca":false},{"name":"Tomonobu Fujita","is_ca":false},{"name":"Shoichi Hazama","is_ca":false},{"name":"Nobuaki Suzuki","is_ca":false},{"name":"Hiroaki Nagano","is_ca":false},{"name":"Kiyotaka Okuno","is_ca":false},{"name":"Toshihiko Torigoe","is_ca":false},{"name":"Noriyuki Sato","is_ca":false},{"name":"Tomohisa Furuhata","is_ca":false},{"name":"Ichiro Takemasa","is_ca":false},{"name":"Kyogo Itoh","is_ca":false},{"name":"Prabhudas S. Patel","is_ca":false},{"name":"Hemangini H. Vora","is_ca":false},{"name":"Birva Shah","is_ca":false},{"name":"Jayendrakumar B. Patel","is_ca":false},{"name":"Kruti N. Rajvik","is_ca":false},{"name":"Shashank Pandya","is_ca":false},{"name":"Shilin N. Shukla","is_ca":false},{"name":"Yili Wang","is_ca":false},{"name":"Guanjun Zhang","is_ca":false},{"name":"Yutaka Kawakami","is_ca":false},{"name":"Francesco M. Marincola","is_ca":false},{"name":"Paolo A. Ascierto","is_ca":false},{"name":"Daniel J. Sargent","is_ca":false},{"name":"Bernard A. Fox","is_ca":false},{"name":"Jérôme Galon","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07818886738008371,"gpt":0.3702558735660371,"spread":0.2920670061859534,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02967102,0.001055449,0.001240994,0.003837938,0.001075296,0.002436424,0.001585449,0.001839217,0.001782838],"category_scores_gemma":[0.05328301,0.0004880287,0.001416041,0.002977289,0.00144813,0.001748696,0.002289636,0.001660495,0.001188895],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001237232,"about_ca_system_score_gemma":0.001634426,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002953299,"about_ca_topic_score_gemma":0.003932623,"domain_scores_codex":[0.9873618,0.004760384,0.001253558,0.002205335,0.003415945,0.001003011],"domain_scores_gemma":[0.9497426,0.01387139,0.005313269,0.009820048,0.01930933,0.001943386],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005255301,0.0002991542,0.9107832,0.0002819988,0.002038837,0.0001515753,0.0006925705,0.002407204,0.002714757,0.001081046,0.006819567,0.06747478],"study_design_scores_gemma":[0.0009841848,0.001908283,0.9573658,0.0004063431,0.003051456,0.001587465,0.0006865632,0.01224363,0.003950759,0.001992675,0.01568427,0.0001387047],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9604679,0.007828747,0.01107102,0.00111418,0.0006714446,0.0003337008,0.0037056,0.0001349054,0.01467254],"genre_scores_gemma":[0.9882451,0.0006812637,0.004622417,0.0002672132,0.0001869312,0.0001375168,0.004953651,0.00007995835,0.0008259108],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02967102,"threshold_uncertainty_score":0.1569172,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2797309423","doi":"10.1056/nejmoa1802357","title":"Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma","year":2018,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1853,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Genentech; EUSA Pharma; Merck Sharp and Dohme; Eisai; Universiteit van Amsterdam; Incyte; LEO Pharma; Massachusetts Medical Society; Sun Pharma; Regeneron Pharmaceuticals; Syndax Pharmaceuticals; Sanofi; Amgen; Pfizer; Les Laboratories Pierre Fabre; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Pembrolizumab; Adjuvant; Placebo; Stage (stratigraphy); Medicine; Melanoma; Oncology; Internal medicine; Cancer research; Cancer; Biology; Immunotherapy; Pathology","authors":[{"name":"Alexander M.M. Eggermont","is_ca":false},{"name":"Christian U. Blank","is_ca":false},{"name":"Mario Mandalà","is_ca":false},{"name":"Georgina V. Long","is_ca":false},{"name":"Victoria Atkinson","is_ca":false},{"name":"Stéphane Dalle","is_ca":false},{"name":"Andrew Haydon","is_ca":false},{"name":"Mikhail Lichinitser","is_ca":false},{"name":"Adnan Khattak","is_ca":false},{"name":"Matteo S. Carlino","is_ca":false},{"name":"Shahneen Sandhu","is_ca":false},{"name":"James Larkin","is_ca":false},{"name":"Susana Puig","is_ca":false},{"name":"Paolo A. Ascierto","is_ca":false},{"name":"Piotr Rutkowski","is_ca":false},{"name":"Dirk Schadendorf","is_ca":false},{"name":"Rutger H.T. Koornstra","is_ca":false},{"name":"Leonel F. Hernandez‐Aya","is_ca":false},{"name":"Michele Maio","is_ca":false},{"name":"Alfonsus Johannes Maria van den Eertwegh","is_ca":false},{"name":"Jean-Jacques Grob","is_ca":false},{"name":"Ralf Gutzmer","is_ca":false},{"name":"Rahima Jamal","is_ca":true},{"name":"Paul Lorigan","is_ca":false},{"name":"Nageatte Ibrahim","is_ca":false},{"name":"Sandrine Marréaud","is_ca":false},{"name":"Alexander C. J. van Akkooi","is_ca":false},{"name":"Stefan Suciu","is_ca":false},{"name":"Caroline Robert","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03049556086374712,"gpt":0.3167479901321354,"spread":0.2862524292683883,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001441593,0.0006861074,0.001806818,0.0002739044,0.0002038232,0.0004943332,0.0004039794,0.0006117101,0.001929872],"category_scores_gemma":[0.001476776,0.0002806869,0.000984657,0.0002041151,0.0004202478,0.0003455417,0.0002844002,0.001459027,0.000302818],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005363318,"about_ca_system_score_gemma":0.0009803104,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006645778,"about_ca_topic_score_gemma":0.001173855,"domain_scores_codex":[0.9995974,0.0002380833,0.00003722175,0.00004637781,0.00003456766,0.00004643468],"domain_scores_gemma":[0.9992557,0.0002745898,0.0001771268,0.00003287016,0.00003117247,0.0002285042],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.925862,0.007934527,0.001434835,0.0007713746,0.0008105992,0.00008927257,0.00008427809,0.0007665954,0.01055011,0.00006822373,0.0004323099,0.05119593],"study_design_scores_gemma":[0.426096,0.553597,0.0121622,0.000174753,0.001251398,0.0001975541,0.0000535106,0.001685213,0.003221907,0.0002281468,0.001311213,0.00002114859],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929844,0.005210684,0.0002690047,0.0001813074,0.000171889,0.0004917994,0.0001225716,0.00002751465,0.0005408292],"genre_scores_gemma":[0.9955837,0.002388197,0.0004291301,0.0002374142,0.0001361998,0.0005457481,0.0001404552,0.000004095637,0.00053504],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001929872,"threshold_uncertainty_score":0.007623971,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3109853980","doi":"10.1016/s0140-6736(20)32531-9","title":"Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial","year":2020,"lang":"en","type":"article","venue":"The Lancet","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1800,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Carboplatin; Gemcitabine; Internal medicine; Pembrolizumab; Triple-negative breast cancer; Breast cancer; Oncology; Chemotherapy; Docetaxel; Metastatic breast cancer; Placebo; Taxane; Cancer; Pathology; Cisplatin; Immunotherapy","authors":[{"name":"Javier Cortés","is_ca":false},{"name":"David W. Cescon","is_ca":true},{"name":"Hope S. Rugo","is_ca":false},{"name":"Zbigniew Nowecki","is_ca":false},{"name":"Seock‐Ah Im","is_ca":false},{"name":"Mastura Md Yusof","is_ca":false},{"name":"Carlos Gallardo","is_ca":false},{"name":"Oleg Lipatov","is_ca":false},{"name":"Carlos H. Barrios","is_ca":false},{"name":"Esther Holgado","is_ca":false},{"name":"Hiroji Iwata","is_ca":false},{"name":"Norikazu Masuda","is_ca":false},{"name":"Marco Torregroza Otero","is_ca":false},{"name":"Erhan Gökmen","is_ca":false},{"name":"Sherene Loi","is_ca":false},{"name":"Zifang Guo","is_ca":false},{"name":"Jing Zhao","is_ca":false},{"name":"Gursel Aktan","is_ca":false},{"name":"Vassiliki Karantza","is_ca":false},{"name":"Peter Schmid","is_ca":false},{"name":"F. Vidal Luis","is_ca":false},{"name":"Gomez Abuin Gonzalo","is_ca":false},{"name":"Diego Kaen","is_ca":false},{"name":"Kowalwszyn Ruben","is_ca":false},{"name":"Molina Matias","is_ca":false},{"name":"Varela Mirta","is_ca":false},{"name":"Sally Baron-Hay","is_ca":false},{"name":"Begbie Stephen","is_ca":false},{"name":"Clingan Philip","is_ca":false},{"name":"Loi Sherene","is_ca":false},{"name":"Sabanathan Dhanusha","is_ca":false},{"name":"Andrea Gombos","is_ca":false},{"name":"Donatienne Taylor","is_ca":false},{"name":"Carlos Barrios","is_ca":false},{"name":"Leandro Brust","is_ca":false},{"name":"Costa Fabiano","is_ca":false},{"name":"de Freitas Junior Ruffo","is_ca":false},{"name":"Roberto Hegg","is_ca":false},{"name":"Lacerda Domicio Carvalho","is_ca":false},{"name":"Lissa Fernando Cezar Toniazzi","is_ca":false},{"name":"Rocha Roberto Odebrecht","is_ca":false},{"name":"Scalabrini Neto Antonio Orlando","is_ca":false},{"name":"Silva Felipe","is_ca":false},{"name":"Cescon David","is_ca":true},{"name":"Danielle Charpentier","is_ca":false},{"name":"Xinni Song","is_ca":false},{"name":"Yu Joanne","is_ca":false},{"name":"Alejandro Acevedo","is_ca":false},{"name":"Gallardo Carlos","is_ca":false},{"name":"Salas Claudio","is_ca":false},{"name":"Sanchez Cesar","is_ca":false},{"name":"Eduardo Yañez","is_ca":false},{"name":"Gomez Diaz Alvaro","is_ca":false},{"name":"Sanchez Jesus","is_ca":false},{"name":"Holeckova Petra","is_ca":false},{"name":"Kral Zdenek","is_ca":false},{"name":"Bohuslav Melichar","is_ca":false},{"name":"Katarína Petráková","is_ca":false},{"name":"Prausova Jana","is_ca":false},{"name":"Vesna Glavicic","is_ca":false},{"name":"Jakobsen Erik","is_ca":false},{"name":"Jensen Jeanette","is_ca":false},{"name":"Søren Linnet","is_ca":false},{"name":"Tamás Lörincz","is_ca":false},{"name":"Bonnefoi Herve","is_ca":false},{"name":"Isabelle Desmoulins","is_ca":false},{"name":"Hardy-Bessard Anne-Claire","is_ca":false},{"name":"Luís Teixeira","is_ca":false},{"name":"Blohmer Jens-Uwe","is_ca":false},{"name":"Fasching Peter","is_ca":false},{"name":"Dirk Forstmeyer","is_ca":false},{"name":"Nadia Harbeck","is_ca":false},{"name":"Huober Jens","is_ca":false},{"name":"Kaczerowsky Flores de Sousa Anna","is_ca":false},{"name":"Kurbacher Christian","is_ca":false},{"name":"Sibylle Loibl","is_ca":false},{"name":"Lueftner Diana","is_ca":false},{"name":"Park-Simon Tjoung-Won","is_ca":false},{"name":"Schumann Raquel Von","is_ca":false},{"name":"Pauline Wimberger","is_ca":false},{"name":"Chow Louis","is_ca":false},{"name":"Kwong Ava","is_ca":false},{"name":"Ngan Kai Cheong Roger","is_ca":false},{"name":"Peter Arkosy","is_ca":false},{"name":"Tibor Csőszi","is_ca":false},{"name":"Zsuzsanna Kahán","is_ca":false},{"name":"Landherr László","is_ca":false},{"name":"Mahr Karoly","is_ca":false},{"name":"Gábor Rubovszky","is_ca":false},{"name":"Kelly Catherine","is_ca":false},{"name":"O'Reilly Seamus","is_ca":false},{"name":"Saverio Cinieri","is_ca":false},{"name":"DAlessio Antonietta","is_ca":false},{"name":"Ricevuto Enrico","is_ca":false},{"name":"Tomoyuki Aruga","is_ca":false},{"name":"Takaaki Fujii","is_ca":false},{"name":"Inoue Kenichi","is_ca":false},{"name":"Takashi Ishikawa","is_ca":false},{"name":"Ito Yoshinori","is_ca":false},{"name":"Tsutomu Iwasa","is_ca":false},{"name":"Yoshimasa Kosaka","is_ca":false},{"name":"Matsumoto Koji","is_ca":false},{"name":"Yasuo Miyoshi","is_ca":false},{"name":"Hirofumi Mukai","is_ca":false},{"name":"Seigo Nakamura","is_ca":false},{"name":"Naoki Niikura","is_ca":false},{"name":"Ohtani Shoichiro","is_ca":false},{"name":"Osaki Akihiko","is_ca":false},{"name":"Yasuaki Sagara","is_ca":false},{"name":"Masato Takahashi","is_ca":false},{"name":"Yuko Tanabe","is_ca":false},{"name":"Kenji Tamura","is_ca":false},{"name":"Koichiro Tsugawa","is_ca":false},{"name":"Junichiro Watanabe","is_ca":false},{"name":"Yamamoto Naohito","is_ca":false},{"name":"Yutaka Yamamoto","is_ca":false},{"name":"Teruo Yamauchi","is_ca":false},{"name":"Bustam Anita","is_ca":false},{"name":"M.Y. Mastura","is_ca":false},{"name":"Gomez Villanueva Angel","is_ca":false},{"name":"Juarez Ramiro Alejandro","is_ca":false},{"name":"Martinez Rodriguez Jorge","is_ca":false},{"name":"Morales-Vasquez Flavia","is_ca":false},{"name":"Reyes Contreras Jessica","is_ca":false},{"name":"Beelen Karin","is_ca":false},{"name":"Tjan-Heijnen Vivianne","is_ca":false},{"name":"Porter David","is_ca":true},{"name":"Ewa Chmielowska","is_ca":false},{"name":"Nowakowska-Zajdel Ewa","is_ca":false},{"name":"Nowecki Zbigniew","is_ca":false},{"name":"Radecka Barbara","is_ca":false},{"name":"Joanna Streb","is_ca":false},{"name":"Szczylik Cezary","is_ca":false},{"name":"R. Tarnawski","is_ca":false},{"name":"Zurawski Bogdan","is_ca":false},{"name":"Arkhipov Alexander","is_ca":false},{"name":"Natalia Fadeeva","is_ca":false},{"name":"Meshcheryakov Andrey","is_ca":false},{"name":"Moiseyenko Vladimir","is_ca":false},{"name":"Mukhametshina Guzel","is_ca":false},{"name":"Ahn Jin Hee","is_ca":false},{"name":"Im Seock-Ah","is_ca":false},{"name":"Lee Keun Seok","is_ca":false},{"name":"Park Kwong Hwa","is_ca":false},{"name":"Park Yeon Hee","is_ca":false},{"name":"Bermejo de las Heras Begona","is_ca":false},{"name":"Cortes Javier","is_ca":false},{"name":"Cruz Jurado Josefina","is_ca":false},{"name":"Garcia Saenz Jose","is_ca":false},{"name":"Maria Gion","is_ca":false},{"name":"Zamora Adelantado Esther","is_ca":false},{"name":"Chien-Ting Liu","is_ca":false},{"name":"Mei-Ching Liu","is_ca":false},{"name":"Chiun‐Sheng Huang","is_ca":false},{"name":"Tsao Chao-Jung","is_ca":false},{"name":"Ling-Ming Tseng","is_ca":false},{"name":"Çağatay Arslan","is_ca":false},{"name":"Basaran Gul","is_ca":false},{"name":"İrfan Çiçin","is_ca":false},{"name":"Erhan Gokmen","is_ca":false},{"name":"Molinas Mandel Nil","is_ca":false},{"name":"Özgüroğlu Mustafa","is_ca":false},{"name":"Ozyilkan Ozgur","is_ca":false},{"name":"Sinan Yavuz","is_ca":false},{"name":"C. R. Williams Steve","is_ca":false},{"name":"Graham Janine","is_ca":false},{"name":"MacPherson Iain","is_ca":false},{"name":"Schmid Peter","is_ca":false},{"name":"Turner Nicholas","is_ca":false},{"name":"Tuthill Mark","is_ca":false},{"name":"Twelves Christopher","is_ca":false},{"name":"W Duncan","is_ca":false},{"name":"Hryhoriy Adamchuk","is_ca":false},{"name":"Oleksandr Berzoy","is_ca":false},{"name":"Bondarenko Igor","is_ca":false},{"name":"Kolesnik Oleksii","is_ca":false},{"name":"O. Kolesnik","is_ca":false},{"name":"Komisarenko Hanna","is_ca":false},{"name":"Leshchenko Iurii","is_ca":false},{"name":"Nasonova Alla","is_ca":false},{"name":"Otchenash Natalya","is_ca":false},{"name":"Ponomarova Olga","is_ca":false},{"name":"Rusyn Andrii","is_ca":false},{"name":"Sergii Shevnya","is_ca":false},{"name":"Yaroslav Shparyk","is_ca":false},{"name":"Dmytro Trukhin","is_ca":false},{"name":"Grygorii Ursol","is_ca":false},{"name":"Vynnychenko Ihor","is_ca":false},{"name":"Sibel Blau","is_ca":false},{"name":"Madhu Chaudhry","is_ca":false},{"name":"Michael Chung","is_ca":false},{"name":"C. Patrick","is_ca":false},{"name":"C. Scott","is_ca":false},{"name":"Jennifer R. Diamond","is_ca":false},{"name":"Hargis Jeffrey","is_ca":false},{"name":"Irvin William","is_ca":false},{"name":"Randa Loutfi","is_ca":false},{"name":"Lu Janice","is_ca":false},{"name":"Mena Raul","is_ca":false},{"name":"Moore Susan","is_ca":false},{"name":"Rita Nanda","is_ca":false},{"name":"Ira Oliff","is_ca":false},{"name":"Omene Coral","is_ca":false},{"name":"Panella Timothy","is_ca":false},{"name":"Panwalkar Amit","is_ca":false},{"name":"Brian J. Patson","is_ca":false},{"name":"Hope Rugo","is_ca":false},{"name":"Irina Rybalova","is_ca":false},{"name":"Schleider Michael","is_ca":false},{"name":"Siegel Robert","is_ca":false},{"name":"Simon Michael","is_ca":false},{"name":"Stampleman Laura","is_ca":false},{"name":"Sumrall Bradley","is_ca":false},{"name":"Tsai Michaela","is_ca":false},{"name":"Frances Valdes-Albini","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1378372333894381,"gpt":0.4138224453152746,"spread":0.2759852119258366,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001801561,0.002071189,0.003490606,0.0005519,0.0004993777,0.001171895,0.001110336,0.00225999,0.01014401],"category_scores_gemma":[0.001634623,0.0008056305,0.002077576,0.0004650534,0.001339599,0.001270415,0.0004831637,0.003170807,0.00169523],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007851884,"about_ca_system_score_gemma":0.001043835,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001361051,"about_ca_topic_score_gemma":0.002576913,"domain_scores_codex":[0.999463,0.0002400146,0.00003210411,0.0001297819,0.00003654863,0.00009861179],"domain_scores_gemma":[0.9993955,0.000193726,0.0001313913,0.00004515854,0.00003348701,0.000200748],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9859915,0.003186912,0.0001014813,0.0005923121,0.0004168491,0.00001771515,0.0000302399,0.0001515259,0.001483654,0.00008967397,0.0004471189,0.007490886],"study_design_scores_gemma":[0.9634804,0.03511599,0.0004154814,0.00003166476,0.0002191072,0.00001269688,0.00001180516,0.0001550773,0.0001515419,0.00009423377,0.0003032076,0.000008921486],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9712752,0.01070049,0.00128197,0.001321441,0.001779539,0.007700333,0.001691805,0.000289314,0.003959995],"genre_scores_gemma":[0.9735314,0.005897978,0.002213702,0.001990512,0.0007476402,0.007352525,0.001154157,0.0000417314,0.007070308],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01014401,"threshold_uncertainty_score":0.03393513,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2945057866","doi":"10.1038/s41568-019-0144-6","title":"Tertiary lymphoid structures in the era of cancer immunotherapy","year":2019,"lang":"en","type":"review","venue":"Nature reviews. Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1784,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Labex Immuno-Oncology; Sorbonne Université; Institut National de la Santé et de la Recherche Médicale; Institute of Cancer Research; Institut National Du Cancer; Association pour la Recherche sur le Cancer","keywords":"Immunotherapy; Cancer immunotherapy; Medicine; Cancer; Immunology; Internal medicine","authors":[{"name":"Catherine Sautès‐Fridman","is_ca":false},{"name":"Florent Petitprez","is_ca":false},{"name":"Julien Caldéraro","is_ca":false},{"name":"Wolf H. Fridman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03471973675741632,"gpt":0.4036705072742845,"spread":0.3689507705168682,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007312483,0.0008787463,0.001717731,0.001901735,0.0003297413,0.001584509,0.001027899,0.001957187,0.004962787],"category_scores_gemma":[0.0009386995,0.0003108454,0.0004756656,0.001724645,0.0008560683,0.00185132,0.001178793,0.003420593,0.002932409],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001275117,"about_ca_system_score_gemma":0.001433085,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008716027,"about_ca_topic_score_gemma":0.001971379,"domain_scores_codex":[0.9997298,0.00006088909,0.00002850882,0.00004018624,0.0000977594,0.00004284536],"domain_scores_gemma":[0.9995022,0.0002195155,0.00008121524,0.0000137724,0.0001234791,0.00005979956],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.000127733,0.00004503855,0.0001429009,0.0117498,0.00004021026,0.000184582,0.00004185131,0.000387914,0.001739248,0.009211402,0.08068287,0.8956466],"study_design_scores_gemma":[0.00001773333,0.00005233433,0.0003433274,0.002576696,0.00004407766,0.0007687123,0.00002968372,0.00007135893,0.0001992155,0.003733803,0.9921524,0.00001064285],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003163261,0.9985369,0.0000560139,0.0005168416,0.0003529038,0.000001413268,0.00000875282,0.000004390182,0.0004910199],"genre_scores_gemma":[0.0005143793,0.9973997,0.00008947556,0.0006391541,0.0006648452,0.000003930135,0.00002222146,0.000001375831,0.0006649269],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004962787,"threshold_uncertainty_score":0.0166021,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1990675339","doi":"10.1016/s0140-6736(14)60958-2","title":"Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial","year":2014,"lang":"en","type":"article","venue":"The Lancet","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1761,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Ipilimumab; Internal medicine; Clinical endpoint; Adverse effect; Refractory (planetary science); Cohort; Clinical trial; Melanoma; Response Evaluation Criteria in Solid Tumors; Gastroenterology; Surgery; Phases of clinical research; Cancer; Immunotherapy","authors":[{"name":"Caroline Robert","is_ca":false},{"name":"Antoni Ribas","is_ca":false},{"name":"Jedd D. Wolchok","is_ca":false},{"name":"F. Stephen Hodi","is_ca":false},{"name":"Omid Hamid","is_ca":false},{"name":"Richard Kefford","is_ca":false},{"name":"Jeffrey S. Weber","is_ca":false},{"name":"Anthony M. Joshua","is_ca":true},{"name":"Wen-Jen Hwu","is_ca":false},{"name":"Tara C. Gangadhar","is_ca":false},{"name":"Amita Patnaik","is_ca":false},{"name":"Roxana Dronca","is_ca":false},{"name":"Hassane M. Zarour","is_ca":false},{"name":"Richard W. Joseph","is_ca":false},{"name":"Peter D. Boasberg","is_ca":false},{"name":"Bartosz Chmielowski","is_ca":false},{"name":"Christine Mateus","is_ca":false},{"name":"Michael A. Postow","is_ca":false},{"name":"Kevin Gergich","is_ca":false},{"name":"Jeroen Elassaiss‐Schaap","is_ca":false},{"name":"Xiaoyun Li","is_ca":false},{"name":"Robert Iannone","is_ca":false},{"name":"Scot Ebbinghaus","is_ca":false},{"name":"Soonmo Peter Kang","is_ca":false},{"name":"Adil Daud","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03062678598511109,"gpt":0.3242064810358412,"spread":0.2935796950507301,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003245996,0.002845577,0.004221736,0.0004793212,0.0006705007,0.001958917,0.001294077,0.002228184,0.005790249],"category_scores_gemma":[0.002959124,0.001143615,0.003709601,0.0005111485,0.00170421,0.00193308,0.0006283458,0.005429523,0.001357549],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00160424,"about_ca_system_score_gemma":0.001000059,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001122701,"about_ca_topic_score_gemma":0.001805521,"domain_scores_codex":[0.9984131,0.0008461134,0.0000625195,0.0003148354,0.00008754927,0.0002758771],"domain_scores_gemma":[0.9984641,0.0004530211,0.0003526554,0.0002603245,0.00009066597,0.0003791623],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9844892,0.003581092,0.0008329683,0.0001977602,0.001286784,0.0000350673,0.00005075047,0.0003670411,0.002024182,0.00006325534,0.0005351815,0.006536719],"study_design_scores_gemma":[0.9352221,0.05866689,0.003688937,0.00002474521,0.0009776794,0.00004705934,0.00003101922,0.0003174911,0.0003091976,0.0001994389,0.0004932889,0.00002217321],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913381,0.003327304,0.0004754906,0.0005747717,0.0004004033,0.001537157,0.0009232838,0.0000572088,0.001366381],"genre_scores_gemma":[0.9896991,0.001807247,0.0007774161,0.0009167676,0.0004737624,0.002018428,0.001348539,0.00003413305,0.002924635],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005790249,"threshold_uncertainty_score":0.01937038,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2910245285","doi":"10.1200/jco.18.00149","title":"Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1716,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Kingston General Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Lung cancer; Chemotherapy; Internal medicine; Hazard ratio; Oncology; Tolerability; Clinical endpoint; Chemotherapy regimen; Surgery; Cancer; Confidence interval; Randomized controlled trial; Immunotherapy; Adverse effect","authors":[{"name":"Martin Reck","is_ca":false},{"name":"Delvys Rodríguez‐Abreu","is_ca":false},{"name":"Andrew Robinson","is_ca":true},{"name":"Rina Hui","is_ca":false},{"name":"Tibor Csőszi","is_ca":false},{"name":"Andrea Fülöp","is_ca":false},{"name":"Maya Gottfried","is_ca":false},{"name":"Nir Peled","is_ca":false},{"name":"Ali Tafreshi","is_ca":false},{"name":"Sinéad Cuffe","is_ca":false},{"name":"Mary O’ Brien","is_ca":false},{"name":"Suman Rao","is_ca":false},{"name":"Katsuyuki Hotta","is_ca":false},{"name":"Kristel Vandormael","is_ca":false},{"name":"Antonio Riccio","is_ca":false},{"name":"Jing Yang","is_ca":false},{"name":"M. Catherine Pietanza","is_ca":false},{"name":"Julie R. Brahmer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06235330001325926,"gpt":0.4207660967554982,"spread":0.3584127967422389,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009646003,0.0008754477,0.002036453,0.0004345941,0.0002384221,0.0008546412,0.00130913,0.0007249898,0.004287345],"category_scores_gemma":[0.01055482,0.0004464539,0.004777201,0.0004683204,0.000368158,0.000853802,0.0006990473,0.001731911,0.0003474011],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008649815,"about_ca_system_score_gemma":0.0007954619,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0011063,"about_ca_topic_score_gemma":0.001819319,"domain_scores_codex":[0.993218,0.004897254,0.0003252117,0.0006953342,0.0006463272,0.0002177701],"domain_scores_gemma":[0.9922998,0.003852878,0.001876436,0.001168685,0.0003958466,0.0004063823],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8445023,0.002623045,0.03533982,0.001220603,0.03306606,0.0001811202,0.0001415257,0.007429079,0.005855503,0.000367018,0.004022516,0.06525126],"study_design_scores_gemma":[0.2947522,0.1944775,0.3698161,0.0001885455,0.08654241,0.0007288952,0.000133306,0.02845736,0.0102859,0.001442709,0.01300121,0.0001738866],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9836933,0.003008842,0.004575294,0.0002813852,0.0001118135,0.001277187,0.0047897,0.0001382335,0.002124135],"genre_scores_gemma":[0.990405,0.0003995086,0.002402706,0.000357121,0.00009006479,0.0006263761,0.004423589,0.00003564284,0.001260029],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009646003,"threshold_uncertainty_score":0.05101353,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2946386783","doi":"10.1016/s1470-2045(19)30167-6","title":"Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1681,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"William Osler Health System","funders":"F. Hoffmann-La Roche","keywords":"Carboplatin; Medicine; Paclitaxel; Atezolizumab; Chemotherapy; Oncology; Nab-paclitaxel; Open label; Internal medicine; Lung cancer; Cisplatin; Cancer; Randomized controlled trial; Nivolumab; Immunotherapy","authors":[{"name":"Howard West","is_ca":false},{"name":"Michael McCleod","is_ca":false},{"name":"Maen Hussein","is_ca":false},{"name":"Alessandro Morabito","is_ca":false},{"name":"Achim Rittmeyer","is_ca":false},{"name":"Henry Jacob Conter","is_ca":true},{"name":"Hans‐Georg Kopp","is_ca":false},{"name":"Davey B. Daniel","is_ca":false},{"name":"Steven McCune","is_ca":false},{"name":"Tarek Mekhail","is_ca":false},{"name":"Alona Zer","is_ca":false},{"name":"Niels Reinmuth","is_ca":false},{"name":"Ahad A. Sadiq","is_ca":false},{"name":"Alan Sandler","is_ca":false},{"name":"Wei Lin","is_ca":false},{"name":"Tania Ochi Lohmann","is_ca":false},{"name":"Venice Archer","is_ca":false},{"name":"Lijia Wang","is_ca":false},{"name":"Marcin Kowanetz","is_ca":false},{"name":"Federico Cappuzzo","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04848363890646765,"gpt":0.3745263839184664,"spread":0.3260427450119987,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001436069,0.001654114,0.003255459,0.0004323825,0.0002972732,0.001330272,0.001050701,0.001718516,0.005388233],"category_scores_gemma":[0.001600775,0.0006528576,0.002665903,0.0004110274,0.001095064,0.001309871,0.0005818301,0.004262108,0.001004379],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008365454,"about_ca_system_score_gemma":0.0008349705,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001128154,"about_ca_topic_score_gemma":0.002456475,"domain_scores_codex":[0.999467,0.0002713145,0.00002721836,0.0001078579,0.00004012597,0.00008655836],"domain_scores_gemma":[0.9993384,0.0002209096,0.0001440123,0.00004824136,0.00003468196,0.0002136695],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9768663,0.003732312,0.0004754365,0.0005931242,0.001077492,0.0000234917,0.00005103008,0.0003888814,0.001942782,0.0001040249,0.0008094474,0.01393559],"study_design_scores_gemma":[0.9091512,0.0872168,0.001623417,0.00003647053,0.0005854188,0.00003762478,0.00002580048,0.0004491236,0.000259013,0.0001356174,0.0004628479,0.00001657619],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9893066,0.004456061,0.0004360082,0.0007439046,0.000680422,0.00139186,0.0009042886,0.0001335074,0.001947351],"genre_scores_gemma":[0.989004,0.002355227,0.001054181,0.0009492929,0.0004053717,0.001457063,0.001224642,0.00003598972,0.003514351],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005388233,"threshold_uncertainty_score":0.0180254,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2117878645","doi":"10.1158/1078-0432.ccr-09-0265","title":"Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 Antibody","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1648,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; York University; Chemotherapy Foundation; Breast Cancer Research Foundation; U.S. Department of Defense","keywords":"Abscopal effect; Radiation therapy; Medicine; CD8; Cancer research; Antibody; Immunotherapy; Growth inhibition; Nasopharyngeal carcinoma; Carcinoma; Dose fractionation; Regimen; Immune system; Oncology; Internal medicine; Immunology; Cell growth; Biology","authors":[{"name":"Md. Zahidunnabi Dewan","is_ca":false},{"name":"Ashley E. Galloway","is_ca":false},{"name":"Noriko Kawashima","is_ca":false},{"name":"J. Keith DeWyngaert","is_ca":false},{"name":"James S. Babb","is_ca":false},{"name":"Silvia C. Formenti","is_ca":false},{"name":"Sandra Demaria","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1219258312480413,"gpt":0.4906271966923983,"spread":0.3687013654443569,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001823767,0.0004634037,0.0005489899,0.0002844466,0.0000867779,0.0001457541,0.0002399272,0.0002012137,0.001528751],"category_scores_gemma":[0.0001256078,0.0001430748,0.0003478024,0.0001169519,0.0002292832,0.0001310763,0.0001619951,0.0006401736,0.0003559837],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001501539,"about_ca_system_score_gemma":0.0002348855,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002373699,"about_ca_topic_score_gemma":0.0006071358,"domain_scores_codex":[0.9998299,0.00003892689,0.000009191624,0.00003072228,0.0000395462,0.00005171302],"domain_scores_gemma":[0.9998531,0.00003006443,0.00003482281,0.00002809437,0.00001009641,0.0000437382],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005942277,0.0004331321,0.0003228904,0.00006768854,0.00002318821,0.00003255254,0.00001097444,0.0001971154,0.9939218,0.00004400929,0.0000562838,0.004296228],"study_design_scores_gemma":[0.0001957842,0.01482269,0.009791841,0.00001881012,0.0001196798,0.0003968054,0.00002386861,0.001220512,0.9718431,0.00004897366,0.001510404,0.000007421751],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972107,0.0007587373,0.0008932771,0.00003159868,0.00003163051,0.000043316,0.00006684371,0.0000604102,0.0009034845],"genre_scores_gemma":[0.9974602,0.0004720373,0.0008881383,0.00004260275,0.00002687832,0.00003910686,0.0001501818,0.00001117319,0.0009097203],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001528751,"threshold_uncertainty_score":0.005114138,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2139591061","doi":"10.1158/0008-5472.can-11-1620","title":"Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1645,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Cancer Institute; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; U.S. Public Health Service","keywords":"Immune system; Cancer; Cancer research; Receptor; Antibody; Immunology; Ipilimumab; Biology; Inhibitory postsynaptic potential; CD8; Blockade; Cancer cell; Immune tolerance; Knockout mouse; Immunotherapy; Neuroscience; Biochemistry","authors":[{"name":"Seng‐Ryong Woo","is_ca":false},{"name":"Meghan E. Turnis","is_ca":false},{"name":"Monica V. Goldberg","is_ca":false},{"name":"Jaishree Bankoti","is_ca":false},{"name":"Mark Selby","is_ca":false},{"name":"Christopher J. Nirschl","is_ca":false},{"name":"Matthew L. Bettini","is_ca":false},{"name":"David M. Gravano","is_ca":false},{"name":"Peter Vogel","is_ca":false},{"name":"Chih Long Liu","is_ca":false},{"name":"Stephanie Tangsombatvisit","is_ca":false},{"name":"Joseph F. Grosso","is_ca":false},{"name":"George J. Netto","is_ca":false},{"name":"Matthew P. Smeltzer","is_ca":false},{"name":"Alcides Chaux","is_ca":false},{"name":"Paul J. Utz","is_ca":false},{"name":"Creg J. Workman","is_ca":false},{"name":"Drew M. Pardoll","is_ca":false},{"name":"Alan J. Korman","is_ca":false},{"name":"Charles G. Drake","is_ca":false},{"name":"Dario A.A. Vignali","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05320576067752921,"gpt":0.3317385669488215,"spread":0.2785328062712923,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001442973,0.0003574842,0.0002458547,0.0002232292,0.0001037521,0.0004082032,0.0001800558,0.0001920531,0.0006148735],"category_scores_gemma":[0.00009646305,0.0001214592,0.0002378266,0.0001188883,0.0002709109,0.0001851052,0.000342748,0.0006045045,0.0002002762],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002526683,"about_ca_system_score_gemma":0.0002468325,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001409183,"about_ca_topic_score_gemma":0.0004189049,"domain_scores_codex":[0.9998734,0.00001983948,0.000007056054,0.00001643496,0.00002644987,0.00005683994],"domain_scores_gemma":[0.9999226,0.0000141915,0.00002174883,0.00001006831,0.000003798766,0.00002756469],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002436912,0.00005523536,0.0005932049,0.00002985979,0.000008947666,0.0000606367,0.00001049761,0.0003973085,0.9940593,0.000300001,0.00005217791,0.004189152],"study_design_scores_gemma":[0.00009442813,0.001098373,0.003436625,0.000006404356,0.00005567941,0.000425374,0.00002035147,0.002512754,0.9899592,0.0003076653,0.002077335,0.000005895942],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942264,0.001734205,0.002751398,0.00007090224,0.00001676079,0.00001499878,0.00004819166,0.00008653076,0.001050636],"genre_scores_gemma":[0.9981578,0.0003765229,0.001004397,0.00002769733,0.000007519798,0.0000100016,0.00003233249,0.000006495503,0.0003771767],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0006148735,"threshold_uncertainty_score":0.002056956,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3128131226","doi":"10.1038/s41571-021-00473-5","title":"PD-L1 as a biomarker of response to immune-checkpoint inhibitors","year":2021,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1560,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Biomarker; Concordance; Biomarker discovery; Oncology; Companion diagnostic; Immune checkpoint; Clinical trial; PD-L1; Cancer; Disease; Internal medicine; Immunotherapy; Bioinformatics; Biology; Proteomics","authors":[{"name":"Deborah B. Doroshow","is_ca":false},{"name":"Sheena Bhalla","is_ca":false},{"name":"Mary Beth Beasley","is_ca":false},{"name":"Lynette M. Sholl","is_ca":false},{"name":"Keith M. Kerr","is_ca":false},{"name":"Sacha Gnjatic","is_ca":false},{"name":"Ignacio I. Wistuba","is_ca":false},{"name":"David L. Rimm","is_ca":false},{"name":"Ming‐Sound Tsao","is_ca":true},{"name":"Fred R. Hirsch","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1525086424784524,"gpt":0.5349054464247085,"spread":0.3823968039462561,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001293575,0.001020007,0.002203325,0.001662961,0.0001314762,0.001233854,0.0008329708,0.001040451,0.001394844],"category_scores_gemma":[0.002235721,0.0002872797,0.0007389111,0.001490255,0.0004329873,0.0008537755,0.0006072524,0.002176594,0.0009298136],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008320188,"about_ca_system_score_gemma":0.001156214,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0011316,"about_ca_topic_score_gemma":0.001897634,"domain_scores_codex":[0.9996407,0.00008278984,0.00005849744,0.00006545806,0.0001237495,0.00002880431],"domain_scores_gemma":[0.9990829,0.0005439791,0.0001392774,0.00001789121,0.0001781535,0.0000378345],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000221009,0.00005270617,0.0005057952,0.01026335,0.0002390374,0.00007580683,0.00001791723,0.0004273812,0.0008256427,0.002107332,0.02172571,0.9635383],"study_design_scores_gemma":[0.0002455845,0.0005589825,0.004190713,0.01263498,0.001336802,0.001383619,0.00006403381,0.0008337311,0.001732644,0.004456829,0.972497,0.00006513736],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009533158,0.9989618,0.0001062643,0.0002887973,0.0001710064,0.000003904689,0.00002036315,0.000004106967,0.0003483571],"genre_scores_gemma":[0.001990771,0.9961817,0.0002882299,0.0006284972,0.0003830998,0.00001699303,0.00006648295,0.000001619142,0.0004426426],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002203325,"threshold_uncertainty_score":0.006841123,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2789315292","doi":"10.1016/j.jacc.2018.02.037","title":"Myocarditis in Patients Treated With Immune Checkpoint Inhibitors","year":2018,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1542,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Ted Rogers Centre for Heart Research; Toronto General Hospital; University of Toronto","funders":"National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute; National Cancer Institute; National Institutes of Health; Kohlberg Foundation; Sarnoff Cardiovascular Research Foundation; Canadian Institutes of Health Research; Harvard University Center for AIDS Research; American Heart Association","keywords":"Medicine; Myocarditis; Immune system; Immune checkpoint; Immunology; Internal medicine; Immunotherapy","authors":[{"name":"Syed Mahmood","is_ca":false},{"name":"Michael G. Fradley","is_ca":false},{"name":"Justine V. Cohen","is_ca":false},{"name":"Anju Nohria","is_ca":false},{"name":"Kerry L. Reynolds","is_ca":false},{"name":"Lucie Heinzerling","is_ca":false},{"name":"Ryan J. Sullivan","is_ca":false},{"name":"Rongras Damrongwatanasuk","is_ca":false},{"name":"Carol L. Chen","is_ca":false},{"name":"Dipti Gupta","is_ca":false},{"name":"Michael Constantin Kirchberger","is_ca":false},{"name":"Magid Awadalla","is_ca":false},{"name":"Malek Hassan","is_ca":false},{"name":"Javid J. Moslehi","is_ca":false},{"name":"Sachin Shah","is_ca":false},{"name":"Sarju Ganatra","is_ca":false},{"name":"Paaladinesh Thavendiranathan","is_ca":true},{"name":"Donald P. Lawrence","is_ca":false},{"name":"John D. Groarke","is_ca":false},{"name":"Tomas G. Neilan","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.006600490092082035,"gpt":0.2368405581345571,"spread":0.2302400680424751,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003224752,0.0002697272,0.0005691994,0.0004256494,0.0004537312,0.000791788,0.0001848938,0.000597092,0.002244312],"category_scores_gemma":[0.001551467,0.0001801219,0.0005895467,0.0004961655,0.0002411475,0.0004601037,0.0002843433,0.0008518739,0.0002004056],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002712531,"about_ca_system_score_gemma":0.0003292242,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005452886,"about_ca_topic_score_gemma":0.0008796183,"domain_scores_codex":[0.9996747,0.00006892398,0.00004029232,0.00006016652,0.00005822559,0.00009771812],"domain_scores_gemma":[0.9994697,0.0001314041,0.0002086983,0.00001851162,0.00003337224,0.0001382714],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002824734,0.000192369,0.9745952,0.00008242766,0.0003031481,0.003214659,0.00007152901,0.0001010648,0.001410143,0.0001351185,0.0007427428,0.01632687],"study_design_scores_gemma":[0.0002402523,0.0008912081,0.9892196,0.00008728016,0.0003694284,0.006667057,0.0003192673,0.0003467802,0.0002120124,0.0002369753,0.001396496,0.00001374128],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9887384,0.004966037,0.000154232,0.0006666436,0.0001471927,0.00002165727,0.0001591785,0.00001114372,0.005135461],"genre_scores_gemma":[0.9976379,0.001151143,0.00007153893,0.0002842387,0.0002916099,0.00001162469,0.0002118975,0.000002509781,0.0003376557],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002244312,"threshold_uncertainty_score":0.007508039,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2896600825","doi":"10.1016/s1470-2045(18)30700-9","title":"Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial","year":2018,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1409,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Ono Pharmaceutical; Bristol-Myers Squibb","keywords":"Ipilimumab; Nivolumab; Medicine; Internal medicine; Oncology; Immunotherapy; Cancer","authors":[{"name":"F. Stephen Hodi","is_ca":false},{"name":"Vanna Chiarion‐Sileni","is_ca":false},{"name":"René González","is_ca":false},{"name":"Jean-Jacques Grob","is_ca":false},{"name":"Piotr Rutkowski","is_ca":false},{"name":"C. Lance Cowey","is_ca":false},{"name":"Christopher D. Lao","is_ca":false},{"name":"Dirk Schadendorf","is_ca":false},{"name":"John Wagstaff","is_ca":false},{"name":"Reinhard Dummer","is_ca":false},{"name":"Pier Francesco Ferrucci","is_ca":false},{"name":"Michael Smylie","is_ca":false},{"name":"Andrew Hill","is_ca":false},{"name":"David Hogg","is_ca":true},{"name":"Iván Márquez‐Rodas","is_ca":false},{"name":"Joel Jiang","is_ca":false},{"name":"Jasmine I. Rizzo","is_ca":false},{"name":"James Larkin","is_ca":false},{"name":"Jedd D. Wolchok","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.059457284228469,"gpt":0.3855917897477813,"spread":0.3261345055193123,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003002837,0.001743852,0.002991277,0.000393988,0.0003877135,0.001412676,0.001170035,0.002018235,0.004666755],"category_scores_gemma":[0.002533619,0.0006652029,0.003564826,0.0003672662,0.001231366,0.001540654,0.0006387323,0.004321244,0.001026548],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001109391,"about_ca_system_score_gemma":0.0008640326,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001426132,"about_ca_topic_score_gemma":0.002850078,"domain_scores_codex":[0.9989017,0.0006663247,0.00004806115,0.0001735914,0.0000625976,0.0001475588],"domain_scores_gemma":[0.9986687,0.0005035638,0.0002844,0.0001151541,0.00005813583,0.0003701265],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9841275,0.001945246,0.0005567081,0.0003754981,0.001489071,0.00002100971,0.00003956338,0.0003567301,0.001150996,0.00007194017,0.0006418975,0.009223809],"study_design_scores_gemma":[0.9468643,0.04830842,0.002498664,0.000044031,0.001052334,0.00002799777,0.00002794036,0.000361023,0.0002294098,0.0001761786,0.0003915267,0.00001819051],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9869451,0.006883196,0.0004862803,0.0009162442,0.0006652562,0.00124222,0.000955089,0.0000996176,0.001807025],"genre_scores_gemma":[0.9902418,0.002380492,0.001053218,0.0009745004,0.0004235962,0.001079814,0.001107645,0.00003522572,0.002703754],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004666755,"threshold_uncertainty_score":0.0158807,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1859257957","doi":"10.1002/path.4287","title":"Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours","year":2013,"lang":"en","type":"review","venue":"The Journal of Pathology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1347,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Labex Immuno-Oncology; Cancer Research Institute; Qatar National Research Fund; Institut National de la Santé et de la Recherche Médicale; Institut National Du Cancer; Assistance publique-Hôpitaux de Paris; Fonds National de la Recherche Luxembourg; European Commission; Pathological Society of Great Britain and Ireland; National Center for Advancing Translational Sciences; Japan Association for Chemical Innovation; Society for Immunotherapy of Cancer","keywords":"Medicine; Oncology; Colorectal cancer; Cancer staging; Cancer; Stage (stratigraphy); Internal medicine; Immune system; TNM staging system; Neoplasm staging; Immunology; Biology","authors":[{"name":"Jérôme Galon","is_ca":false},{"name":"Bernhard Mlecnik","is_ca":false},{"name":"Gabriela Bindea","is_ca":false},{"name":"Helen K. Angell","is_ca":false},{"name":"Anne Berger","is_ca":false},{"name":"Christine Lagorce","is_ca":false},{"name":"Alessandro Lugli","is_ca":false},{"name":"Inti Zlobec","is_ca":false},{"name":"Arndt Hartmann","is_ca":false},{"name":"Carlo Bifulco","is_ca":false},{"name":"Irıs D. Nagtegaal","is_ca":false},{"name":"Richard Palmqvist","is_ca":false},{"name":"Giuseppe Masucci","is_ca":false},{"name":"Gerardo Botti","is_ca":false},{"name":"Fabiana Tatangelo","is_ca":false},{"name":"Paolo Delrio","is_ca":false},{"name":"Michele Maio","is_ca":false},{"name":"Luigi Laghi","is_ca":false},{"name":"Fabio Grizzi","is_ca":false},{"name":"Martin Asslaber","is_ca":false},{"name":"Corrado D’Arrigo","is_ca":false},{"name":"Fernando Vidal‐Vanaclocha","is_ca":false},{"name":"Eva Závadová","is_ca":false},{"name":"Lotfi Chouchane","is_ca":false},{"name":"Pamela S. Ohashi","is_ca":true},{"name":"Sara Hafezi‐Bakhtiari","is_ca":true},{"name":"Bradly G. Wouters","is_ca":true},{"name":"Michael H. A. Roehrl","is_ca":true},{"name":"Linh N Nguyen","is_ca":true},{"name":"Yutaka Kawakami","is_ca":false},{"name":"Shoichi Hazama","is_ca":false},{"name":"Kiyotaka Okuno","is_ca":false},{"name":"Shuji Ogino","is_ca":false},{"name":"Peter Gibbs","is_ca":false},{"name":"Paul Waring","is_ca":false},{"name":"Noriyuki Sato","is_ca":false},{"name":"Toshihiko Torigoe","is_ca":false},{"name":"Kyogo Itoh","is_ca":false},{"name":"Prabhudas S. Patel","is_ca":false},{"name":"Shilin N. Shukla","is_ca":false},{"name":"Yili Wang","is_ca":false},{"name":"Scott Kopetz","is_ca":false},{"name":"Frank A. Sinicrope","is_ca":false},{"name":"Viorel Scripcariu","is_ca":false},{"name":"Paolo A. Ascierto","is_ca":false},{"name":"Francesco M. Marincola","is_ca":false},{"name":"Bernard A. Fox","is_ca":false},{"name":"Franck Pagès","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07554092438918289,"gpt":0.3444991782666527,"spread":0.2689582538774699,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03302651,0.001736823,0.002428333,0.006508643,0.001012706,0.00533135,0.003553725,0.00309318,0.001740677],"category_scores_gemma":[0.03447529,0.0006471041,0.001519446,0.005602694,0.006021746,0.006609122,0.00545157,0.01273696,0.002306829],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004819595,"about_ca_system_score_gemma":0.01041765,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009737046,"about_ca_topic_score_gemma":0.006328388,"domain_scores_codex":[0.9883131,0.004796831,0.001468863,0.00145022,0.003288765,0.0006823295],"domain_scores_gemma":[0.9682401,0.007151433,0.003069327,0.001682114,0.01670653,0.003150369],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000724718,0.0001912608,0.02342372,0.002019457,0.0002457175,0.0003002147,0.0007007598,0.002039067,0.00433545,0.1081726,0.1539512,0.7038958],"study_design_scores_gemma":[0.000133052,0.0008687089,0.02468958,0.002886444,0.0002093047,0.002528599,0.000679195,0.006458924,0.002412845,0.06458692,0.894281,0.0002654485],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"methods","genre_gemma":"review","genre_scores_codex":[0.0304436,0.2633985,0.4162697,0.1971714,0.0602197,0.001425427,0.004038265,0.001832216,0.02520117],"genre_scores_gemma":[0.1194555,0.1110969,0.6484517,0.06426268,0.03436888,0.001661193,0.009961674,0.000866942,0.009874589],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.03302651,"threshold_uncertainty_score":0.1746629,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3049052172","doi":"10.1126/science.abc3421","title":"Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy","year":2020,"lang":"en","type":"article","venue":"Science","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1341,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Alberta Children's Hospital; University of Calgary","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Alberta Innovates; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Inosine; Immunotherapy; Microbiome; Computational biology; Chemistry; Biology; Immunology; Immune system; Bioinformatics; Biochemistry; Adenosine","authors":[{"name":"Lukas F. Mager","is_ca":true},{"name":"Regula Burkhard","is_ca":true},{"name":"Nicola Pett","is_ca":true},{"name":"Noah C.A. Cooke","is_ca":true},{"name":"Kirsty Brown","is_ca":true},{"name":"Hena R. Ramay","is_ca":true},{"name":"Seungil Paik","is_ca":true},{"name":"John Stagg","is_ca":true},{"name":"Ryan A. Groves","is_ca":true},{"name":"Marco Gallo","is_ca":true},{"name":"Ian A. Lewis","is_ca":true},{"name":"Markus B. Geuking","is_ca":true},{"name":"Kathy D. McCoy","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01902200474979086,"gpt":0.2797730999589675,"spread":0.2607510952091767,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002627396,0.0001934606,0.0003629953,0.000197163,0.0001783468,0.0006724246,0.00009653971,0.0005083098,0.002231318],"category_scores_gemma":[0.0006151291,0.0001722536,0.0002507044,0.0001533281,0.0002785468,0.0004131372,0.0003609904,0.001245041,0.0004661019],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003127741,"about_ca_system_score_gemma":0.0002984458,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002982711,"about_ca_topic_score_gemma":0.0005356985,"domain_scores_codex":[0.9997787,0.00006079412,0.00001159999,0.00004146305,0.00004333471,0.00006407015],"domain_scores_gemma":[0.9997752,0.00003224177,0.00008405688,0.00001505652,0.0000306072,0.00006280362],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01446779,0.001115702,0.04027915,0.0008216373,0.0002782713,0.000350777,0.000416272,0.0004278049,0.8440603,0.0009658937,0.006683487,0.09013277],"study_design_scores_gemma":[0.0008184287,0.01357753,0.6616275,0.0003404391,0.0007050444,0.001169231,0.001113242,0.002812885,0.2617465,0.003226905,0.05274934,0.0001128682],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9730117,0.01636854,0.001637194,0.001899249,0.0005749657,0.00007200186,0.001068298,0.0001283057,0.005239766],"genre_scores_gemma":[0.9909967,0.004255213,0.00065944,0.0008416155,0.0001989163,0.00007574706,0.0004230944,0.00002771826,0.002521508],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002231318,"threshold_uncertainty_score":0.007464528,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4226329559","doi":"10.3390/curroncol29050247","title":"Immune Checkpoint Inhibitors in Cancer Therapy","year":2022,"lang":"en","type":"review","venue":"Current Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1280,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false},"ca_institutions":"","funders":"","keywords":"Nivolumab; Durvalumab; Medicine; Ipilimumab; Avelumab; Pembrolizumab; Atezolizumab; Immunotherapy; CTLA-4; Immune checkpoint; Cancer; Cancer immunotherapy; Lung cancer; Oncology; Immunology; Immune system; Cancer research; Internal medicine; T cell","authors":[{"name":"Yavar Shiravand","is_ca":false},{"name":"Faezeh Khodadadi","is_ca":false},{"name":"Seyyed Mohammad Amin Kashani","is_ca":false},{"name":"Seyed Reza Hosseini‐Fard","is_ca":false},{"name":"Shadi Hosseini","is_ca":false},{"name":"Habib Sadeghirad","is_ca":false},{"name":"Rahul Ladwa","is_ca":false},{"name":"Kenneth J. O’Byrne","is_ca":false},{"name":"Arutha Kulasinghe","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2411030219700868,"gpt":0.483593654542637,"spread":0.2424906325725502,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005044064,0.0005856608,0.0008591261,0.001612025,0.0001812338,0.0007866113,0.0005885148,0.0008071055,0.00483101],"category_scores_gemma":[0.0006391259,0.000167666,0.0005441622,0.001246211,0.0002720924,0.00086061,0.0005569904,0.001954841,0.002173451],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00053248,"about_ca_system_score_gemma":0.0008293194,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005763964,"about_ca_topic_score_gemma":0.001364203,"domain_scores_codex":[0.9997826,0.0000460479,0.00002860084,0.00003016044,0.00008973716,0.00002289087],"domain_scores_gemma":[0.9997544,0.0001115347,0.00003831234,0.000007903846,0.0000682529,0.00001960457],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007402608,0.00006620946,0.0001297133,0.011872,0.00008755583,0.0001124969,0.00003398917,0.0002631831,0.001178121,0.003053652,0.03769585,0.9454331],"study_design_scores_gemma":[0.00002397445,0.00007358281,0.0004024827,0.003387753,0.0000770055,0.0006939074,0.00001976168,0.00006908933,0.000301216,0.001398767,0.9935439,0.000008584225],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000115009,0.9978361,0.00009520036,0.0004058944,0.000310917,0.000006969622,0.00002070991,0.00000848344,0.001200733],"genre_scores_gemma":[0.0009176098,0.9971921,0.0001793948,0.0003990362,0.0002717332,0.000009095226,0.00004352222,0.000001691839,0.0009857801],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00483101,"threshold_uncertainty_score":0.01616138,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2557730509","doi":"10.1016/j.jtho.2016.11.2228","title":"PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project","year":2016,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1254,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Celgene; AstraZeneca","keywords":"Immunohistochemistry; Medicine; Staining; Pathology; Companion diagnostic; Lung cancer; Cancer; Internal medicine","authors":[{"name":"Fred R. Hirsch","is_ca":false},{"name":"Abigail McElhinny","is_ca":false},{"name":"Dave Stanforth","is_ca":false},{"name":"James Ranger‐Moore","is_ca":false},{"name":"Malinka Jansson","is_ca":false},{"name":"Karina Kulangara","is_ca":false},{"name":"William D. Richardson","is_ca":false},{"name":"Penny Towne","is_ca":false},{"name":"Debra Hanks","is_ca":false},{"name":"Bharathi Vennapusa","is_ca":false},{"name":"Amita Mistry","is_ca":false},{"name":"Rasika Kalamegham","is_ca":false},{"name":"Steve Averbuch","is_ca":false},{"name":"James Novotny","is_ca":false},{"name":"Eric H. Rubin","is_ca":false},{"name":"Kenneth Emancipator","is_ca":false},{"name":"Ian McCaffery","is_ca":false},{"name":"J. Andrew Williams","is_ca":false},{"name":"Jill Walker","is_ca":false},{"name":"John Longshore","is_ca":false},{"name":"Ming‐Sound Tsao","is_ca":true},{"name":"Keith M. Kerr","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04763398284113613,"gpt":0.4766245741671307,"spread":0.4289905913259946,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02488243,0.001218006,0.001055849,0.001704836,0.001057516,0.002041173,0.00203376,0.001457009,0.002093788],"category_scores_gemma":[0.01142215,0.0006237045,0.0009817409,0.001022922,0.001124305,0.001463884,0.002981466,0.002033381,0.001148265],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002798246,"about_ca_system_score_gemma":0.002718426,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003748687,"about_ca_topic_score_gemma":0.004854537,"domain_scores_codex":[0.9865118,0.005658343,0.0004932789,0.001728331,0.004810318,0.0007978724],"domain_scores_gemma":[0.9854941,0.003357083,0.001445441,0.00194324,0.005875653,0.001884409],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.03948991,0.01524768,0.3527015,0.001060913,0.002166101,0.0004078255,0.001090259,0.009321554,0.1799585,0.002375893,0.03913482,0.357045],"study_design_scores_gemma":[0.006443292,0.0393462,0.6354449,0.0001881936,0.001642778,0.002021666,0.0008474468,0.01220754,0.220912,0.001600252,0.0791205,0.0002252219],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9093848,0.00748796,0.03394753,0.003163213,0.0004115374,0.005415896,0.02434547,0.001113227,0.01473047],"genre_scores_gemma":[0.8946285,0.00200439,0.03598412,0.002529144,0.0001548869,0.003426517,0.05337838,0.0006387761,0.007255347],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02488243,"threshold_uncertainty_score":0.1315924,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2747107882","doi":"10.1016/s0140-6736(17)31601-x","title":"Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)","year":2017,"lang":"en","type":"article","venue":"The Lancet","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1239,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Pembrolizumab; Ipilimumab; Medicine; Open label; Oncology; Open label study; Internal medicine; Clinical trial; Adverse effect; Immunotherapy; Cancer","authors":[{"name":"Jacob Schachter","is_ca":false},{"name":"Antoni Ribas","is_ca":false},{"name":"Georgina V. Long","is_ca":false},{"name":"Ana Arance","is_ca":false},{"name":"Jean‐Jacques Grob","is_ca":false},{"name":"Laurent Mortier","is_ca":false},{"name":"Adil Daud","is_ca":false},{"name":"Matteo S. Carlino","is_ca":false},{"name":"Catriona M. McNeil","is_ca":false},{"name":"Michal Lotem","is_ca":false},{"name":"James Larkin","is_ca":false},{"name":"Paul Lorigan","is_ca":false},{"name":"Bart Neyns","is_ca":false},{"name":"Christian U. Blank","is_ca":false},{"name":"Teresa M. Petrella","is_ca":true},{"name":"Omid Hamid","is_ca":false},{"name":"Scot Ebbinghaus","is_ca":false},{"name":"Nageatte Ibrahim","is_ca":false},{"name":"Caroline Robert","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.133872475199361,"gpt":0.4107823894404024,"spread":0.2769099142410414,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002923225,0.001777201,0.002674768,0.0004119086,0.0004286565,0.001349562,0.001114672,0.001779058,0.005531872],"category_scores_gemma":[0.002062581,0.0007395148,0.002860145,0.0004580567,0.001272285,0.001988207,0.0006215741,0.004953548,0.001188472],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001139574,"about_ca_system_score_gemma":0.0009691077,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001189211,"about_ca_topic_score_gemma":0.002144339,"domain_scores_codex":[0.9990759,0.0005360685,0.0000379372,0.0001378876,0.00005880785,0.0001532732],"domain_scores_gemma":[0.9987746,0.0003798402,0.0002720569,0.0001236943,0.00005010251,0.0003996904],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9765958,0.003586305,0.0004471255,0.000307265,0.0007412976,0.00002489949,0.00004640583,0.0004295447,0.003127224,0.00005982017,0.0006462756,0.01398805],"study_design_scores_gemma":[0.9162723,0.0773693,0.004092646,0.00002876768,0.0006564988,0.00004182728,0.0000326154,0.0003458104,0.0004257834,0.0001753381,0.0005396291,0.00001950123],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9893398,0.004334771,0.0006524941,0.000880776,0.000438254,0.001232495,0.001299859,0.00009417487,0.00172749],"genre_scores_gemma":[0.9886607,0.002213947,0.001514429,0.001321392,0.0004269024,0.001508607,0.001443021,0.00005319637,0.0028579],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005531872,"threshold_uncertainty_score":0.01850599,"prediction_status":"machine_predicted_unvalidated"},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"agree"},{"id":"W2095826876","doi":"10.1016/s1470-2045(09)70334-1","title":"Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study","year":2009,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1187,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Ipilimumab; Adverse effect; Clinical endpoint; Internal medicine; Melanoma; Clinical trial; Intention-to-treat analysis; Phases of clinical research; Randomized controlled trial; Gastroenterology; Surgery; Immunotherapy; Cancer","authors":[{"name":"Jedd D. Wolchok","is_ca":false},{"name":"Bart Neyns","is_ca":false},{"name":"Gerald P. Linette","is_ca":false},{"name":"Sylvie Négrier","is_ca":false},{"name":"Jose Lutzky","is_ca":false},{"name":"L. Thomas","is_ca":false},{"name":"William Waterfield","is_ca":false},{"name":"Dirk Schadendorf","is_ca":false},{"name":"Michael Smylie","is_ca":true},{"name":"Troy H. Guthrie","is_ca":false},{"name":"Jean‐Jacques Grob","is_ca":false},{"name":"Jason Chesney","is_ca":false},{"name":"Kevin M. Chin","is_ca":false},{"name":"Kun Chen","is_ca":false},{"name":"Axel Hoos","is_ca":false},{"name":"Steven O’Day","is_ca":false},{"name":"Célèste Lebbé","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03300815461349548,"gpt":0.3521155906350885,"spread":0.319107436021593,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002016576,0.002310963,0.004962175,0.0006056585,0.0005166639,0.001338097,0.0010525,0.002441659,0.0056446],"category_scores_gemma":[0.001656699,0.001240856,0.001833938,0.0007572002,0.001469574,0.001712346,0.0005779857,0.003744387,0.001444455],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007752011,"about_ca_system_score_gemma":0.001092387,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000879898,"about_ca_topic_score_gemma":0.001389656,"domain_scores_codex":[0.9992082,0.0003692177,0.00004444033,0.0001663354,0.0000569312,0.0001549947],"domain_scores_gemma":[0.9990076,0.0002482396,0.0001949669,0.000117542,0.00005947424,0.0003722003],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9740831,0.008385796,0.000772359,0.0003182663,0.0005908835,0.00003380122,0.00005913021,0.0003239255,0.005098063,0.00003818953,0.0004028585,0.009893635],"study_design_scores_gemma":[0.9069921,0.08911771,0.0026323,0.00001261603,0.0003545155,0.00002278652,0.00001640088,0.0002174821,0.0002554864,0.00005641118,0.0003060573,0.00001604886],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929788,0.002140452,0.0004805416,0.0004178372,0.0003117535,0.001905016,0.000596108,0.00007542758,0.001094116],"genre_scores_gemma":[0.9878253,0.002428534,0.001279916,0.00119523,0.0005566459,0.002728543,0.001014069,0.00003600035,0.002935729],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0056446,"threshold_uncertainty_score":0.01888305,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2947775394","doi":"10.1200/jco.19.00934","title":"Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1185,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Pembrolizumab; Overall survival; Lung cancer; Safety profile; Phases of clinical research; Survival rate; Cancer; Lung","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.04314214802703654,"gpt":0.41046673368768,"spread":0.3673245856606435,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001846958,0.0004583306,0.0006459915,0.0002604552,0.0002612264,0.0005700823,0.0003765298,0.0005607826,0.0008561437],"category_scores_gemma":[0.00118641,0.0001548807,0.001121918,0.0002659355,0.0002796113,0.0005381521,0.00029578,0.000968816,0.0002022866],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006727204,"about_ca_system_score_gemma":0.00040797,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00060029,"about_ca_topic_score_gemma":0.001252929,"domain_scores_codex":[0.99961,0.0001675237,0.00003226772,0.00007563266,0.00006549234,0.00004900581],"domain_scores_gemma":[0.9991114,0.0001658844,0.0003421814,0.00006538136,0.00006428594,0.0002508247],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1815963,0.007561227,0.6841184,0.0007813181,0.005541081,0.0004598277,0.0003411403,0.003834673,0.009730494,0.0001605794,0.006412074,0.09946293],"study_design_scores_gemma":[0.02610672,0.05308412,0.9097929,0.0001217845,0.00266117,0.0007398803,0.0001253774,0.002311574,0.001623115,0.0001451567,0.00324658,0.00004157398],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956253,0.002592132,0.0002001723,0.0001627139,0.00003254167,0.00005949845,0.0008404686,0.00001334101,0.0004737913],"genre_scores_gemma":[0.9961199,0.0007111621,0.0001275062,0.0002237841,0.00005705197,0.00005939916,0.002417395,0.000004097214,0.0002798524],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001846958,"threshold_uncertainty_score":0.009767771,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3009099064","doi":"10.1200/jco.19.03136","title":"Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non–Small-Cell Lung Cancer","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1154,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Hôpital Charles-Le Moyne","funders":"","keywords":"Pemetrexed; Medicine; Pembrolizumab; Lung cancer; Internal medicine; Hazard ratio; Placebo; Oncology; Progression-free survival; Response Evaluation Criteria in Solid Tumors; Surgery; Cancer; Progressive disease; Chemotherapy; Confidence interval; Pathology; Immunotherapy; Cisplatin","authors":[{"name":"Shirish M. Gadgeel","is_ca":false},{"name":"Delvys Rodríguez‐Abreu","is_ca":false},{"name":"Giovanna Speranza","is_ca":true},{"name":"Emilio Esteban","is_ca":false},{"name":"Enriqueta Felip","is_ca":false},{"name":"Manuel Dómine","is_ca":false},{"name":"Rina Hui","is_ca":false},{"name":"Maximilian J. Hochmair","is_ca":false},{"name":"Philip R. Clingan","is_ca":false},{"name":"Steven Powell","is_ca":false},{"name":"Susanna Y. Cheng","is_ca":true},{"name":"Helge Bischoff","is_ca":false},{"name":"Nir Peled","is_ca":false},{"name":"Francesco Grossi","is_ca":false},{"name":"Ross Jennens","is_ca":false},{"name":"Martin Reck","is_ca":false},{"name":"Edward B. Garon","is_ca":false},{"name":"Silvia Novello","is_ca":false},{"name":"Belén Rubio‐Viqueira","is_ca":false},{"name":"Michael Boyer","is_ca":false},{"name":"Takayasu Kurata","is_ca":false},{"name":"Jhanelle E. Gray","is_ca":false},{"name":"Jing Yang","is_ca":false},{"name":"Tuba Öcek Baş","is_ca":false},{"name":"M. Catherine Pietanza","is_ca":false},{"name":"Marina Chiara Garassino","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1020767828221736,"gpt":0.432874076965801,"spread":0.3307972941436275,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008134195,0.001317069,0.003929759,0.001221455,0.0003247976,0.001617596,0.001335328,0.001037736,0.0117489],"category_scores_gemma":[0.01195274,0.000723857,0.009599088,0.001685517,0.00025417,0.001295991,0.001107672,0.002274224,0.001410549],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001600803,"about_ca_system_score_gemma":0.001672184,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003240621,"about_ca_topic_score_gemma":0.007268632,"domain_scores_codex":[0.9939179,0.003290142,0.0005954698,0.000743755,0.001142197,0.000310468],"domain_scores_gemma":[0.9936399,0.002488716,0.001848956,0.0007784866,0.0009074987,0.0003365757],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7076643,0.001220295,0.01609198,0.01506324,0.1020061,0.0002587469,0.0001324178,0.003465297,0.005128681,0.000762166,0.06820032,0.08000656],"study_design_scores_gemma":[0.3827682,0.03799922,0.1781381,0.002903207,0.2766388,0.0009868219,0.0001556096,0.003382353,0.003978368,0.001327628,0.1114632,0.000258497],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5188974,0.1184525,0.008549722,0.004001757,0.003784005,0.01472206,0.2948784,0.001172984,0.03554117],"genre_scores_gemma":[0.8139512,0.01648247,0.007222956,0.006304524,0.001341772,0.006087393,0.1366208,0.0004757408,0.01151323],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0117489,"threshold_uncertainty_score":0.04301828,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2963476376","doi":"10.1016/s1470-2045(19)30388-2","title":"Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study","year":2019,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1153,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"Merck Sharp and Dohme; Les Laboratories Pierre Fabre; Merck; Meso Scale Diagnostics; Roche; British Microcirculation Society; Amgen","keywords":"Ipilimumab; Pembrolizumab; Post-hoc analysis; Open label; Medicine; Post hoc; Oncology; Internal medicine; Clinical trial; Immunotherapy; Cancer","authors":[{"name":"Caroline Robert","is_ca":false},{"name":"Antoni Ribas","is_ca":false},{"name":"Jacob Schachter","is_ca":false},{"name":"Ana Arance","is_ca":false},{"name":"Jean‐Jacques Grob","is_ca":false},{"name":"Laurent Mortier","is_ca":false},{"name":"Adil Daud","is_ca":false},{"name":"Matteo S. Carlino","is_ca":false},{"name":"Catriona M. McNeil","is_ca":false},{"name":"Michal Lotem","is_ca":false},{"name":"James Larkin","is_ca":false},{"name":"Paul Lorigan","is_ca":false},{"name":"Bart Neyns","is_ca":false},{"name":"Christian U. Blank","is_ca":false},{"name":"Teresa M. Petrella","is_ca":true},{"name":"Omid Hamid","is_ca":false},{"name":"Shu-Chih Su","is_ca":false},{"name":"Clemens Krepler","is_ca":false},{"name":"Nageatte Ibrahim","is_ca":false},{"name":"Georgina V. Long","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04835099458072202,"gpt":0.3901170919169451,"spread":0.3417660973362231,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003135255,0.001882151,0.003397858,0.0004586636,0.0004253052,0.001381757,0.001120321,0.001658187,0.005906601],"category_scores_gemma":[0.002167792,0.0007157131,0.002810247,0.0004517135,0.001278678,0.001980364,0.0005299829,0.004250428,0.001205747],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000877868,"about_ca_system_score_gemma":0.0008404616,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001196962,"about_ca_topic_score_gemma":0.002086209,"domain_scores_codex":[0.9989416,0.0006013688,0.00004960034,0.0001629677,0.00006922303,0.000175203],"domain_scores_gemma":[0.9987789,0.0004668239,0.0002785528,0.0001016975,0.00006208794,0.0003119513],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.983634,0.00272751,0.0002108085,0.0004216694,0.0007545332,0.00001867505,0.0000305821,0.0003089301,0.001573638,0.00005016556,0.0003689955,0.009900494],"study_design_scores_gemma":[0.934469,0.06183074,0.001931321,0.00003358276,0.0005731414,0.00002240121,0.00002399324,0.0003209599,0.0003059383,0.0001095999,0.0003644737,0.00001488106],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9856907,0.006419362,0.0009340206,0.0006387478,0.0006134927,0.001980607,0.00128399,0.0001411258,0.002297976],"genre_scores_gemma":[0.9859838,0.0035911,0.001650907,0.001094808,0.0005304482,0.001894575,0.001375659,0.00004622949,0.003832437],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005906601,"threshold_uncertainty_score":0.0197596,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3154805493","doi":"10.1200/jco.21.00174","title":"Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1109,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Kingston General Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Chemotherapy; Lung cancer; Hazard ratio; Oncology; Clinical endpoint; Cancer; Surgery; Randomized controlled trial; Immunotherapy; Confidence interval","authors":[{"name":"Martin Reck","is_ca":false},{"name":"Delvys Rodríguez‐Abreu","is_ca":false},{"name":"Andrew Robinson","is_ca":true},{"name":"Rina Hui","is_ca":false},{"name":"Tibor Csőszi","is_ca":false},{"name":"Andrea Fülöp","is_ca":false},{"name":"Maya Gottfried","is_ca":false},{"name":"Nir Peled","is_ca":false},{"name":"Ali Tafreshi","is_ca":false},{"name":"Sinéad Cuffe","is_ca":false},{"name":"Mary O’Brien","is_ca":false},{"name":"Suman Rao","is_ca":false},{"name":"Katsuyuki Hotta","is_ca":false},{"name":"Ticiana Leal","is_ca":false},{"name":"Jonathan W. Riess","is_ca":false},{"name":"Erin Jensen","is_ca":false},{"name":"Bin Zhao","is_ca":false},{"name":"M. Catherine Pietanza","is_ca":false},{"name":"Julie R. Brahmer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08258638092140791,"gpt":0.4375760962292222,"spread":0.3549897153078143,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001846955,0.0004969647,0.001412948,0.0003842457,0.0003533933,0.0005990709,0.0003442767,0.0007107889,0.002062466],"category_scores_gemma":[0.001936759,0.0001967322,0.002195633,0.0002326491,0.0004017418,0.0006987596,0.0003736959,0.001401366,0.000330324],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008711096,"about_ca_system_score_gemma":0.0005737061,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006595688,"about_ca_topic_score_gemma":0.00152016,"domain_scores_codex":[0.9991887,0.0003736842,0.00006626579,0.0001230705,0.0001044001,0.0001439037],"domain_scores_gemma":[0.9989121,0.0002025301,0.0003978526,0.00006813586,0.00005001945,0.0003693693],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8258236,0.01469319,0.03912129,0.0006016319,0.004227155,0.000127918,0.0001185953,0.003025883,0.004469945,0.0001863885,0.002497188,0.1051072],"study_design_scores_gemma":[0.1441044,0.596019,0.2431728,0.0001933869,0.00425897,0.000306455,0.0001206775,0.004597287,0.003074841,0.0005954417,0.003498005,0.00005882498],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936898,0.003959774,0.0002972933,0.0002737335,0.0001620917,0.0002517071,0.0004804268,0.00001740035,0.0008678136],"genre_scores_gemma":[0.9973447,0.0006520136,0.0001673869,0.0002540896,0.0001268334,0.0002435262,0.0006575474,0.000003220557,0.0005507508],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002062466,"threshold_uncertainty_score":0.009767771,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3217126890","doi":"10.1200/jco.21.02229","title":"Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1104,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Alberta Cancer Foundation","funders":"National Cancer Institute; EMD Serono; Genentech; National Institute for Health and Care Research; Regeneron Pharmaceuticals; Amgen; Celldex Therapeutics; Array BioPharma; Bristol-Myers Squibb","keywords":"Nivolumab; Ipilimumab; Melanoma; Metastatic melanoma; Clinical trial; Immunotherapy","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.07445865462662754,"gpt":0.4172274161971886,"spread":0.342768761570561,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001462872,0.000381012,0.0008786551,0.0002106879,0.0003149183,0.0004977289,0.0002934766,0.0005482822,0.001411486],"category_scores_gemma":[0.001050559,0.0001360988,0.001240785,0.0001660326,0.0003389964,0.0004732285,0.000250312,0.00129132,0.0002759342],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004839983,"about_ca_system_score_gemma":0.0004190403,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000286169,"about_ca_topic_score_gemma":0.000793509,"domain_scores_codex":[0.9996543,0.0001426728,0.00002760111,0.00005726587,0.00004760197,0.0000706005],"domain_scores_gemma":[0.9991964,0.0001530339,0.0002247227,0.00004255068,0.0000404538,0.0003428046],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6926301,0.01176916,0.1147434,0.0007893926,0.003857503,0.0004063276,0.0001950602,0.004567482,0.01463116,0.0001937631,0.003693044,0.1525237],"study_design_scores_gemma":[0.09144557,0.5618232,0.3283553,0.0002396356,0.003633594,0.000856765,0.0001438702,0.004232776,0.004309725,0.0006152577,0.004278771,0.00006559282],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948619,0.003873247,0.000144743,0.0002280234,0.00008948347,0.00006284539,0.0002203649,0.000009747335,0.0005094923],"genre_scores_gemma":[0.9978955,0.00065086,0.0001144421,0.0002508629,0.0001460591,0.00007198717,0.0004267212,0.000002150719,0.0004414348],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001462872,"threshold_uncertainty_score":0.007736504,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4285992810","doi":"10.1056/nejmoa2202809","title":"Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer","year":2022,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1096,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"Merck","keywords":"Pembrolizumab; Triple-negative breast cancer; Medicine; Chemotherapy; Breast cancer; Oncology; Internal medicine; Cancer; Immunotherapy","authors":[{"name":"Javier Cortés","is_ca":false},{"name":"Hope S. Rugo","is_ca":false},{"name":"David W. Cescon","is_ca":true},{"name":"Seock‐Ah Im","is_ca":false},{"name":"Mastura Md Yusof","is_ca":false},{"name":"Carlos Gallardo","is_ca":false},{"name":"Oleg Lipatov","is_ca":false},{"name":"Carlos H. Barrios","is_ca":false},{"name":"José Manuel Pérez-García","is_ca":false},{"name":"Hiroji Iwata","is_ca":false},{"name":"Norikazu Masuda","is_ca":false},{"name":"Marco Torregroza Otero","is_ca":false},{"name":"Erhan Gokmen","is_ca":false},{"name":"Sherene Loi","is_ca":false},{"name":"Zifang Guo","is_ca":false},{"name":"Xuan Zhou","is_ca":false},{"name":"Vassiliki Karantza","is_ca":false},{"name":"Wilbur Pan","is_ca":false},{"name":"Peter Schmid","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01369630633823049,"gpt":0.2953716532372217,"spread":0.2816753468989912,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001252286,0.0005650551,0.00156789,0.0003039281,0.0002526343,0.0003888934,0.0003653907,0.0004496436,0.002977942],"category_scores_gemma":[0.0008485641,0.0002203873,0.0007725316,0.0002428586,0.0003423441,0.0003105915,0.0002369075,0.001234822,0.0004120509],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004620672,"about_ca_system_score_gemma":0.0009067251,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004399262,"about_ca_topic_score_gemma":0.001094526,"domain_scores_codex":[0.9996449,0.0001991714,0.0000233402,0.00004474305,0.00003315218,0.00005467512],"domain_scores_gemma":[0.9995758,0.0001111455,0.0001089592,0.00003338463,0.00002323421,0.0001475575],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8913039,0.009872115,0.002695599,0.000665308,0.0008374465,0.00007359299,0.00006611755,0.001173496,0.008689898,0.0001902179,0.001066621,0.08336572],"study_design_scores_gemma":[0.7555281,0.2259119,0.01159621,0.00009554996,0.000788008,0.0001557898,0.00002235621,0.0007424082,0.002597424,0.0002548407,0.002294243,0.00001309347],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930584,0.002638051,0.0003275978,0.0003413812,0.0001545119,0.001841613,0.0002556447,0.00003312109,0.001349682],"genre_scores_gemma":[0.9925246,0.001965788,0.0009882627,0.0003832349,0.0001818278,0.002655157,0.0002993031,0.000006267493,0.0009956866],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002977942,"threshold_uncertainty_score":0.009962201,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2338494814","doi":"10.1001/jama.2016.4059","title":"Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma","year":2016,"lang":"en","type":"article","venue":"JAMA","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1062,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Ipilimumab; Pembrolizumab; Internal medicine; Melanoma; Oncology; Clinical endpoint; Clinical trial; Cohort; Immunotherapy; Cancer","authors":[{"name":"Antoni Ribas","is_ca":false},{"name":"Omid Hamid","is_ca":false},{"name":"Adil Daud","is_ca":false},{"name":"F. Stephen Hodi","is_ca":false},{"name":"Jedd D. Wolchok","is_ca":false},{"name":"Richard Kefford","is_ca":false},{"name":"Anthony M. Joshua","is_ca":true},{"name":"Amita Patnaik","is_ca":false},{"name":"Wen-Jen Hwu","is_ca":false},{"name":"Jeffrey S. Weber","is_ca":false},{"name":"Tara C. Gangadhar","is_ca":false},{"name":"Peter Hersey","is_ca":false},{"name":"Roxana Dronca","is_ca":false},{"name":"Richard W. Joseph","is_ca":false},{"name":"Hassane M. Zarour","is_ca":false},{"name":"Bartosz Chmielowski","is_ca":false},{"name":"Donald P. Lawrence","is_ca":false},{"name":"Alain P. Algazi","is_ca":false},{"name":"Naiyer A. Rizvi","is_ca":false},{"name":"Brianna Hoffner","is_ca":false},{"name":"Christine Mateus","is_ca":false},{"name":"Kevin Gergich","is_ca":false},{"name":"Jill A. Lindia","is_ca":false},{"name":"Maxine Giannotti","is_ca":false},{"name":"Xiaoyun Li","is_ca":false},{"name":"Scot Ebbinghaus","is_ca":false},{"name":"Soonmo Peter Kang","is_ca":false},{"name":"Caroline Robert","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.004169126603923786,"gpt":0.2152291648597737,"spread":0.2110600382558499,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002208993,0.0002134664,0.0004567182,0.0003634754,0.0002173056,0.0003483222,0.0002101474,0.0004956446,0.001162544],"category_scores_gemma":[0.003648264,0.0001571015,0.0005427915,0.0003713215,0.0001805628,0.0004498852,0.0002538634,0.0006653547,0.0001376814],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002617527,"about_ca_system_score_gemma":0.000242506,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003565924,"about_ca_topic_score_gemma":0.0006321559,"domain_scores_codex":[0.9990681,0.0003930362,0.00008911243,0.0002091945,0.0001560356,0.00008456206],"domain_scores_gemma":[0.996856,0.001112616,0.001346318,0.0001760785,0.0002057934,0.0003032595],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.01391197,0.0004646652,0.9701034,0.00009523981,0.0006497682,0.00004379212,0.00004911445,0.0004330596,0.001273449,0.00002927521,0.0003434005,0.01260291],"study_design_scores_gemma":[0.0007721069,0.003676406,0.9929603,0.00001755857,0.0003675439,0.0002035247,0.00003366136,0.0009573085,0.0003555872,0.00005991363,0.000587592,0.000008498872],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977544,0.001425471,0.0001233575,0.00008731796,0.00001077088,0.00002292525,0.000268685,0.000004864328,0.0003021972],"genre_scores_gemma":[0.9994299,0.0001190046,0.00005691087,0.00004400874,0.00002425792,0.00001516498,0.0002007411,0.000001233123,0.0001086343],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002208993,"threshold_uncertainty_score":0.01168239,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3047081808","doi":"10.1016/j.cell.2020.07.005","title":"Coordinated Cellular Neighborhoods Orchestrate Antitumoral Immunity at the Colorectal Cancer Invasive Front","year":2020,"lang":"en","type":"article","venue":"Cell","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1045,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Diabetes and Digestive and Kidney Diseases; National Human Genome Research Institute; Juno Therapeutics; U.S. Food and Drug Administration; Stanford Bio-X; Defence Science and Technology Laboratory; Hamilton Health Sciences Foundation; National Institutes of Health; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; University of Oxford; Parker Institute for Cancer Immunotherapy; U.S. Department of Defense; Silicon Valley Community Foundation; University of Bern; National Institute of Allergy and Infectious Diseases; Celgene; National Heart, Lung, and Blood Institute; Pfizer; Bill and Melinda Gates Foundation; National Cancer Institute; Kenneth Rainin Foundation; Cancer Research Institute; Cancer Research UK; National Science Foundation","keywords":"Biology; Colorectal cancer; Immunity; Cellular immunity; Cancer; Immunology; Cancer research; Immune system; Genetics","authors":[{"name":"Christian M. Schürch","is_ca":false},{"name":"Salil S. Bhate","is_ca":false},{"name":"Graham L. Barlow","is_ca":false},{"name":"Darci J. Phillips","is_ca":false},{"name":"Luca Noti","is_ca":false},{"name":"Inti Zlobec","is_ca":false},{"name":"Pauline Chu","is_ca":false},{"name":"Sarah Black","is_ca":false},{"name":"János Demeter","is_ca":false},{"name":"David R. McIlwain","is_ca":false},{"name":"Shigemi Kinoshita","is_ca":false},{"name":"Nikolay Samusik","is_ca":false},{"name":"Yury Goltsev","is_ca":false},{"name":"Garry P. Nolan","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02454438960022445,"gpt":0.2543532474892553,"spread":0.2298088578890309,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007719519,0.00009918885,0.0001447965,0.0002241439,0.0001543297,0.0003946793,0.00007762141,0.0001134944,0.0003222994],"category_scores_gemma":[0.0001591556,0.0001177981,0.00006426835,0.0001384938,0.0001746141,0.0001928193,0.0002790414,0.0001492092,0.0001146632],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002222978,"about_ca_system_score_gemma":0.0001914607,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005621368,"about_ca_topic_score_gemma":0.001471073,"domain_scores_codex":[0.999908,0.00001729647,0.000004189447,0.00002404988,0.00002148068,0.0000250874],"domain_scores_gemma":[0.999897,0.0000151054,0.00004130557,0.00001007656,0.00001656305,0.00001988808],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001876246,0.00001386653,0.01622879,0.00002093973,0.000006021837,0.00007631975,0.00006703308,0.0005004603,0.9784393,0.0003866052,0.00005021647,0.004022808],"study_design_scores_gemma":[0.00002726179,0.0004236832,0.37553,0.00001688879,0.00006077962,0.001144477,0.0007824114,0.01137139,0.6047493,0.0008691744,0.00500453,0.00002010559],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977447,0.0001851173,0.001544207,0.00001638863,0.000001250494,0.000005745791,0.00004436327,0.00001816756,0.000440113],"genre_scores_gemma":[0.9986802,0.00006213199,0.001028311,0.00000751305,0.000001296131,0.000006452782,0.00003943636,0.00000288121,0.0001718406],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0005621368,"threshold_uncertainty_score":0.001612902,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2125885282","doi":"10.1200/jco.2014.58.1967","title":"Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1023,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Medicine; Carboplatin; Chemotherapy; Oncology; Human Epidermal Growth Factor Receptor 2; Triple-negative breast cancer; Internal medicine; Triple negative; Breast cancer; Cancer research; Epidermal growth factor receptor; Receptor; Pathology; Cancer; Cisplatin","authors":[{"name":"Carsten Denkert","is_ca":false},{"name":"Gϋnter von Minckwitz","is_ca":false},{"name":"Jan C. Brase","is_ca":false},{"name":"Bruno V. Sinn","is_ca":false},{"name":"Stephan Gade","is_ca":false},{"name":"Ralf Kronenwett","is_ca":false},{"name":"Berit M. Pfitzner","is_ca":false},{"name":"Christoph Salat","is_ca":false},{"name":"Sherene Loi","is_ca":false},{"name":"Wolfgang Schmitt","is_ca":false},{"name":"Christian Schem","is_ca":false},{"name":"Karin Fisch","is_ca":false},{"name":"Silvia Darb‐Esfahani","is_ca":false},{"name":"Keyur Mehta","is_ca":false},{"name":"Christos Sotiriou","is_ca":false},{"name":"Stephan Wienert","is_ca":false},{"name":"Peter Klare","is_ca":false},{"name":"Fabrice André","is_ca":false},{"name":"Frederick Klauschen","is_ca":false},{"name":"Jens‐Uwe Blohmer","is_ca":false},{"name":"Kristin Krappmann","is_ca":false},{"name":"Marcus Schmidt","is_ca":false},{"name":"Hans Tesch","is_ca":false},{"name":"Sherko Kümmel","is_ca":false},{"name":"Hans‐Peter Sinn","is_ca":false},{"name":"Christian Jackisch","is_ca":true},{"name":"Manfred Dietel","is_ca":false},{"name":"Toralf Reimer","is_ca":false},{"name":"Michael Untch","is_ca":false},{"name":"Sibylle Loibl","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03804349880468626,"gpt":0.3858530708677692,"spread":0.3478095720630829,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005642175,0.0001869442,0.0002922773,0.000135617,0.00007829665,0.0002086665,0.0001345479,0.0002476552,0.0007462537],"category_scores_gemma":[0.0008024811,0.0001250049,0.0002286331,0.0001399683,0.0001746574,0.0001679547,0.000131655,0.0003564007,0.0001107052],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000313297,"about_ca_system_score_gemma":0.0002363144,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003227382,"about_ca_topic_score_gemma":0.0007626133,"domain_scores_codex":[0.9998038,0.00008273902,0.0000170336,0.00003497732,0.0000348374,0.00002657685],"domain_scores_gemma":[0.9995852,0.0001505066,0.0001060019,0.00002666037,0.00002185295,0.0001097256],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.09529666,0.002303106,0.8039027,0.0002482571,0.0004746833,0.0002460254,0.0001707295,0.001455593,0.04463955,0.00004978955,0.0005680839,0.05064472],"study_design_scores_gemma":[0.001458774,0.01524502,0.9760985,0.00002126843,0.0002355824,0.0004841918,0.00008002685,0.001363792,0.003982644,0.00004831899,0.0009747104,0.000007173392],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9995087,0.0002563876,0.00002522566,0.00001815109,0.000003666389,0.00001164549,0.00003767028,0.000002184533,0.0001362583],"genre_scores_gemma":[0.9995537,0.00007374492,0.00005208364,0.00002550925,0.000008084136,0.00002064311,0.0001311001,8.256291e-7,0.0001342435],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0007462537,"threshold_uncertainty_score":0.002983928,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2983284890","doi":"10.1200/jco.19.02107","title":"Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability–High/Mismatch Repair–Deficient Metastatic Colorectal Cancer: KEYNOTE-164","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1014,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Pembrolizumab; Cohort; Colorectal cancer; Tolerability; Oncology; Microsatellite instability; Irinotecan; Progression-free survival; Clinical endpoint; Oxaliplatin; Response Evaluation Criteria in Solid Tumors; Cancer; Surgery; Phases of clinical research; Adverse effect; Chemotherapy; Clinical trial; Immunotherapy","authors":[{"name":"Dung T. Le","is_ca":false},{"name":"Tae Won Kim","is_ca":false},{"name":"Eric Van Cutsem","is_ca":false},{"name":"Ravit Geva","is_ca":false},{"name":"Dirk Jäger","is_ca":false},{"name":"Hiroki Hara","is_ca":false},{"name":"Matthew Burge","is_ca":false},{"name":"Bert H. O’Neil","is_ca":false},{"name":"Petr Kavan","is_ca":true},{"name":"Takayuki Yoshino","is_ca":false},{"name":"Rosine Guimbaud","is_ca":false},{"name":"Hiroya Taniguchi","is_ca":false},{"name":"Elena Élez","is_ca":false},{"name":"Salah‐Eddin Al‐Batran","is_ca":false},{"name":"Patrick M. Boland","is_ca":false},{"name":"Todd S. Crocenzi","is_ca":false},{"name":"Chloé E. Atreya","is_ca":false},{"name":"Yi Cui","is_ca":false},{"name":"Tong Dai","is_ca":false},{"name":"Patricia Marinello","is_ca":false},{"name":"Luis A. Díaz","is_ca":false},{"name":"Thierry André","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1353295079761783,"gpt":0.4909100416450203,"spread":0.355580533668842,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001721942,0.001265942,0.001209894,0.0003295442,0.0003947412,0.0007040731,0.0007303903,0.0008758027,0.003805772],"category_scores_gemma":[0.0007773715,0.000513775,0.0006159067,0.0003425473,0.000604491,0.0007691372,0.0003459552,0.002154334,0.0008366777],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008700805,"about_ca_system_score_gemma":0.001720747,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007652747,"about_ca_topic_score_gemma":0.00246127,"domain_scores_codex":[0.9996578,0.0001663437,0.00002009843,0.00005833765,0.00004439436,0.00005300025],"domain_scores_gemma":[0.9993281,0.00007218629,0.000189984,0.00005556722,0.0000549024,0.000299219],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6206783,0.1596224,0.01578213,0.001429441,0.001285406,0.0004088887,0.0003678854,0.002559752,0.1016043,0.0003984135,0.006285326,0.08957777],"study_design_scores_gemma":[0.5682686,0.4065216,0.01452614,0.00005431264,0.0002817709,0.0003708089,0.00007481747,0.001060247,0.005681141,0.0001614421,0.002972342,0.00002677658],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924729,0.001046726,0.0006546027,0.0001947649,0.00006680626,0.003531298,0.0009472016,0.00006845982,0.00101725],"genre_scores_gemma":[0.9873806,0.001245069,0.00262605,0.0006539822,0.0001441664,0.003812736,0.002057067,0.00002213898,0.002058163],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003805772,"threshold_uncertainty_score":0.01273161,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1996863944","doi":"10.1038/ncomms6241","title":"Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression","year":2014,"lang":"en","type":"article","venue":"Nature Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":995,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; National Natural Science Foundation of China; National Institutes of Health; Cancer Prevention and Research Institute of Texas","keywords":"Immunosuppression; Metastasis; Epithelial–mesenchymal transition; Cancer research; microRNA; CD8; Cell; Biology; PD-L1; Cancer; Immunology; Medicine; Immunotherapy; Immune system; Internal medicine; Gene","authors":[{"name":"Limo Chen","is_ca":false},{"name":"Don L. Gibbons","is_ca":false},{"name":"Sangeeta Goswami","is_ca":false},{"name":"María Angélica Cortez","is_ca":false},{"name":"Young‐Ho Ahn","is_ca":false},{"name":"Lauren A. Byers","is_ca":false},{"name":"Xuejun Zhang","is_ca":false},{"name":"Xiaohui Yi","is_ca":false},{"name":"David Dwyer","is_ca":false},{"name":"Wei Lin","is_ca":false},{"name":"Lixia Diao","is_ca":false},{"name":"Jing Wang","is_ca":false},{"name":"Jonathon D. Roybal","is_ca":false},{"name":"Mayuri Patel","is_ca":false},{"name":"Christin Ungewiss","is_ca":false},{"name":"David H. Peng","is_ca":false},{"name":"Scott Antonia","is_ca":false},{"name":"Melanie Mediavilla-Varela","is_ca":false},{"name":"Gordon Robertson","is_ca":true},{"name":"Steven J.M. Jones","is_ca":true},{"name":"Milind Suraokar","is_ca":false},{"name":"James W. Welsh","is_ca":false},{"name":"Baruch Erez","is_ca":false},{"name":"Ignacio I. Wistuba","is_ca":false},{"name":"Lieping Chen","is_ca":false},{"name":"Di Peng","is_ca":false},{"name":"Shanshan Wang","is_ca":false},{"name":"Stephen E. Ullrich","is_ca":false},{"name":"John V. Heymach","is_ca":false},{"name":"Jonathan M. Kurie","is_ca":false},{"name":"F. Xiao‐Feng Qin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.009676409783834309,"gpt":0.2715045231762708,"spread":0.2618281133924365,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001531543,0.0002419125,0.0002626777,0.000388499,0.0002570106,0.0007144854,0.000183728,0.0002247999,0.001453253],"category_scores_gemma":[0.0001858118,0.0002338378,0.0002454074,0.0001592792,0.0003022982,0.0003450058,0.0004863868,0.0006788394,0.0004463443],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004822265,"about_ca_system_score_gemma":0.0003461213,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005143608,"about_ca_topic_score_gemma":0.0008623879,"domain_scores_codex":[0.9997613,0.00002846945,0.00001300992,0.00005310567,0.0000563737,0.00008777792],"domain_scores_gemma":[0.9999018,0.00000940741,0.00003803416,0.000006775677,0.00001423484,0.0000298636],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000286182,0.0000348327,0.001666486,0.00004842198,0.000009993146,0.0001563846,0.00003264238,0.0001123014,0.9934012,0.0008814296,0.0002203215,0.003149764],"study_design_scores_gemma":[0.0001035937,0.0003642137,0.05044808,0.00001882077,0.00004937671,0.0009521627,0.000236675,0.007084019,0.9287742,0.0008716088,0.01107265,0.00002442614],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9835504,0.003844328,0.006839267,0.0003349369,0.00007299644,0.00004265591,0.0003658237,0.0002901573,0.004659327],"genre_scores_gemma":[0.9959298,0.000485117,0.001033109,0.00006710221,0.000009877491,0.00003027061,0.0002252688,0.00002668933,0.002192853],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001453253,"threshold_uncertainty_score":0.004861593,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2904444972","doi":"10.1200/jco.2018.78.2276","title":"T-Cell–Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":992,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Oncology; Clinical endpoint; Cancer; Response Evaluation Criteria in Solid Tumors; Lung cancer; KRAS; Clinical trial; Phases of clinical research; Immunotherapy; Colorectal cancer","authors":[{"name":"Patrick A. Ott","is_ca":false},{"name":"Yung‐Jue Bang","is_ca":false},{"name":"Sarina A. Piha‐Paul","is_ca":false},{"name":"Albiruni R. Abdul Razak","is_ca":true},{"name":"Jaafar Bennouna","is_ca":false},{"name":"Jean‐Charles Soria","is_ca":false},{"name":"Hope S. Rugo","is_ca":false},{"name":"Roger B. Cohen","is_ca":false},{"name":"Bert H. O’Neil","is_ca":false},{"name":"Janice M. Mehnert","is_ca":false},{"name":"Juanita Lopez","is_ca":false},{"name":"Toshihiko Doi","is_ca":false},{"name":"Emilie M.J. van Brummelen","is_ca":false},{"name":"Răzvan Cristescu","is_ca":false},{"name":"Ping Yang","is_ca":false},{"name":"Kenneth Emancipator","is_ca":false},{"name":"Karen Stein","is_ca":false},{"name":"Mark Ayers","is_ca":false},{"name":"Andrew K. Joe","is_ca":false},{"name":"Jared Lunceford","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0401353546324534,"gpt":0.3951411541431732,"spread":0.3550057995107199,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002899431,0.0005764595,0.0007286699,0.0004366727,0.0002713946,0.0007400503,0.0004577143,0.0004320864,0.001311856],"category_scores_gemma":[0.002323773,0.0002932235,0.0007146837,0.0005153617,0.0004364856,0.000613757,0.0006185006,0.0008795476,0.0002724506],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005986908,"about_ca_system_score_gemma":0.0006314291,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003225736,"about_ca_topic_score_gemma":0.0005926365,"domain_scores_codex":[0.999087,0.0003143636,0.00009754535,0.0002534379,0.0001693056,0.00007826591],"domain_scores_gemma":[0.9981765,0.0003507059,0.0008819916,0.000143246,0.0001349366,0.0003126778],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1256521,0.003614902,0.8068542,0.000320344,0.002049848,0.0001017217,0.0002021641,0.001778014,0.0206212,0.0001058761,0.001023169,0.03767634],"study_design_scores_gemma":[0.01617576,0.04931613,0.9166377,0.00006788305,0.002053474,0.0008513772,0.0001539946,0.004822649,0.006958862,0.0002603678,0.002657873,0.00004394096],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986488,0.0004629308,0.0001041553,0.00003780443,0.000004755003,0.00008121085,0.0003529451,0.000006373568,0.0003009323],"genre_scores_gemma":[0.9988062,0.0001274319,0.0002043897,0.00005641946,0.00001180631,0.00006372552,0.0006180947,0.000002647263,0.0001091841],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002899431,"threshold_uncertainty_score":0.01533377,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2154610258","doi":"10.4049/jimmunol.170.3.1257","title":"Blockade of Programmed Death-1 Ligands on Dendritic Cells Enhances T Cell Activation and Cytokine Production","year":2003,"lang":"en","type":"article","venue":"The Journal of Immunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":962,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's Health Research Institute","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute","keywords":"Cytokine; T cell; Cell biology; Chemistry; CD28; PD-L1; Biology; Molecular biology; Immunology; Immune system; Immunotherapy","authors":[{"name":"Julia A. Brown","is_ca":false},{"name":"David M. Dorfman","is_ca":false},{"name":"Fengrong Ma","is_ca":false},{"name":"Elizabeth Sullivan","is_ca":false},{"name":"Oliver Munoz","is_ca":false},{"name":"Clive R. Wood","is_ca":true},{"name":"Edward Greenfield","is_ca":false},{"name":"Gordon J. Freeman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01358979827491239,"gpt":0.2543486964007138,"spread":0.2407588981258014,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001944242,0.000463853,0.0004066326,0.0001643984,0.00009823335,0.0003435349,0.0001545488,0.000225302,0.0007678886],"category_scores_gemma":[0.0002050384,0.0001158469,0.0002133324,0.0001548127,0.0001683202,0.000162722,0.0001848432,0.0007490441,0.0002814947],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002194372,"about_ca_system_score_gemma":0.000249879,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001666933,"about_ca_topic_score_gemma":0.0002657459,"domain_scores_codex":[0.9996922,0.00005652905,0.00002131565,0.00003332203,0.0000588375,0.0001378214],"domain_scores_gemma":[0.9998048,0.00006353084,0.00002820931,0.00002088781,0.00001742298,0.00006512531],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005499467,0.0001962792,0.0002055167,0.00005880369,0.000007863593,0.00004903884,0.00001665196,0.0002644354,0.9946409,0.00008072973,0.00006418412,0.003865604],"study_design_scores_gemma":[0.0001010111,0.002011883,0.001610967,0.000007482659,0.00002322898,0.0001353424,0.00001079467,0.001438203,0.9928417,0.0000419526,0.00177356,0.000003946139],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956625,0.001185749,0.001153105,0.00006772134,0.00004421589,0.00003228536,0.0001029541,0.00005255015,0.001698996],"genre_scores_gemma":[0.996549,0.0007629064,0.001219654,0.00007824895,0.00003738445,0.00003721132,0.000186107,0.00001163954,0.001117938],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0007678886,"threshold_uncertainty_score":0.002568841,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2560704457","doi":"10.1016/s1470-2045(16)30624-6","title":"Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study","year":2016,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":961,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; Ottawa Hospital; Princess Margaret Cancer Centre; Juravinski Cancer Centre; University of Toronto; McMaster University","funders":"National Cancer Institute; University of Oxford","keywords":"Nivolumab; Ipilimumab; Medicine; Tolerability; Internal medicine; Lung cancer; Oncology; Cancer; Surgery; Adverse effect; Immunotherapy","authors":[{"name":"Matthew D. Hellmann","is_ca":false},{"name":"Naiyer A. Rizvi","is_ca":false},{"name":"Jonathan W. Goldman","is_ca":false},{"name":"Scott Gettinger","is_ca":false},{"name":"Hossein Borghaei","is_ca":false},{"name":"Julie R. Brahmer","is_ca":false},{"name":"Neal Ready","is_ca":false},{"name":"David E. Gerber","is_ca":false},{"name":"Laura Q.M. Chow","is_ca":false},{"name":"Rosalyn A. Juergens","is_ca":true},{"name":"Frances A. Shepherd","is_ca":true},{"name":"Scott A. Laurie","is_ca":true},{"name":"William J. Geese","is_ca":false},{"name":"Shruti Agrawal","is_ca":false},{"name":"Tina C. Young","is_ca":false},{"name":"Xuemei Li","is_ca":false},{"name":"Scott Antonia","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08906368332496893,"gpt":0.4350249849294019,"spread":0.345961301604433,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003734068,0.001981157,0.002731945,0.0004913421,0.0005290761,0.001676163,0.001058406,0.001672437,0.002763827],"category_scores_gemma":[0.002551839,0.0009486742,0.002949941,0.0005631314,0.001110814,0.001782045,0.0004508407,0.002918649,0.0008367244],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001219717,"about_ca_system_score_gemma":0.001175039,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001634911,"about_ca_topic_score_gemma":0.003121032,"domain_scores_codex":[0.9987181,0.0007443323,0.00005133091,0.000244088,0.0001049757,0.0001371151],"domain_scores_gemma":[0.9984348,0.0005133307,0.0003188884,0.0002228401,0.000103837,0.0004062736],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9481148,0.01428009,0.00541743,0.0005415175,0.003687005,0.00006380218,0.00009134047,0.0009180941,0.003694024,0.00006050598,0.001008125,0.02212324],"study_design_scores_gemma":[0.7826654,0.186597,0.02123707,0.00005828284,0.005404721,0.000148791,0.0001095884,0.001369185,0.001143418,0.0001666496,0.001032748,0.0000672618],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947753,0.002128334,0.0003072507,0.0002028134,0.0001569618,0.0006818435,0.0009991815,0.00006421207,0.0006840279],"genre_scores_gemma":[0.993687,0.001407067,0.0008652543,0.0005887907,0.0002065228,0.0005838005,0.001584747,0.00003320241,0.001043635],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003734068,"threshold_uncertainty_score":0.01974785,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3016280944","doi":"10.3747/co.27.5223","title":"A Review of Cancer Immunotherapy: From the Past, to the Present, to the Future","year":2020,"lang":"en","type":"review","venue":"Current Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":953,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Immunotherapy; Cancer immunotherapy; Cancer; Radiation therapy; Standard of care; Personalized medicine; Oncology; Intensive care medicine; Internal medicine; Bioinformatics","authors":[{"name":"Khashayar Esfahani","is_ca":true},{"name":"Liya Roudaia","is_ca":true},{"name":"Najwa Buhlaiga","is_ca":true},{"name":"Sonia V. del Rincón","is_ca":true},{"name":"Neha Papneja","is_ca":true},{"name":"Wilson H. Miller","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1219660166743838,"gpt":0.4657855366725746,"spread":0.3438195199981908,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006304549,0.0007202431,0.0009060343,0.002590069,0.0003627986,0.001488136,0.0006324915,0.001146941,0.00520212],"category_scores_gemma":[0.001459054,0.000242904,0.0004585992,0.003063546,0.0004662895,0.002096951,0.0006557707,0.002013554,0.002610225],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007189445,"about_ca_system_score_gemma":0.001632367,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008688172,"about_ca_topic_score_gemma":0.001823258,"domain_scores_codex":[0.9997324,0.00006341511,0.0000384933,0.00004497259,0.00009643753,0.00002422637],"domain_scores_gemma":[0.9993291,0.0003582043,0.0000782374,0.00001518784,0.0001519422,0.00006737877],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007420481,0.00006986158,0.000209835,0.02301567,0.00007602781,0.0001866183,0.0001344064,0.0002579807,0.001398362,0.005610843,0.1023822,0.8665839],"study_design_scores_gemma":[0.000004959262,0.0000446163,0.0003442031,0.004423892,0.00004798779,0.0006984643,0.00005793325,0.00003641115,0.000143477,0.001845679,0.9923419,0.00001047779],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005997893,0.9976762,0.0001016281,0.0007432998,0.0005442956,0.000002988859,0.00001639798,0.000006828413,0.0008483938],"genre_scores_gemma":[0.0003624617,0.9978047,0.0001618781,0.0005526398,0.000527834,0.00000410383,0.00002500916,0.000001773396,0.0005595591],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00520212,"threshold_uncertainty_score":0.01740283,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2743419024","doi":"10.1093/annonc/mdx286","title":"Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review","year":2017,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":921,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Internal medicine; Adverse effect; Rash; Nivolumab; Immunology; Pneumonitis; Cancer; Immunotherapy; Lung","authors":[{"name":"Leila Khoja","is_ca":false},{"name":"Daphne Day","is_ca":true},{"name":"Tom Wei‐Wu Chen","is_ca":false},{"name":"L.L. Siu","is_ca":true},{"name":"Aaron R. Hansen","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1276813283897447,"gpt":0.4176656272783881,"spread":0.2899842988886434,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003138244,0.001084978,0.006437965,0.002668765,0.0002787364,0.001454087,0.001265898,0.001180397,0.003420855],"category_scores_gemma":[0.01243155,0.0005960595,0.01109247,0.00424799,0.000444674,0.001283378,0.001139324,0.001158496,0.0002129773],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001067998,"about_ca_system_score_gemma":0.002439928,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004399534,"about_ca_topic_score_gemma":0.01712955,"domain_scores_codex":[0.9975648,0.0005544933,0.001080054,0.0003578871,0.0003348648,0.0001079439],"domain_scores_gemma":[0.99242,0.00504078,0.00193476,0.0001182067,0.0003934556,0.00009273565],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.001394791,0.0000327403,0.005557773,0.8324426,0.09826475,0.0001413698,0.0001418458,0.0002680533,0.0003225234,0.00017753,0.0021484,0.05910755],"study_design_scores_gemma":[0.001356789,0.0006150299,0.02810837,0.2559629,0.6863678,0.0007973961,0.0002967127,0.0001818904,0.0003154619,0.000577707,0.02530676,0.0001131801],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001391973,0.9979823,0.00007694074,0.00006289975,0.00004160228,0.0000506269,0.0002842243,0.000003721177,0.0001056382],"genre_scores_gemma":[0.03444863,0.9637331,0.0005075644,0.0006341165,0.00008696095,0.0001121923,0.0003432559,0.000005277888,0.0001288941],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006437965,"threshold_uncertainty_score":0.01659679,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}